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ABSTRACT
Caliciviruses cause important diseases of humans and animals; noroviruses are 
responsible for outbreaks of gastroenteritis in man, and feline calicivirus (FCV) 
causes an upper respiratory tract infection in cats. Since 2003, murine norovirus 
(MNV) has been used as a model for norovirus infection since human noroviruses 
are unable to replicate in tissue culture. Caliciviruses have a positive-sense RNA 
genome of about 7 to 8  kb, with a viral protein, VPg, covalently linked to the 5' end 
of the RNA. The VPg acts as a novel proteinaceous ‘cap substitute’ and interacts 
with the cap-binding protein, eIF4E. To further analyse the requirement of translation 
initiation factors for calicivirus translation, I have investigated the effect of FCV and 
MNV infection on eIF4E and its regulator, 4E-BP1. I found that FCV and MNV 
infection have different effects on the phosphorylation status of eIF4E and its 
regulator, 4E-BP1. For both viruses, eIF4E is phosphorylated and 4E-BP1 is 
dephosphorylated during the course of infection. This would be expected to inhibit 
host cell protein synthesis. This has led me to investigate the signalling pathways 
involved in mediating these effects. Using specific inhibitors I have shown that 
phosphorylation of eIF4E during FCV and MNV infection occurs through activation 
of the MEK/MAPK pathway, while 4E-BP1 phosphorylation occurs through 
PI3K/mT0R activation. When I use specific inhibitors are used to block either the 
p38 or MEK pathways, replication of MNV is inhibited. However, FCV replication 
is only inhibited by MEK inhibition. In addition, eIF4E phosphorylation is prevented 
by blocking p38 but not MEK. This suggests that the changes in eIF4E 
phosphorylation may not affect the interaction between eIF4E and VPg or be 
important for FCV and MNV replication. These changes may therefore only be 
involved in host-cell shut-off. In contrast, inhibition of the mTOR pathway
significantly inhibited both FCV and MNV replication, suggesting that the 
phosphorylation status of 4E-BP1 during infection is important for virus replication. 
I hypothesise that the change in phosphorylation status of 4E-BP1 may lead to the 
inhibition of eIF4F complex formation and therefore calicivirus translation; this may 
affect the switch from translation to replication of the viral RNA. I propose that the 
mTOR pathway could be a target for antiviral therapy. I have also further 
investigated the exact requirements for components of the eIF4F cap-binding 
complex for translation initiation on FCV and MNV mRNA. I have shown that a 
small-molecule inhibitor of the eIF4E-eIF4G interaction has a greater inhibitory 
effect on FCV than MNV replication, demonstrating a requirement by FCV for 
eIF4E and an intact eIF4G for viral RNA translation.
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Introduction
Viruses are non-living entities that require living organisms including animals and plants 
in order to be able to replicate. Unlike living organisms, viruses lack the necessary 
machinery to synthesise their own proteins. A viral particle is made up of the genetic 
materials, ribonucleic acid (RNA) or deoxyribonucleic acid (DNA), and capsid proteins. 
Viruses are classified according to whether the genome comprises single- or double­
stranded RNA, or DNA. Viruses with single-stranded RNA genomes are further 
classified by whether their RNA is positive or negative sense. Within cells, the viral 
mRNA must be translated using the host-cell translation machinery to produce the viral 
proteins which can then be used to make copies of the viral genetic material. Positive- 
sense, single-stranded viral RNA can undergo both translation (fi*om a 5’ to 3' direction) 
and replication (from a 3' to 5' direction) on the same strand, suggesting a strong 
regulation of these two steps. The viral proteins produced by the host cell translation 
machinery enable virus infectivity and replication.
1.1 The Caliciviruses
Caliciviruses are positive-sense single-stranded RNA viruses, with a genomic RNA of 
approximately 7.5 kb in size and a virion diameter of approximately 35-40 nm. The name 
of the virus originates from the Latin word calyx which means chalice or cup, and which 
refers to the cup-shaped depressions on the surface of the viral capsid (Green et al, 2000) 
(Figure 1.1). The Caliciviridae family is divided into five genera; Vesivirus, Lagovirus,
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Figure 1.1 Electron microscope images of caliciviruses
Electron microscope images of members of Caliciviridae (bar = 50 nm). Adapted from 
United States Environmental Protection Agency.
('http://www.epa.gov/microbes/calici.html and 
http://www.epa.gov/microbes/norwalk.htmn
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Norovirus (Norwalk virus), Sapporo-like virus (reviewed in Green et al, 2000), 
Nebovirus (reviewed in Oliver er al, 2006) (Table 1.1). They all share the same common 
features, namely the possession of a genome-linked viral protein (VPg) covalently linked 
at the 5' end via a conserved tyrosine-24 (Mitra et al, 2004) and a poly(A) tail at the 3' 
end of their RNA genome (reviewed in Goodfellow, 2011).
1.1.1 Human Norovirus (HuNoV)
Norovirus and Sapporo-like viruses are two genera of the Caliciviridae that cause 
infection in humans, resulting in gastroenteritis (Thiel & Konig, 1999; Moreno-Espinosa 
et al, 2004; reviewed in Thornton et. al, 2004). Norovirus infection is responsible for 
about 50% of epidemic viral gastroenteritis cases worldwide (Widdowson et al, 2005) 
and has been shown to result from food contamination or from airborne virus perpetuated 
via the fecal-oral route. The infection causes nausea, vomiting, diarrhoea, abdominal 
cramps and fever (reviewed in Glass er al, 2009). One reason for the prevalence of 
noroviruses is their ability to infect healthy adults even at low doses and norovirus 
gastroenteritis outbreaks occur in closed systems such as restaurants (Oyofo et al, 1999; 
Marks et al, 2000; Hirakata et al, 2005; Baker et al, 2011), schools (Marks et al, 2003; 
Kim et al, 2005), cruise ships (Oyofo et al, 1999; Widdowson et al, 2004; Cramer et 
al, 2006), in nursing homes and hospitals (Khanna et al, 2003; Marks et al, 2003; 
Schmid et al, 2005) and even in a concert hall (Evans et al, 2002).
For 30 years, the study of human noroviruses (Norwalk virus) has been faced with the 
problems associated with the inability to grow these viruses in cells or organ culture and
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Taxonomy of the Caliciviruses
Genus Viruses
Norovirus
Snow mountain norovirus, Murine norovirus, 
Lordsdale norovirus, Hawaii norovirus, 
Southampton norovirus. Desert shield virus
Lagovirus Rabbit hemorrhagic disease virus, European brown hare syndrome virus
Sapporo virus London virus, Manchester virus, Sapporo virus, Houston virus, Parkville virus
Vesivirus Feline calicivirus, vesicular exanthema of sWine virus, San Miguel sea lion virus
Nebovirus Newbury 1 virus
Table 1.1 Members of the Caliciviridae family
The classification is approved by The International Committee on Taxonomy of Viruses 
(ICTV) 2011 (reviewed in Green et. al., 2000; Oliver et al, 2006; Farkas et al, 2008).
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there is no small-animal model for human norovirus infection (reviewed in Hutson et. al, 
2004; Lay et al, 2010). The importance of this disease in humans has prompted research 
leading to the discovery of new antibodies produced against human norovirus in infected 
swine (Bank-wolf et al, 2010). Animal models such as chimpanzees (Bok et al, 2011), 
gnotobiotic (Gn) pigs (Cheetham et al, 2006) and gnotobiotic (Gn) calves (Souza et al, 
2008) have been used in the study of pathogenesis and infection of human norovirus. 
Although human noroviruses cannot be cultured in tissue culture, both murine norovirus 
and feline calicivirus have been used by scientists as a model system for the study of 
norovirus infection (further discussed in Section 1.1.3).
1.1.2 Feline Calicivirus (FCV)
Feline calicivirus (FCV) is a member of the Vesivirus genus and causes respiratory 
disease in cats (Wilson et al, 2004; Coyne et al, 2006). The symptoms of infection 
include ocular and nasal discharge, pneumonia, arthritis and acute febrile lameness (Khan 
& Gillespie, 1971; Dawson et al, 1994; Cai et al., 2002). Recently, an FCV-associated 
virulent systemic disease (VSD) has been described with symptoms such as pyrexia, 
cutaneous oedema, anorexia, jaundice and ulcerative dermatitis and which leads to 50% 
mortality (Coyne et al, 2006). To date, although there are many vaccines available on the 
market effective in reducing or preventing disease caused by FCV, these vaccines do not 
fully protect against the new virulent FCV strains (reviewed in Radford et al, 2007). 
FCV was used as one of the original model systems for norovirus but in 2003 the 
discovery of murine norovirus-1 (MNV) that was able to grow in tissue culture and for
Chapter 1____________________    Introduction
which there is also a small animal model, has provided a more appropriate model for 
norovirus.
1.1.3 Murine Norovirus-1 (MNV)
Karst et al. (2003) were the first group to discover a previously unknown mouse virus 
with a genome arrangement and sequence that is almost similar to that of other calicivirus 
genomes. The polyadenylated virus genome had three open reading frames (ORFl, 0RF2 
and 0RF3) like that normally found in calicivirus genomes. By phylogenetic analysis, the 
unknown virus was classified and named as murine norovirus 1 (MNV) and categorized 
as a Norovirus member. Inflammation in lung (pneumonia), liver (hepatitis) and 
abdominal cavity are normally associated with MNV infection (Ward et al., 2006). MNV 
is able to replicate in cultured cells such as macrophages and dendritic cells and even in 
mice, thus provides a good model for study of norovirus infection. (Wobus et al., 2004; 
reviewed in Wobus et al, 2006). Cox et al. (2009) have demonstrated that RAW 264.7 
and BV2 cells provide the best systems for the study of murine norovirus replication and 
infection, and that they have similar susceptibility to MNV infection.
1.2 FCV and MNV Genomes
The RNA genomes of Caliciviridae (Burrough & Brown, 1978) have a 15-kDa viral 
protein covalently linked through a conserved tyrosine-24, to the 5' end. FCV and MNV 
genomes were originally thought to comprise three open reading frames (ORFl, ORF2
Chapter 1__________________________________________   Introduction
and 0RF3). However, recently, a novel open reading frame, 0RF4, was identified that 
lies within the 0RF2 region of the MNV genome and which expresses the newly 
identified protein VFl (McFadden et ah, 2011).
FCV nonstmctural proteins: p5.6, p32, p39 (NTPase), p30, pl3 (VPg) and p76 (Pro-Pol) 
(Sosnovtsev et al., 2002; Bailey et al., 2010) are encoded in ORFl. Similarly to FCV, the 
MNV nonstmctural proteins: p38.3 (N-terminal protein), p39.6 (NTPase), p i8.6, pl4.3 
(VPg), p i9.2 (Protease), and p57.5 (Polymerase) are also encoded by ORFl (Sosnovtsev 
et al, 2006). Polyproteins expressed by ORFl during FCV and MNV infection are 
cleaved by their own viral protease to produce mature proteins via autocatalytic 
processing. This protein has been designated as the 3C-like protease due to its similarities 
with the picomavims 3C-protease.
New viral strands of FCV and MNV RNA produced by the RNA transcription process 
will be packaged in viral capsids formed from structural proteins (encoded by 0RF2 and 
0RF3) before being released from host cells (Jiang et al., 1992; Carter et al, 1992; 
reviewed in Wobus et al., 2006).
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1.2.1 Nonstructural proteins
a) Feline caiicivirus (FCV)
FCV RNA encodes a number of proteins that are necessary for the FCV RNA 
transcription process (Figure 1.2). Translation of this RNA generates a polyprotein that is 
cleaved by the FCV 3C-like protease to form the mature proteins. This polyprotein, 
including the proteinase itself, is encoded by ORFl. The 3C-like (3CL) protease is a 
chymotrypsin-like cysteine proteinase that cleaves the polyprotein to produce the viral 
non-structural proteins: p5.6, p32, p39 (NTPase), p30 (3A), pl3 (VPg) and p76 (Pro-Pol) 
(Sosnovtsev et al., 2002; Bailey et al., 2010). The FCV protease is also involved in 
cleavage of the capsid protein precursor, encoded by 0RF2, to generate the mature major 
capsid protein (VPl) (Carter et al, 1992; Sosnovstev et al., 1998).
A replicative polymerase enzyme namely the proteinase-polymerase (Pro-Pol) precursor 
protein is an FCV RNA-dependent RNA polymerase (RdRp) active form. Reduced 
polymerase activity was observed when 163 amino acids at the amino terminus of ProPol 
were deleted (Wei et al, 2001). p32 protein has been shown to interact with NTPase, 3A 
and ProPol. Interaction of VPg and VPl with ProPol was also observed in FCV 
infection. In addition, the ProPol also weakly interacts with VP2 (Kaiser et al, 2006).
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Figure 1.2 FCV genomic and subgenomic RNAs
The diagram represents genomic and subgenomic RNAs of FCV. Nonstructural protein 
are encoded in ORFl, while structural proteins are encoded in ORF2 and ORF3 (Based 
on Sosnovtsev et aL, 2000; Sosnovtsev et ai, 2002; Bailey et ai, 2010).
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Production of these nonstructural proteins is important for formation of the replication 
complex that will be used for the RNA transcription process (Sosnovtsev et al., 2002; 
Chaudhry et al, 2006):
b) Murine norovirus-1 (MNV)
Like FCV RNA, the MNV genome also encodes a number of proteins (Figure 1.3) that 
are important for its RNA transcription process. MNV also requires 3C-like (3CL) 
proteinase (Pro) for polyprotein cleavage. This MNV protease mediates the cleavage at 
different sites to generate mature nonstructural proteins; p38.3 (Nterm), p39.6 (NTPase), 
p i8.6 (3A), pl4.3 (VPg), pl9.2 (Pro) and p57.5 (Pol) proteins (Sosnovtsev et aL, 2006). 
The N-term protein interacts with endoplasmic reticulum (ER) while the 3A-like protein 
interacts with endosomes. Furthermore, the viral protease was found to localize within 
the cytoplasm and mitochondria (Hyde & MacKenzie, 2010). As mentioned above, MNV 
RNA polyprotein cleavage generates polymerase protein (Pol). Two forms of the 
polymerase generated from the cleavage are identified as Pro-Pol and mature polymerase. 
Both forms of the polymerase were identified as RNA-dependent RNA polymerase 
(RdRp) active forms (Belliot et al, 2005). The MNV RdRp has been shown to have 
similar physiological characteristics to three human norovirus RdRp (Gll.b, GII.4 and 
GII.7) and also to human sappovirus RdRp (GI and GIT), making it more relevant to the 
study of human norovirus (Bull et al, 20\l).
Localization of the polymerase (Pol) in the cytoplasm and nucleus was also observed 
(Hyde & MacKenzie, 2010). Recently, a novel virulence factor, VFl, encoded by ORF4
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Figure 1.3 HuNoV and MNV genomic and subgenomic RNAs
The diagram represents genomic and subgenomic RNAs o f a) human norovirus (HuNoV) 
and B) murine norovirus (MNV). Nonstructural proteins are encoded by O R Fl, while 
structural proteins are encoded by ORF2 and 0R F3. A novel virulence factor, VFl is 
encoded by 0R F4 which overlaps with ORF2 (Based on Jiang et aL, 1992; Glass et al., 
2000; Sosnovstev et al., 2006; reviewed in Karst, 2010; Me Fadden et a/., 2011)
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has been reported to be synthesized during MNV infection. VFl is required to delay cell 
apoptosis but was found to have no effect on viral RNA translation and replication 
(McFadden et al., 2011).
1.2.2 Structural Proteins
a) FCV and MNV structural proteins
Feline caiicivirus (FCV) capsid proteins are known as the major capsid protein (VPl) and 
the minor capsid protein (VP2) and are translated from the second and third open reading 
frames (0RF2 and 0RF3) of the subgenomic RNA (Carter et al, 1992; Sosnovtsev et al., 
2000). The viral capsid proteins are not only required for virus particle assembly and 
packaging but are also necessary for binding of the viral particle to the host cell receptor 
(Tan et al., 2003; Asanaka et al, 2005). The FCV capsid precursor synthesized from 
0RF2 is cleaved by the virus-encoded proteinase encoded in ORFl to form the mature 
capsid protein (Sosnovstev et al, 1998). The FCV minor capsid protein (VP2) is required 
for viral replication as mutation within the 0RF3 region is lethal for the virus. This has 
been shown by deleting either the entire 0RF3 region or specific sequences at the 5'- and 
3'-ends of 0RF3 (Sosnovtsev et al, 2005). VP2 also increases major capsid protein 
(VPl) stability and expression levels, thus protecting VPl from being degraded 
(Bertolotti-Ciarlet et al., 2003). FCV VPg has also been shown to interact with the major 
capsid protein, VPl and the viral RNA polymerase Pro/Pol (Kaiser et al, 2006), 
suggesting that VPg could be involved in the caiicivirus encapsidation process. Similarly
13
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to FCV, MNV VPl and VP2 proteins are also expressed from ORFl and 0RF2 of the 
viral subgenomic RNA. The VP2 was identified as a cleavage product from VPl (Jiang et 
ah, 1992; Glass et al, 2000). These viral proteins are important for MNV RNA 
packaging and host-cell binding as demonstrated by replacing lycine with glutamine at 
amino acid residue 296 in VPl which resulted in a decrease of MNV inactivity (Bailey 
et al, 2008; Taube et al., 2010; Strong et al., 2012).
The caiicivirus capsid proteins are translated via a novel termination-dependent 
reinitiation mechanism (Meyer, 2003; McCormick et al., 2008).
b) Termination-reinitiation process
Caiicivirus subgenomic RNAs are synthesised from 0RF2 and 0RF3 of caiicivirus 
genomes through the transcription process (Herbert et al, 1996). The approximately 75- 
kDa major capsid protein (VPl) and 10-kDa minor capsid protein (VP2) are encoded 
within the ORFl and 0RF2 regions of the subgenomic RNA. The VPl produced 
immediately after translation has a leader peptide attached at the N-terminus which is 
removed by the viral protease to generate a mature capsid protein (Carter et al, 1992; 
Jiang et al, 1992; Sosnovstev et al, 1998). The FCV and MNV VP2 are proteins 
synthesised through a novel mechanism known as termination-dependent reinitiation. 
This mechanism involves a short 0RF2 upstream sequence that is crucial for the 
reinitiation of the translation process for VP2 synthesis (Meyers, 2003; McCormick et al,
2008). This sequence is known as the termination upstream ribosomal binding site 
(TURBS) region. The TURBS contains two sequence motifs necessary for ORF2
14
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translation which are located between the end of ORFl and the start of 0RF2 of the FCV 
subgenomic RNA and have been reported to be important for the synthesis of this small 
capsid protein (VP2). Deletion of nucleotides within this region reduced the expression 
level of VP2. The crucial regions in the TURBS sequence as reported by Luttermann & 
Meyers (2007) for FCV are located between nucleotides -70 to -55 and nucleotides -30 to 
-7 upstream of start/stop sites. For MNV, expression requires the nucleotide sequence ~ 
40-43 in the stop/start motif (Napthine et. al., 2009). The first one is UGGGA which is a 
conserved motif in caiicivirus genomes and it presents at the same position upstream of 
the 3' end of mRNA of caliciviruses (Figure 1.4). This motif was identified to be 
complimentary to a sequence in 18S rRNA (Luttermann & Meyers, 2007). The second 
TURBS motif is not a conserved motif and is responsible for determining the position of 
the ribosome near the 3' terminus of ORF to allow translation initiation (Lutterman & 
Meyers, 2007; Meyers, 2003 and 2007).
1.3 FCV and MNV replication cycles
1.3.1 Virus attachment and entry
Junction adhesion molecule 1 (JAM-1) has been identified as a receptor for the binding of 
FCV F4 ahead of the virus entering the cell. Binding of the JAM-1 receptor to the outer 
face of the P2 domain of VPl induces conformational changes to the capsid protein 
which are important for viral capsid uncoating and genome delivery into the host cells 
(Ossiboff et al., 2010; Bhella et al, 2008). In Crandell Rees feline kidney (CRFK) cells.
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18S rRNA 3‘ gccgcccaguacccuuauugcggcg 5'
FCV 5‘ gccuccuacaugggaauucaauugg 3'
MNV 5‘ uuggccucugugggaaguuuggcaa 3'
Figure 1.4 A conserved motif in TURBS that is complementary with a sequence 
in 18S rRNA
Complementarity between UGGGA sequence in TURBS (red) with a sequence in 18S 
rRNA (blue) allows termination reinitiation translation for synthesizing minor capsid 
protein (VP2) (Luttermann & Meyers, 2007; Napthine et. al., 2009).
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this virus entry can be prevented with anti-feline JAM-1 antibodies that reduce the 
attachment of the virus and therefore reduce not only cytopathic effect (CPE) of the cells 
but virus replication as well (Makino et al., 2006). Mutation of Ig-like extracellular 
domain, D1 of the JAM-1 receptor also inhibited binding to the FCV capsid (Ossiboff & 
Parker, 2007). Furthermore, removal of a 2,6-linked sialic acid by treating the cells with 
Vibrio cholerae neuraminidase reduced the FCV binding to the cells and resulted in a 
reduced infection demonstrating a requirement by FCV for a 2,6-linked sialic acid (Stuart 
and Brown, 2007). As soon as the FCV binds to the receptor, it penetrates the cell 
through clathrin-mediated endocytosis as demonstrated by Stuart and Brown (2006).
Like FCV, MNV also requires sialic acid as a binding receptor on its macrophage host 
cells, RAW 264.7. This requirement was verified by using V. cholerae neuraminidase to 
remove sialic acid fi*om the cell surface. The treatment caused a reduction in virus titre, 
confirming that entry of MNV into the cells is neuraminidase sensitive (Taube et al., 
2009). A glycan-binding site identified in MNV capsid is also important for the viral 
attachment to N-linked glycan receptors on the cell surface (Taube et al, 2012). In 
addition, MNV infection on RAW 264.7 and dendritic cells is pH-independent. A 
decrease in endosome pH normally leads to uncoating of the viral capsid but surprisingly, 
MNV replication was found not to be affected by endosomal pH changes (Perry et al., 
2009). Unlike FCV, MNV is unable to enter cells via the clathrin- and caveolae- 
dependent pathways but instead uses a dynamin- and cholesterol-dependent pathway to 
enter cells (Gerondopoulos et a/., 2010; Perry & Wobus, 2010). As soon as viruses bind 
to the cell surface, they undergo an uncoating stage in order to release their RNA into the
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cytoplasm. Once inside the host cells, the viruses start to manipulate and hijack the host 
cell translation machinery for the translation of their own proteins (see Section 1.6.2).
1.3.2 RNA transcription
During viral replication, the p32 protein of FCV has been reported to interact with other 
nonstructural proteins; p39; p30; and p76. The FCV p76 protease/RNA polymerase 
(ProPol) protein strongly interacts with VPg and the major capsid protein, VPl, and 
weakly interacts with the minor capsid protein, VP2 (Kaiser et al, 2006). Synthesis of 
new viral RNA during viral infection occurs by colocalization of p32, p39 and p30 
proteins on cytoplasmic membrane vesicles for formation of the viral RNA replication 
complex (Bailey et al, 2010). This replication complex binds to the 3’ end of the viral 
RNA and moves to the 5' end to transcribe the RNA.
From analysis of the active replication complex isolated from FCV-infected cells VPl 
has been found to be the most abundant of the viral proteins (Green et al., 2002) and the 
presence of VPg in the replication complex is necessary for the inactivity of wild-type 
FCV RNA (Sosnovtsev & Green, 1995).
As mentioned in Section 1.2.1, caiicivirus nonstructural proteins are required in the 
generation of subgenomic RNA from the genomic RNA. Our understanding of how the 
viral subgenomic RNA is formed is still unclear. When Green et al. (2002) purified FCV 
replication complexes, they detected two negative sense RNAs with one of them being 
the full-length genomic RNA (~8kb) while the other was the subgenomic RNA (~2.5kb).
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Asanaka et al. (2005) conducted a study in cells with inactivated Norwalk Virus (NV) 
RNA Pol. The viral RNAs were produced from cDNA by using recombinant modified 
vaccinia virus that expressed the bacteriophage T7 RNA polymerase (MVA/T7). The 
ODD amino acid sequence in the RNA Pol active site was deleted to impair the function 
of the polymerase. No NV subgenomic RNA was detected, supporting the view that 
synthesis of the subgenomic RNA occurs through transcription of the viral genomic 
RNA.
The genomic viral RNAs produced from the transcription process are incorporated into a 
viral particle before release of particles from the host cells by a process of cell lysis. 
(Jiang et al., 1992; Anasaka et al., 2005).
1.4 FCV and MNV infection causes apoptosis of cells
Apoptosis or programmed cell death is a cellular process of self-destruction in response 
to external factors such as UV radiation and virus infection. During apoptosis, the cell 
morphology changes, and caspases are produced such as caspase-2, -3, -6, -7, -8 and -9 
that have been shown to participate in apoptosis. Among these caspases, caspase-3 has 
been identified as the most important cause of cell death (reviewed in Porter & Janicke, 
1999). In cells infected with FCV, Al-Molawi et al. (2003) have reported that caspase-2, 
-3 and -7 were activated during the viral infection. Furthermore, caspase-2 was found to 
cause cleavage of the FCV capsid protein. In other studies, caspase-3 and initiation 
caspases caspase-8 and -9 have been shown to be activated during FCV infection
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(Sosnovstev et al., 2003), and the activation of caspase-9 resulting from the release of 
cytochrome c from mitochondria has been shown to trigger activation of caspase-3 
(Natoni et al., 2006). MNV infection has also been reported to induce apoptosis in cells. 
Similar to other virus infections, MNV also triggers the activation of caspases, such as 
caspase-9 and caspase-3, during infection, resulting in cell death. Apoptosis of the cell 
occurs due to inhibition of the apoptotic inhibitor, survivin, as demonstrated by Bok et al. 
(2009) who found that the level of survivin was significantly reduced in RAW 264.7 cells 
infected with MNV. However, McFadden et al. (2011) have shown that cell apoptosis 
could be delayed by a viral protein known as virulence factor-1 (VFl) encoded by open 
reading frame 4 (0RF4). In addition, as was the case for FCV infection, activation of 
caspases was shown to be mediated by cytochrome c release from mitochondria.
1.5 Eukaryotic cap-dependent translation
Translation is a process carried out in the eukaryotic cell by which messenger RNA 
(mRNA) is decoded to produce proteins from amino acids, with the assistance of cellular 
translation factors (initiation, elongation and release factors) and ribosomes. Messenger 
RNA (mRNA) is transcribed from a DNA template in the nucleus and undergoes post- 
transcriptional modification including capping, polyadenylation and splicing. Then, 
mature mRNA is exported from the nucleus to the cytoplasm where translation takes 
place (reviewed in Izaurralde & Zamore, 2009).
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Translation is tightly controlled to regulate gene expression and plays critical roles in cell 
growth, proliferation and development. There are two forms of translational regulation: 
first, a specific mRNA or subset of mRNAs can be regulated and this regulation can be 
either quantitative or qualitative; and second, regulation can be global and modulate the 
rates and patterns of protein synthesis, thus contributing to cell growth and metabolism 
regulation (Nicola & Marvin, 1998).
The process of translation is divided into three main stages: initiation, elongation and 
termination. The rate of translation can be controlled at any of these three stages but 
initiation has been found to be the most important focus for the regulation and control of 
RNA translation (reviewed in Kong & Lasko, 2012).
1.5.1 Translation initiation
Translation initiation in the eukaryotic cell is highly regulated. It is a multi-step process 
involving a large number of protein factors and multiprotein complexes, as well as 
ribosomes. In eukaryotes, this process leads to the assembly of an 80S ribosome on an 
mRNA. At least twelve eukaryotic initiation factors (elFs) and the binding and hydrolysis 
of ATP and GTP are involved in this process. When fully assembled, the 80S initiation 
complex will enter the elongation phase of translation (Pestova et al, 2007).
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1.5.2 Cap-dependent initiation of translation
Most mRNAs in eukaryotic cells are translated by a cap-dependent mechanism. The cap 
consists of a 7-methyl guanosine (m^Gppp) structure attached to the 5' end of the mRNA 
via a triphosphate phosphodiester link (reviewed in Banerjee, 1980). On cellular mRNAs, 
the presence of the m^G cap at the 5' end of the RNA is important for translation 
initiation because it recruits the initiation factors via its interaction with the cap-binding 
protein, eIF4E (Goodfellow & Roberts, 2008). This cap binding protein recruits the 
scaffold protein eIF4G and the RNA helicase eIF4A to form the eIF4F complex which is 
critical to initiate protein synthesis.
1.5.3 Eukaryotic initiation factor 4F complex (eIF4F)
Translation initiation involves recruitment of the ribosome to the messenger RNA 
(mRNA), through interaction between the ribosome and the efF4F complex. The 
translation initiation complex, eIF4F is made up of the cap-binding protein eIF4E, the 
RNA helicase eIF4A and the scaffold protein eIF4G (Figure 1.5).
a) Eukaryotic Initiation factor 4G (eIF4G)
Eukaryotic initiation factor 4G (eIF4G) is a 220-kDa protein and is the largest protein in 
the eIF4F complex. eIF4G acts as a scaffold protein and possesses binding domains for 
the cap-binding protein (eIF4E) and the RNA helicase (eIF4A) as well as binding sites 
for some other factors (reviewed in Lopez-Lastra et al, 2005). It associates with efF4E
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Figure 1.5 Translation initiation complex (eIF4F)
This complex is made up of the associated cap-binding protein (eIF4E), scaffold protein 
(eIF4G) and RNA helicase protein (eIF4A).
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and eIF4A to form the translation initiation complex (eIF4F). Assembly of these 
translation initiation factors to form the eIF4F complex is important as the interaction 
between these proteins enhances their activation which in turn enhances RNA translation. 
eIF4G plays an important role in translation initiation by recruiting the ribosomal subunit 
to the 5' end of mRNA through its interactions with eIF3, which binds directly to both 
efF4G and the ribosome, and eIF4E, which binds to the cap (Figure 1.6) (reviewed in 
Hinnebusch, 2006).
There are two forms of eIF4G: elFGI and elFGII, which share approximately 46% 
identity. Both isoforms possess almost the same biochemical properties (Prevot et al, 
2003). eIF4G possesses three domains: the N-terminal part; a middle core domain and a 
carboxyl-terminal fragment. The eIF4E-binding domain is located near the N-terminus of 
eIF4G while the two eIF4A binding domains are located in the middle (residues 478- 
883) and C-terminal (residues 884-1404) regions of eIF4G (Figure 1.6). Mutation in the 
middle binding region of eIF4G abolished binding of eIF4A and initiation factor 3 (eIF3) 
(Lnataka & Sonenberg, 1997). The eIF3 protein is essential for ribosomal recruitment to 
the 5' end of mRNA (reviewed in Lopez-Lastra et al, 2005). Mnkl is another eIF4G- 
associated protein, and is a protein kinase that binds to the C-terminal region of eIF4G. It 
is involved in the phosphorylation of eIF4E after the cap-binding protein interacts with 
eIF4G (Pyronnet et al, 1999). Poly(A)-binding protein (PABP) also interacts with eLF4G 
to circularize mRNA by connecting the cap structure at the 5' end to poly(A) tail at the 3' 
end of mRNA (Haghighat & Sonenberg, 1997).
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Mnkl
elF4G
Figure 1.6 Interaction of eIF4G with translation initiation factors.
The cap-binding protein, eIF4E, binds to eIF4G in the N-terminal region. eIF4E is 
phosphorylated by Mnkl that is located within the C-terminal region of eIF4G. The RNA 
helicase, eIF4A has two binding sites: one at the middle and the other near the C-terminal 
of eIF4G. These proteins together form the eIF4F complex that is required for translation 
initiation (Taken from Belsham & Sonenberg, 2000).
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b) Eukaryotic initiation factor 4E (elF4E)
Eukaryotic initiation factor 4E (eIF4E) is a 2 5-kDa protein that is also important for 
controlling and modulating cell growth. Overexpression of eIF4E has been reported in a 
number of cases of malignancy and tumor such as breast cancer (Li et ah, 1997; Norton 
et al., 2004). In the cytoplasm, eIF4E forms part of the eIF4F complex and associates 
with the m^G cap structure of the mRNA to initiate protein synthesis (Figure 1.7).
Interaction between eIF4E and eIF4G in the eIF4F complex occurs at a conserved 
domain (Tyr-X-X-X-X-Leu-O, where 0  is any hydrophobic amino acid) (Hershey & 
Merrick, 2000) (See Figure 1.8). Mutation on either the N-terminus of eIF4E or the 
eIF4E binding domain (Y(X)4LO) on eIF4G prevents the interaction of eIF4E and eIF4G 
and thus inhibits protein synthesis (Gross et al, 2003). Although eIF4E itself has affinity 
for the cap structure in the absence of any factors, when bound to eIF4G as part of the 
eIF4F complex, eIF4E shows a greatly increased affinity for the cap (Haghighat & 
Sonenberg, 1997). Binding of the eIF4E protein to the cap-structure activates the mRNA 
and promotes the recruitment of the ribosome to the mRNA.
c) Eukaryotic Initiation Factor 4A (eIF4A)
eIF4A is a 46-kDa protein that binds to the middle and C-terminal fragments of efF4G 
and acts as a RNA helicase to unwind secondary structure in the untranslated region 
(UTR) at the 5' end of the mRNA. The N-terminus of the middle region of efF4G is 
positioned to face the C-terminus of eIF4A and this is important for the interaction of
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eIF4A
AAAAAA
Figure 1.7 Binding of eIF4F complex to cap structure of mRNA
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elF4G
peptide
W102
m7GDP
W73
Figure 1.8 Structure of eIF4E associated with the cap structure (m7Gppp) and 
eIF4G
The cap is bound to eIF4E (blue) at W56 and W102, while eIF4G (red) binds to elF4E at 
W73 (Taken from Goodfellow & Roberts, 2008).
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these two proteins (Obérer et al, 2005). eIF4A is a type of protein known as a DEAD 
(D; Aspartic acid; E: Glutamic acid; A: Alanine; D: Aspartic acid) box protein . These 
proteins possess ATPase and RNA helicase activity which is important for unwinding 
secondary structure in the 5' untranslated region (UTR) of mRNA to facilitate ribosome 
scanning (Linder et. al, 1989; Grifo et. al, 1984) to the initiation codon by the small 
ribosomal subunit (Hershey & Merrick, 2000). It is present in three isoforms: eIF4AI, 
eIF4AII and eIF4AIII with 90-95% similarity of amino acid sequence and biochemical 
properties. Conserved sequence motifs: Q, la, Ib, II, III, IV, V and VI on eIF4A are 
important for ATPase activity, RNA binding and unwinding as well as helicase activity 
(Figure 1.9) (Bleichert & Baserga, 2007). Mutations of these motifs reduced eIF4A 
catalytic activity and impaired RNA binding on the protein (Pause & Sonenberg, 1992).
Binding of eIF4G to two eIF4A domains at the C-terminus of the helicase protein was 
found to enhance the eIF4A activation whereas eIF4A alone did not exibit RNA helicase 
activity (Dominguez et al, 1999). The eIF4A helicase activity is also stimulated by 
eIF4B and eIF4H. These two proteins determine the initial rate of RNA secondary 
structure unwinding and the eIF4H—eIF4A complex has been shown to bind strongly 
and repetitively while unwinding a secondary structure loop (Rogers Jr et al, 2001; Sun 
et al, 2012).
Chaudhry et al. (2006) demonstrated the importance of eEF4A in cells infected with FCV 
and MNV for the replication of both viruses using hippuristanol, an inhibitor that binds to 
the C-terminal domain of eIF4A and inhibits its RNA binding function. The inhibitor 
reduced both FCV and MNV replication which indicates that eIF4A is an important
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Figure 1.9 Conserved sequence motifs on eIF4A (Taken from Bleichert & 
Baserga, 2007).
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factor for translation initiation on caiicivirus RNA. Conserved sequence motifs on eIF4A 
are important for NTP binding, ATPase activity, substrate RNA binding and helicase 
activity (see Figure 1.9).
1.5.4 Poly(A)-binding protein (PABP)
Poly(A)-binding protein (PABP) facilitates the interaction between the 5' cap structure of 
mRNA and the 3' polyadenylated tail of the mRNA through binding to eIF4G which has 
the effect of circularizing the mRNA (Figure 1.10) (Haghihat & Sonenberg, 1997; Gross 
et ah, 2003). This is important to enhance recruitment of ribosomes to mRNA and enable 
ribosome recycling (Wells et al, 1998; Mazumder et al, 2003) An interaction between 
eIF4G and PABP through PABP-binding protein (PAIPl) occurs at the N-terminus of 
eIF4G (Craig et al, 1998).
In yeast, eIF4G binds to PABP at RNA recognition motifs: RRMl and RRM2 (Kessler & 
Sachs, 1998). Meanwhile, in mammalian cells, eFF4G was observed to bind to PABP at 
RRMl, RRM2, RRM3 and RRM4 at the N-terminus of PABP. However, similar to yeast, 
RRMl and RRM2 were identified as the main regions for eIF4G binding (See Figure 
1.11) (Imataka et al, 1998).
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elF4A
elF4G
AAAA
mRNA
Figure 1.10 5'—3' end cross-talk on the mRNA.
The 5' end of mRNA is linked to the 3' end through eIF4E and PABP and their interaction 
with the scaffold protein (elF4G). elF4E binds the cap at the 5'end and PABP binds the 
poly(A)-tail at the 3' end of the mRNA as shown in the figure (Prevot et al, 2003)
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elF4G-
Human PABP '  RRM1 RRM2 pRRM3 [#RM4
Figure 1.11 Binding domain of eIF4G on yeast and human PABP.
In yeast, eIF4G binds PABP at RNA recognition motif 1 (RRMl) and RRM2. 
Meanwhile, human eIF4G can bind to RRMl, RRM2, RRM3 and RRM4 but RRMl and 
RRM2 have been recognised as the main regions for binding of eIF4G (Based on Imataka 
et al, 1998; Kessler & Sachs, 1998).
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1.5.5 Cellular translation overview
A model of the process of cap-dependent translation initiation is shown in Figure 1.12. 
Under normal physiological conditions, the two subunits of the ribosome (40S and 60S) 
tend to remain associated as an inactive ribosome (80S). Binding of eIF5, eIF3, elFl and 
elFlA to the 40S subunit results in dissociation of the 40S and 60S subunits. eIF3 has 
been reported to play many roles including its contribution to the dissociation of the 40S 
from the 60S ribosomal subunit; stimulation of the assembly of the 43 S pre-initiation 
complex and binding to mRNA; and facilitation of mRNA scanning (reviewed in 
Merrick, 2003; Hinnebusch, 2006). Meanwhile, elFl and elFlA were found to enhance 
binding of the ternary complex (eIF2-GTP-Met-tRNA) to the 40S subunit to form the 
43S pre-initiation complex (PIC). The ternary complex comprises eIF2-GTP binary 
complex bound to initiator methionyl-tRNAi (Met-tRNAi) at an A-U base pair (Pestova 
et. aL, 2007). elFI and elFIA regulate conformational changes of the 40S ribosomal 
subunit. These two proteins are responsible for ensuring the fidelity of start codon 
selection by opening a closed structure on the 40S subunit to allow mRNA binding, 
increasing ternary complex binding and sustaining the 40S subunit open conformation 
until the ribosomal subunit reaches the initiation codon (Passmore et. aL, 2007). 
However, only elFlA was found to stabilize the interaction between the ternary complex 
and 40S subunit (Passmore et. aL, 2007).
Recruitment of the 43 S preinitiation complex to the cap-structure of the mRNA and 
association with the poly(A) tail via poly(A)-binding protein (PABP) results in formation
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of the 43 S complex (reviewed in Asano and Sachs, 2007). The 438 complex scans the 
mRNA in the 5' to the 3' direction until it recognises the first initiation codon (AUG). 
This process is aided by eIF4A, playing its role in unwinding the secondary structure of 
the UTR which is required for 438 scanning (reviewed in Svitkin et al, 2001), while eEFl 
is responsible for recognizing the first AUG start codon and also maintaining scanning by 
connecting the hydrolysis of eIF2-GTP with codon—anticodon base pairing (reviewed in 
Nanda et al, 2009).
Once the ribosomal subunit is stably bound to the initiation codon and the AUG codon is 
base-paired with the anti-codon in Met-tRNAi within the ribosomal P-site, a 488 
initiation complex is formed. 8ubsequently initiation factors bound within the 488 
complex are released from the ribosomal subunit. This release of factors is followed by 
dissociation of elFl and elF3 from the 488 complex. Release of eIF2-GTP as eIF2-DTP 
is mediated by elFSB. Finally, 608 ribosomal subunit is recruited to the 408 subunit by 
eIF5B to form the 808 ribosome which now proceeds to the elongation step by translating 
the mRNA sequence to produce protein. The nucleotide recycling protein eIF2B 
catalyzes the exchange of eIF2-bound GDP to GTP, thus ensuring it will be recycled for 
another round of translation (reviewed in Merrick, 2003) (8ee Figure 1.12).
35
Chapter 1 Introduction
eJF2 temaf^ 
complex formahon
elFI elFlA
elF3
43S premitiaoon 
complex formation
E P A
0  mRNA activation Attachment of 
43S complex
.GTP 48S com plex |
Hydnoiysis of 
«IF 2 bound GTP 
Stixanit joining, 
factor drsplacement 
» id  release of elFSB
80S initiation complex
Figure 1.12 Model of the mechanism of cap-dependent initiation.
The 43S pre-initiation complex binds to the 5'-proximal region of the mRNA. 
Recruitment of the 60S subunit to the mRNA is mediated by elF5 (Holeik & Pestova, 
2007).
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1.6 Viral cap-independent translation initiation
Eukaryotic cells usually use a cap-dependent mechanism of translation initiation in which 
translation depends on the binding of the eIF4F complex to the cap structure at the 5' end 
of the mRNA. However, a number of other mechanisms have been discovered that 
mediate protein synthesis, particularly during viral infections. Viruses lack the necessary 
proteins to translate their own RNA and must subvert the cellular translation machinery 
to their own ends. Therefore, most viruses have evolved novel ways to initiate translation.
The translation initiation stage of protein synthesis has been identified as the main target 
for viruses to manipulate the host cell translation machinery such that their own genes are 
preferentially expressed. Viruses use a variety of strategies to ensure that they can 
multiply in host cells. A novel strategy employed by members of the Picornaviridae uses 
an internal ribosome entry site (1RES) element (detailed in Section 1.6.1). This 
translation initiation mechanism does not require binding of the efF4F complex to a cap- 
strueture. Instead, the canonical initiation factors enable direct binding of ribosomal 
subunits to the 1RES element. Host-cell protein synthesis is often inhibited at the same 
time, promoting viral RNA translation (Belsham & Jackson, 2000).
In calicivirus infection, viral RNA translation occurs via a VPg-dependent translation 
mechanism (detailed in Section 1.6.2). In the case of FCV, the translation initiation 
complex (eIF4F) is recruited to the 5' end of the viral RNA through an interaction 
between the cap-binding protein (eIF4E) and VPg whereas in MNV infection, an intact
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eIF4F complex is not required and translation may be initiated via a direct interaction 
between eIF4G and VPg (reviewed in Goodfellow, 2011).
1.6.1 Internal ribosome entry site (IRES)-dependent translation
1RES elements were initially found in virus mRNAs but a subset of cellular RNAs that 
contain 1RES elements has also been reported. However, translation of cellular mRNAs 
using this element only occur under certain conditions such as cellular stress and in 
disease such as cancer (reviewed in Fitzgerald & Semler, 2009). RNA translation via an 
IRES-dependent mechanism was first discovered in cells infected with the picomavirus 
members; encephalomyocarditis virus (EMCV) and poliovirus (PV) where the non­
coding region (NCR) of their RNAs was found to contain a sequence that mediated 
binding of the ribosome directly to that region (Jang et aL, 1988; Pelletier & Sonenberg,
198&X
The 7-8 kb of the positive-sense single stranded picomaviral RNA consists of one open 
reading frame which is translated to produce a polyprotein that is cleaved by the viral 
proteases to produce the viral proteins (reviewed in Fitzgerald & Semler, 2009). In order 
to shut off host-eell cap-dependent translation and take over the cell’s translation 
apparatus for their IRES-dependent protein synthesis, Pieomaviruses such as poliovirus 
(Krausslich et al, 1987), rhinovirus and coxsakievirus (Lamphear et aL, 1993) have been 
shown to use a viral protease to cleave the scaffold protein, eIF4G to break apart the 
eFF4F complex so as to inhibit cap-dependent translation initiation. Furthermore,
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poliovirus (Joachims et aL, 1999; Bonderoff et aL, 2008), hepatitis A virus (HAV) 
(Zhang et aL, 2007) and eoxsakievirus (Kerekatte et aL, 1999) proteases have also been 
reported to cleave poly(A)-binding protein to inhibit reinitiation of eap-dependent 
translation which will make more ribosomes available to the viral RNAs.
However, not all pieomaviruses inhibit the host-cell cap-dependent process in the same 
way. Hepatitis A infection has been shown to require intact eIF4G (Borman & Kean,
1997) while EMCV infection has been found to prevent formation of the eIF4F complex 
by dephosphorylating 4E-BP1 (Gingras et aL, 1996). Additional cellular proteins known 
as IRES-trans-acting factors (ITAFs) have been reported to be required in IRES- 
dependent translation. ITAFs have been identified in many studies and include 
polypyrimidine tract binding protein (PTB) (Mitchell et aL, 2005), poly(rC) binding 
protein 2 (PCBP2) (Blyn et aL, 1997) , hnRNP C1/C2 (Holeik et al, 2003), hnRNP D 
(Pack et aL, 2008), upstream of n-ras (unr) (Schepens et aL, 2007), 45-kDa IRES- 
interacting translation factor (ITAF45) (Pilipenko et al, 2000), and lupus antigen (La) 
(Meerovitch et aL, 1993). Different factors are used by different IRESes and are thought 
to promote IRES-mediated translation by changing the conformation of the 1RES into the 
structure required for binding of ribosomes to the viral RNA (reviewed in Miragall et al,
2009). FMDV 1RES is shown as example in Figure 1.13. The long and highly-structured 
RNA of 1RES elements that recruit ribosomes to the viral RNA vary among 
Picornaviridae members. Studies have identified four different groups of 1RES structure 
each with their own ITAF requirements (Table 1.2).
39
Chapter 1 Introduction
Figure 1.13 Internal ribosome entry site (IRES)-dependent translation initiation.
In this alternative translation mechanism, the small ribosomal subunit directly binds to 
the 1RES structure. The FMDV 1RES requires binding of canonical initiation factors 
(e.g.: eIF2, eIF3, elF4B and eIF4G) and ITAF (e.g.: PTB).
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Table 1.2 Requirements of ITAFs and canonical initiation factors for 
different IRESes
1RES
Group
Group II
Group III
Group IV
Virus
Group I Poliovirus (PV)
Coxsackievirus B3 
(CVB3)
Foot and Mouth 
disease virus 
(FMDV)
Encephalomyocardi 
tis virus (EMCV)
Hepatitis A virus 
(HAV)
Porcine
Teschovirus (PTV- 
1)
ITAF requirement
PTB (Hunt & Jackson,
199^
PCBP2 (Blyn el a/., 1997)
La (Meerovitch et al, 1993; 
Shiroki et. al, 1999)
unr (Boussadia et al, 2003)
PCBP2 (Zell éta l, 2008), 
La (Ray & Das, 2002)
PTB (Niepmann et aL,
1997)
ITAF45 (Pilipenko et aL, 
2000)
La
PTB (Kaminski et al, 1995)
PTB, PCBP2 (Graffera/.
1998)
• Does not require PTB, not 
affected by eo-expression of 
enterovirus 2A protease 
(Kaku et aL, 2002)
Additional
requirements
canonical initiation 
factors eIF4A and 
Met-tRNAi 
(Svitkin et al, 
2001; Bordeleau et 
al, 2006)
Do not need eIF4E
canonical factors 
eIF3, eIF4A, 
eIF4B, efF4G and 
Met-tRNAi (Lopez 
de Quinto et aL, 
2000; Svitkin et aL, 
2001; Bordeleau et 
a/., 2006)
intaet of eIF4F 
complex (Borman 
& Kean, 1997; All 
et aL, 2001) ~
Direct interaction 
between 1RES with 
eFF2, eIF3 and 40S 
ribosomal subunits 
(; Sizova et al,
1998)
Resistant to 
inhibition of eIF4A 
(Chard et aL, 2006)
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In a cap-independent translation mechanism such as IRES-dependent translation the 
interaction between eIF4A and eIF4G is important for enhancing RNA translation. In 
encephalomyocarditis (EMCV) and poliovirus infection, eIF4G was observed to bind to 
the 1RES in the viral RNA and binding of eIF4A to efF4G was found to enhance eIF4F 
complex recruitment to the 1RES. Interaction between eIF4G and the 1RES occurs on a 
Yn-Xm-AUG motif in domain V of the viral RNA 1RES (Breyne et aL, 2009). In 
addition, eIF4A—eIF4G complex also regulates conformational changes of the 1RES 
which are important for identification of the initiation codon and ribosomal binding. 
Unlike cap-dependent translation, binding of the 48S ribosomal complex to the middle- 
third region of eIF4G does not require eIF3 protein. This demonstrates that this 40S 
ribosomal complex may bind directly to eFF4G to initiate IRES-dependent translation. 
(Lomakin et al, 2000; Kolupaeva et al, 2003; Breyne et al, 2009).
As the ribosomal subunit binds directly to the 1RES, binding of the eIF4F complex to the 
5' end of the viral RNA is not required to initiate protein synthesis. In cells infected with 
pieomaviruses, the infection induces cleavage of eIF4G and inhibits host cell protein 
synthesis. Cleavage at the N-terminus (contains eIF4E binding domain) of eEF4G had no 
effect on viral replication as an intact eIF4G is not necessary for translation of the viral 
RNA. The eIF4A helicase and the eentral domains of eFF4G (resulting from eFF4G 
cleavage) are sufficient for picomavirus RNA translation (Belsham & Sonenberg, 2000). 
In vitro, foot-and-mouth disease (FMDV) virus leader proteinase (Lpro) or the human 
rhinovims 2Apro have been shown to cleave efF4G. Glaser and Skem (2000) have 
demonstrated that Lpro and 2Apro are capable of cleaving almost 50% of eIF4G in 4 and
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15 min, respectively, showing that these picomavirus proteases cleave eIF4G very 
efficiently.
1.6.2 Calicivirus VPg - dependent translation
The majority of eukaryotic and viral mRNAs contain a cap structure at the 5’ end of their 
mRNA. However, picomavimses (Ambros & Baltimor, 1978; Golini et al, 1978) and 
calicivimses (Burrough & Brown, 1978) do not have a cap stmcture at the 5' end of their 
RNAs but instead have a genome-linked viral protein termed VPg covalently linked to 
their RNAs. The VPg (l~2-kDa) of picomavimses is not required for viral infectivity and 
is removed by enzymatic activity in the cytoplasm (Ambros Qt al, 1978). However, the 
much larger (~15-kDa) VPg of calicivimses is required for translation of their RNA.
The calicivimses synthesise their viral proteins via VPg-dependent translation 
mechanism. For FCV and MNV, the 15-kDa VPg protein is encoded in open reading 
frame 1 (ORFl) of the RNA genome. VPg has been shown by several groups to be 
important for the calicivirus translation initiation process (Herbert et al, 1997; 
Sosnovtsev & Green, 2000; Daughenbaugh et al., 2003; Daughenbaugh et al., 2006). 
Removal of VPg from the viral RNA by proteinase K dramatically reduces translation 
(Herbert et al, 1997) and mutation of a conserved amino acid, tyrosine (Tyr)-24 in VPg 
has been shown to prevent viral replication (Mitra et al, 2004) indicating that VPg is 
essential for calicivims infection. Goodfellow et al., (2005) first showed that FCV VPg 
interacts directly with eIF4E (Figure 1.14) and this interaction is important for viral
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replication. They demonstrated in vitro that addition of recombinant eIF4E-binding 
protein (4E-BP1) inhibited FCV RNA translation. Chaudhry et al. (2006) further showed 
that the interaction between VPg and eIF4E is essential since depletion of eIF4E from 
rabbit reticulocyte (RRL) inhibited the FCV protein synthesis. Although MNV VPg also 
interacts directly with eIF4E (Chaudhry et al., 2006), the requirement of this interaction 
for MNV RNA translation has yet to be determined. In an in vitro study, the addition of 
4E-BP1 to sequester eIF4E and depletion of eIF4E were found to have no effect on MNV 
RNA translation (Chaudhry et al, 2006). In addition, MNV VPg has been shown to 
interact directly with eIF4G in MNV RNA translation whereas the eIF4E-eIF4G 
interaction is important for FCV translation (reviewed in Goodfellow, 2011) (Figure 
1.14), suggesting that the interaction between VPg and eEF4E might not be crucial for 
MNV RNA translation.
In VPg-dependent translation initiation such as occurs in FCV infection, eIF4G was 
reported to be cleaved later in infection. The protein cleavage was observed to inhibit 
host cell protein synthesis while promoting the viral replication. Although eIF4G is 
cleaved late in FCV infection (Willcocks et al., 2004), the requirement of intact eIF4G 
early in infection is crucial for translation of the viral RNA. Cleavage of eIF4G into two 
fragments using foot and mouth disease virus (FMDV) Lb protease was found to inhibit 
FCV but not MNV protein synthesis demonstrating that intact eIF4G is important in FCV 
infection but not in MNV infection (Chaudhry et al, 2006). As compared to FCV, 
cleavage of efF4G has not been observed in MNV infection. In addition, FCV and MNV 
3C-like proteinases are also involved in the cleavage of poly(A)-binding protein (PABP)
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Figure 1.14 FCV and MNV VPg-dependent translation models
Diagrammatic model of the calicivirus VPg-containing translation initiation complex. 
Models based on published and unpublished data for two members of the Caliciviridae, 
namely feline calicivirus and murine norovirus are illustrated. Initiation factors that 
interact directly with VPg and play a functional role in viral protein synthesis are 
highlighted with a solid red surrounding line, whereas those that bind VPg directly but 
for which the function remains to be determined, are highlighted with a dashed red 
surrounding line. Factors that do not interact directly with VPg, or for which no data 
exist, yet are functionally important for calicivirus translation initiation are displayed 
with a solid block surrounding line. The interaction of poly(A) binding protein (PABP) 
with the 3' poly(A) tail is inferred from published literature on other (+) RNA viruses and 
the presence of a poly(A) tail on the calicivirus genome (Taken from Goodfellow, 2011).
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which will inhibit cellular mRNA translation (Kuyumcu-Martinez et al, 2004; Willcocks 
et al., 2004).
1.7 Cell Signalling and the regulation of eIF4E and 4E-BP1
Activation of the mitogen activated protein kinase (MAPK) signalling pathway has been 
reported to regulate eIF4E activation by phosphorylating the cap-binding protein at 
Serine 209 (Ser209). Although changes to eIF4E phosphorylation have been observed in 
many studies, including cancer and viral infection, the effect of this phosphorylation on 
the function of the protein remains unclear. The eIF4E activation is also regulated by its 
binding proteins, the 4E-BPs. 4E-BPI competes with eIF4G for the same binding site on 
eIF4E. In order for eIF4E to assemble with eIF4A and eIF4G to form the eIF4F complex, 
it must first be released from 4E-BPI. In its active form, 4E-BPI sequesters eIF4E which 
prevents eIF4F complex formation and therefore inhibits RNA translation. The 
mammalian target of rapamycin (mTOR) signalling pathway is responsible for regulating 
4E-BPI activation (Hay & Sonenberg, 2004).
1.7.1 The mitogen activated protein kinase (MAPK) signalling 
pathway
Cellular processes are controlled by the activation of many signalling pathways. A 
number of signalling pathways have been discovered to regulate signal transduction in 
cells. One of these is the mitogen-activated protein kinase (MAPK) signalling pathway
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that converts extracellular signals into intracellular responses. The serine/threonine 
protein kinases make up this pathway are characterized into different groups: 
extracellular regulated kinase I & 2 (ERKI/2), c-Jun amino-terminal kinases (JNKs), 
p38, ERK 3&4 and ERK 5. Among these groups, ERKI/2, JNK and p38 kinases are the 
most extensively studied by researchers as they play important roles in the regulation of 
RNA translation and transcription.
1.7.2 Extracellular sigual-regulated kiuase (ERK)
ERK I or ERK2 kinases are 42 and 44 kDa kinases activated via MAPK in response to 
growth factors or phorbol esters (Wang et al., 1998). They regulate growth and cell 
survival, cell proliferation and transcription (reviewed in Johnson and Lapadat, 2002; 
Zhao et al, 2003; Roux & Blenis, 2004; Hu et al, 2009). Tyrosine (Tyr) and Threonine 
(Thr) are amino acid residues on ERKs that become phosphorylated in response to 
stimulation by growth factors (Figure 1.15). Some studies have reported that upon 
activation as a result of stimulation by growth factors, ERKs are phosphorylated and 
translocated from the cytoplasm to the nucleus and that the rate of translocation is 
dependent on the rate of kinase phosphorylation (Brunet et al., 1999; Lidke et al, 2010; 
Plotnikov et al, 2011). ERKs are deactivated through dephosphorylation by mitogen- 
activated protein kinase phosphatases (MKP3) (Camps et al., 1998). Binding of ERKs at 
the N-terminal non-catalytic domain of MKP3 increased the catalytic activity of MKP3 
up to 100-fold (Kim et al, 2003). Brunnet et al. (1999) reported that binding of inactive
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Figure 1.15 The roles of the extracellular signal-regulated kinase (ERK) signalling 
pathway in RNA translation
The extracellular signal-regulated kinase (ERK) is activated in response to growth 
factors, phorbol esters and viral infection. Activation of the kinase plays a role in cellular 
biological activities including mRNA translation (based on Pyronnet et al., 2000; Monick 
et al., 2006; Roux et a\., 2007).
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MKP3 to ERKs inhibited gene transcription in the nucleus due to the inability of the 
ERKs to translocate from cytoplasm to nucleus. Furthermore, they demonstrated that 
nuclear translocation of ERKs is required for gene expression. To some extent, ERK2 
was also found to act as a transcriptional repressor of interferon signalling by binding to 
GAAAC DNA sequences, repressing the induction of gene expression induced by 
interferon gamma (Hu et al, 2009).
Activation of the ERK MAPK signalling pathway has also been observed in human 
tumours (Kohno & Pouyssegur, 2006; Roberts & Der, 2007; Rasola et al., 2010) and 
studying the signalling pathway might help researchers to understand cancer cell growth 
and thus lead to the development of potential cancer treatment. In the case of 
artherosclerosis, activation of ERK 1/2 was found to cause formation of macrophage foam 
cells via the interferon gamma (IFN-y) signalling pathway (Li et al, 2010).
In addition, ERK is also involved in regulation of mRNA translation. ERK has been 
demonstrated to induce phosphorylation of eIF4E at Ser209 through Mnkl/2 kinases to 
initiate RNA translation (reviewed in Pyronnet, 2000). In Human alveolar macrophages, 
ERK has been reported to inhibit c-Jun N-terminal kinase (JNK) which causes activation 
of protein phosphatase 1 (PPl) (Monick et al, 2006). PPl activates (via 
dephosphorylation) eIF2a, which is important for loading of the ternary complex on to 
the ribosomal subunit for initiation of translation (reviewed in Proud, 2005). ERK also 
stimulates and phosphorylates ribosomal protein S6 (rpS6) at Ser235/236 through the 
RSK/ERK pathway, enhancing recruitment of rpS6 to mRNA (Roux et al, 2007). 
Habelhah et al. (2001) have demonstrated that activation of ERK caused accumulation of
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one of the transcription proteins, heterogeneous nuclear ribonucleoprotein K (hnRNP-K), 
in the cytoplasm, inhibiting RNA translation.
There are a number of inhibitors produced commercially to inhibit ERK 1/2 and their 
upstream kinases, MEKl/2. PD98059 [2'-amino-3'-methoxyflavone], PD184352 [2-(2- 
chloro-4-iodo-phenylamino)-N-cyclopropylmethoxy-3,4-difluoro-benzamide] and U0126 
[l,4-diamino-2,3-dicyano-l,4-bis(2-aminophenylthio)butadiene] are highly specific 
inhibitors that function in preventing phosphorylation of MEKl/2 or ERK 1/2. Recently, 
PD 184352 has been reported to have high potential as an anticancer agent for cancer 
treatment (Dudley et al., 1995; Favata et al., 1998; Fremin & Meloche, 2010). PD98059 
and U0126 were identified as MEK inhibitors that have been determined to have distinct 
binding sites on MEKl/2 which therefore means that they do not compete for ATP. 
Furthermore, these specific inhibitors have less effect on other kinases activities 
(Reviewed in English & Cobb, 2002). Treatment of cancer cells with PD 184352 
prevented the phosphorylation of both ERK MAP kinase and p90 ribosomal S6 kinase 
(p90RSK) thus inducing cell apoptosis (Mattingly et al., 2002; Dai et al., 2001; 
McKinstry et al, 2002). In some cases, either MEK or ERK is also involved in regulation 
of proinflammatory and apoptotic events during viral infection (Gretton & Harris, 2010; 
Xing et. al, 2010) (further discussed in Section 1.7.5). So it would be appear that study 
of the ERK signalling pathway is important for developing new treatments for many 
diseases such as cancer and viral infections.
Since the MEK/ERK signalling pathway has been demonstrated to be involved in the 
regulation and control of cell growth and survival, understanding of how this pathway
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responds to caliciviruses infection might help us to further understand the ability of the 
virus to control the host cells for translation and replication of the viral RNA.
1.7.3 Stress-activated protein kinase (SAPK) p38
p38 MAPK signalling pathway activation has been identified as a key regulator 
governing the response to extracellular stimuli in regulating the many biosynthetic 
processes that are involved in the transcription and translation processes (Figure 1.16). A 
number of studies have reported that the 38-kDa kinase which possesses four isoforms is 
regulated by oxidative stress (Gutierrez-Uzquiza et al., 2011), inflammatory cytokines 
(Raingeaud et al., 1995), UV irradiation (Jinlian et al., 2007) and viral infections 
(Johnson et al, 2000; Hirasawa et al, 2003). Categorized as p38a, p38p, p385 and p38y, 
these kinases are activated by MKK3, MKK4 and MKK6 (Derijard et. al, 1995; Han et. 
al, 1997; Parker et. al., 1998; reviewed in Cuadrado & Nebreda, 2010). Deactivation of 
p38 occurs through dephosphorylation by several MAP kinase phosphatases (MKP) such 
as M3/6 and MKP-3 kinase. However, by comparison with M3/6, MKP-3 only partially 
affects p38 but selectively inhibits ERK (Muda et al, 1996). In addition, protein 
phosphatase 2C (PP2C) has also been shown to remove a phosphate group at the 
serine/threonine residue on p38 (reviewed in Zarubin & Han, 2005). Regulation of p38 
activation is thought to be required for translation initiation, specifically because it is 
responsible for phosphorylating the cap-binding protein, eIF4E, via activation of Mnkl or 
Mnk2 (reviewed in Cuadrado & Nebreda, 2010).
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Figure 1.16 The roles of stress-activated protein kinase (SAPK) p38 signalling 
pathway in RNA translation and transcription.
The activation of p38 is triggered by inflammatory cytokines, osmotic shock, oxidative 
stress and viral infection. Activation of the kinase through phosphorylation regulates 
initiation of RNA translation, controlling the interferon cascade pathway and gene 
transcription (based on Platanias, 2003; Cuadrado & Nebreda, 2010; Ferreiro et al., 
2010).
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The activation of p38 is also important for controlling the interferon cascade. In response 
to viruses, bacteria or tumor cells, proinflammatory proteins, known as interferons (IFNs) 
are produced and released by the affected host cells and then bind to IFN receptors 
expressed on the surface of neighbouring cells. Interaction between the interferons and 
receptors triggers the antiviral and immune responses of the host cells. One of the
consequences is activation of p38 by IFNa and IFN(3 that are important for regulating
downstream kinases in the IFN signalling pathway. Gene transcription depending on 
Type I IFN was shown to require activation of p38a kinase (Li et al, 2004) and blocking
the activation of the kinase has been reported to reduce induction of IFNa-antiviral 
responses. This discovery is important for the study of the mechanism of viral infection 
and antiviral drug development (Uddin et al, 1999; reviewed in Platanias, 2003; 
Katsoulidis et al, 2005).
In addition, activation of p38 has been shown to recruit RNA polymerase and 
transcription initiation factors to targeted genes. Ferreiro et al. (2010) have demonstrated 
that in response to osmotic stress, p38 binds to and phosphorylates transcription factor, 
Elkl which the Elkl serves as an anchor for p38 to bind to gene promote, mediating 
recruitment of RNA polymerase II complex to the targeted gene for transcription process.
As the p38 signalling pathway has been reported to play regulatory roles in a number of 
biological activities within cells, there has been extensive development of kinase 
inhibitors for research. Pyridinyl imidazole compounds: SB203580 and SB202190 are
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compounds capable of blocking the catalytic activity of p38. Analysis of binding of 
SB203580 to p38 using spectrophotometric coupled-enzyme assay and microcalorimeter 
demonstrated inhibition by the inhibitor of the kinase ATPase activity (Young et al, 
1997). SB203580 is highly specific to p38, causing downregulation without affecting the 
activation of other kinases such as stress-activated protein kinases/cJun N-terminal 
kinases (SAPKs/JNKs) (Clerk & Sugden, 1998; Kumar et al, 2007). In addition to its 
inhibitory effect on p38 kinase, this compound was found to upregulate other MAP 
kinases such as extracellular regulated-kinase (ERK) and c-Jun-N terminal kinase (JNK) 
whether in rat adrenal pheochromocytoma cell (PC 12) (New et al., 2001) or human 
hepatoma cells HepG2 (Henklova et al, 2008). However, in a cancer cell line study, 
SB203580 was found to have no effect on activation of JNK, contrary to other studies. 
This finding suggested that activation of a particular kinase in different cell lines is cell- 
type specific, which may explain the different requirements for MAPK in different types 
of cells (Henklova et al, 2008).
1.7.4 Mitogen-activated protein kinase-interacting kinase (Mnk)
Mitogen-activated protein kinase-interacting kinase exists in two isoforms: Mnkl and 
Mnk2 that share approximately 77% similarity at the N-terminus and 65% at the C- 
terminus. During protein synthesis, Mnks were found to act as substrates for ERK and 
p38 MAP kinases (Fukunaga & Hunter, 1997; Waskiewicz et al, 1997) for the regulation 
of phosphorylation of the cap-binding protein, eIF4E (Figure 1.17). Phosphorylation was 
found to occur when eIF4E, eIF4G and the Mnkl/2 participate in eIF4F complex where
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Figure 1.17 The role of mitogen-activated protein kinase-interacting kinases 
(Mnks)
The figure shows the interaction between ERK, p38 and Mnk. The role played by Mnk 
activation in the function of the downstream effectors is still uncertain for example, the 
effect of activation of these kinases on eIF4E/eIF4G proteins (Taken from Buxade et al,
2008).
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eIF4E and Mnk bind to the N- and C-terminus of eIF4G, respectively (Scheper et al., 
2002; Waskiewicz et al, 1999; Pyronnet et al, 2001). Although phosphorylation of 
elF4E through Mnks has been shown to enhance protein synthesis, however, Knauf et al. 
(2001) have reported that Mnks negatively regulate protein synthesis. Addition of 
recombinant active Mnkl in in vitro assay and overexpression of Mnk2 in 293 cells 
inhibited protein synthesis. As well as ERK and p38 MAPK activation, another factor has 
also been reported to involve in regulating Mnks activities. Phosphorylation at N-terminal 
of Mnkl by caspase-cleaved Pak2 kinase at Ser^  ^and Thr^  ^has been reported to reduce 
phosphorylation of elF4G and block binding of Mnkl to elF4G, thus preventing 
phosphorylation of elF4E (Orton et al 2004; Ling et al, 2005).
To date, the role of Mnk2 during mRNA translation is still unclear although a few studies 
have been performed on this kinase. In contrast to Mnkl, Mnk2 is normally found to 
have a high level of basal activity, making it more resistant to the upstream kinases, ERK 
and p38 (reviewed in Scheper & Proud, 2002). However, Scheper et al., (2001) has also
reported that overexpressed Mnk2 can be activated by ERK2 and p38MAPKa/p kinases
to phosphorylate elF4E at Ser209 in vivo. Inhibition of these kinase pathways using 
PD98059 and SB203580, demonstrated that Mnk2 could also be a better substrate for 
MAP kinases operating at a low level of activation. Hu et al. (2012) observed that 
overexpression of Mnk2 during muscle atrophy caused deactivation of elF4G by 
dephosphorylating the scaffold protein at Ser 1108.
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Activation of eIF4E through phosphorylation is associated with an increase in protein 
synthesis, so the level of eIF4E in cells would also contribute to cell growth and 
proliferation. An increase in the level of eIF4E protein has been reported to occur in 
tumours and cancer cell studies (De Benedetti & Harris, 1999; Wang et al, 1999; 
Rosenwald et al, 2001a; Rosenwald et al, 2001b; Kleiner et al, 2009). Inhibition of 
Ras-induced transformation delayed suppression of eIF4E phosphorylation during 
tumorigenesis in a Mnk 1/2 double knock out (Mnk-DKO) mouse model (Ueda et al, 
2010). However, Ueda et al (2004) and group have previously reported that activation of 
Mnkl/2 kinases is only necessary for eIF4E phosphorylation but not for cell growth as 
double knock out of Mnk 1/2 did not affect normal growth of mouse embryonic 
fibroblast.
The requirement of Mnkl/2 activation for eIF4E phosphorylation can also be analysed 
using the Mnk inhibitor, CGP 57380, which has been shown to downregulate Mnkl in 
tissue culture. However, this compound has been found to not only inhibit Mnkl kinase, 
but also other kinases such as MAP kinase 1 (MKKl), casein kinase 1 (CKl) and brain- 
specific kinase 2 (BRSK2), and this lack of specificity makes the interpretation of results 
difficult (Bain et al, 2007). Another potent Mnk inhibitor, the antifungal agent 
cercosporamide, has also been reported to effectively inhibit the Mnk isoforms, 
specifically Mnk2 kinase, and has been used to block eIF4E phosphorylation in a cancer 
cell study (Konicek et al, 2011). Again, similarly to the CGP 57380 compound, 
cercosporamide has also been found to inhibit other kinase including Jak3, GSK3p, 
ALK4 and Piml. Currently, the compound SHN-093 may be used as a negative control
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for CGP57380 as these two compounds have the same chemical structure except that one 
of the hydrogen atoms in the CGP 57380 molecule is replaced by a methyl group (CH3). 
This methylated analogue compound of CGP 57380 does not inhibit the Mnk isoforms 
but inhibits the same other kinases as CGP 57380 (Hou et al, 2012). As eIF4E has been 
shown to be phosphorylated by Mnkl and Mnk2, it is of interest to analyse the 
requirement for activation of these kinases during viral infection (Schumann & 
Dobbelstein, 2006; Banerjee et al., 2002). Downregulating or blocking these kinases by 
Mnkl/2 inhibitor (CGP 57380) not only prevented phosphorylation of eIF4E but also 
reduced viral RNA translation and replication (Karaca et al, 2004; Walsh & Mohr, 2004; 
Gastello et al, 2009).
Since Mnkl or Mnk2 is normally activated during viral infection, investigation of the 
effect of FCV and MNV infections on the activation of Mnks and phosphorylation of 
eIF4E, and both virus replications can be performed using the p38 inhibitor CGP57380, 
and mock inhibitor SHN-093, as a negative control experiment.
a) Phosphorylation of eIF4G
eIF4G activity has also been reported to be regulated by phosphorylation. 
Phosphorylation of this scaffold protein was observed to occur via Mnkl (Pyronnet et al, 
1999) and p21-activated protein kinase 2 (Pak2) (Orton et al, 2004). Under stress 
conditions such as hyperosmotic stress, Pak2 is activated and phosphorylates eIF4G to 
inhibit cap-dependent translation. The phosphorylation occurs through binding of Pak2 to
58
Chapter 1____________________________________________________ Introduction
eIF4G in the same region as the binding site for eIF4E. Under stress conditions, this 
protein was found to compete with eIF4E for the binding site. This resulted in a drop in 
affinity for eIF4E and inhibition of protein synthesis. This inhibition was only observed 
in cap-dependent translation and not in IRES-dependent translation (Ling et. al, 2005). 
In addition, under apoptotic conditions, Pak2 is cleaved by caspase 3 which then 
phosphorylates Mnkl kinase. Mnkl is activated by ERK/p38 mitogen activated protein 
kinase (MAPK). Phosphorylation via MAPK activation on the Thrl97/202 residues 
activates Mnkl and allows it to phosphorylate eIF4E. However, in Orton et al. (2004), 
phosphorylation of Mnkl Ser27 and Thr22 by the caspase 3-cleaved Pak2 was observed 
not to activate Mnkl. Under these conditions, eIF4E phosphorylation is not affected by 
the Pak2-phosphorylated Mnkl, but eIF4G phosphorylation is still inhibited due to 
prevention of Mnkl binding to eIF4G.
b) Phosphorylation of eIF4E
Eukaryotic initiation factor 4E (eIF4E) is phosphorylated in the presence of growth 
factors, hormones, and viral infection. The Ser209 residue of eIF4E is a major target for 
eIF4E phosphorylation (reviewed in Joshi et al., 1995; and Goodfellow & Roberts, 2008). 
A number of studies have shown that phosphorylation of eIF4E occurs via the mitogen- 
activated protein kinase (MAPK) signalling pathway. The most extensively studied 
cascades are those of the extracellular-regulated signal kinase (ERK MAPK) and the 
stress-activated kinase p38 (p38 MAPK). These two cascades have been reported to 
phosphorylate the MAP-kinase interacting kinases, Mnkl and Mnk2, leading to
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phosphorylation of eIF4E when the translation initiation factors, eIF4E and eIF4A, and 
Mnkl/2 bind to eIF4G to form the eIF4F complex. (Fukunaga & Hunter, 1997; 
Waskiewicz et al., 1997; reviewed in Pyronnet et al., 2000; Walsh & Mohr, 2004; 
Shvevgert et al, 2010). Why eIF4E becomes phosphorylated during translation initiation 
is still unclear although there is a variety of conflicting evidence. Phosphorylation of 
efF4E has been observed to increase the affinity of eIF4E for the mRNA cap structure 
leading to enhanced translation (Lamphear & Panniers, 1990; Minich et al, 1994; Rau et 
al., 1996), however, it has also been reported to reduce the affinity for the cap (Wang et. 
al, 1998; Scheper et al., 2002) and hence to inhibit translation. Phosphorylation of eIF4E 
has also been reported to be important for a subset of mRNA associated with 
inflammation and cancer (Furic et al, 2010). Irrespective of the phosphorylation state of 
eIF4E, binding of eIF4G to eIF4E has also been reported to increase eIF4E affinity for 
the cap-structure of the mRNA (Haghighat & Sonenberg, 1997). The same effect has also 
been observed during infection with potyvirus, a plant virus, where eIF4G was found to 
enhance the interaction between eIF4E and the viral VPg (Grzela et al., 2006).
In addition, protein kinase C (PKC) was also claimed to phosphorylate eIF4E in response 
to stimulation by growth factors or insulin. The PKC plays a role in regulating the MAPK 
pathway for the control of eIF4E function, and incubation of recombinant eIF4E with 
purified PKC in vitro resulted in the phosphorylation of eIF4E on Ser209 (Whalen et al., 
1996).
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1.7.5 Effect of viral infection on MAPK activation and eIF4E
phosphorylation
During viral infection, eIF4E is normally phosphorylated which we would expect, on 
balance, to enhance the translation initiation process. The active eIF4E is thought to 
increase the affinity of the eIF4F complex for the cap structure at the 5' end of the mRNA 
(reviewed in Mohr, 2006; Walsh & Mohr, 2004). During virus infection, p38 MAPK 
normally becomes activated owing to cellular stress. p38 MAPK activation has also been 
shown to be required for promoting viral replication in viral infections such as those of 
herpes simplex virus (HSV-1) (Karaca et al, 2004; Walsh & Mohr, 2004), reovirus 
(Norman et al, 2004; Ji et ah, 2009), bursal disease virus (IBDV) (Khatri & Sharma,
2006), porcine circovirus type 2 (PV2) (Wei et al, 2009), human coronavirus 229E 
(HCoV-229E) (Kono et al, 2008), Sindbis virus (SINV) (Nakatsue et al, 1998), 
encephalomyocarditis virus (EMCV) (Kleijn et al, 1996; Hirasawa et al, 2003) and 
hepatitis C virus (HCV) (George et al, 2012). Norman et al (2004) demonstrated that 
activation of this kinase occurred through the Ras /Guanine nucleotide-exchange factors/ 
p38 kinase (Ras/RalGEF/p3 8) pathway during the benign human reovirus virus infection. 
In avian reovirus infection, activation of p38 MAPK happens via the activation of p38 
upstream kinase, adenosine 5'-monophosphate-activated protein kinase (AMPK) in order 
to phosphorylate eIF4E (Ji et al, 2009).
Furthermore, p38 activation during virus infection normally contributes to apoptosis 
(Mortola & Larsen, 2010; Su et. al, 2002; Nakatsue et. al., 1998) by activation of
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specific proteases known as caspases (Sumbayev & Yasinska, 2006). Studies with 
Newcastle disease virus (NDV) (Bian et. al., 2011), Bluetongue virus (BTV) (Mortola & 
Larsen, 2010) and Japanese encephalitis (JE) (Su et. al., 2002) virus infections have 
concluded that caspase activation during viral infection occurs via activation of MAPK 
signalling. In calicivirus infection, Al-Molawi et al. (2003) have demonstrated that 
caspase 2, -3 and -7 were activated for cell apoptosis and feline calicivirus (FCV)-capsid 
protein cleavage. Nakatsue et al, (1998) have shown in a study of SINV infection that 
phosphorylation of heat shock protein 27 (HSP27) activates p38 which is responsible for 
delaying apoptosis during viral infection, thus indirectly promoting the viral RNA 
translation and replication.
In infection with some viruses such as IBDV (Khatri & Sharma, 2006) and coronavirus 
(Cheung et. al., 2005), upregulation of p38 kinase has been shown to cause activation of 
macrophage cells for producing and releasing proinflammatory cytokines to influence 
neighbour cells. For example, expression of the cytokines C-X-C motif chemokine 10 
(CXCLl 0)/IFN-gamma-inducible protein 10 and chemokine (C-C motif) ligand 2 
(CCL2)/monocyte chemotactic protein 1 SARS-CoV have both been detected in severe 
acute respiratory syndrome (SARS) coronavirus-infected macrophage cells (Cheung et 
al, 2005).
Although activation of translation initiation factors in the eIF4F complex has been shown 
to be controlled by activation of MAP kinases, in some viral infection studies, the 
presence of viral proteins is also important for enhancing activation of this pathway.
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HCV2a NS5A protein has been shown to induce the activation level of p38 for eIF4E
phosphorylation. The NS5A protein was also observed to enhance expression of Mnkl 
and mediate eIF4F complex loading to the cap structure of mRNA thus enhancing host­
cell translation which resulted in hepatocellular carcinoma development. Furthermore, 
NS5A was found by immunoblotting to bind directly to the eIF4F complex (George et 
al, 2012). In another study, Walsh & Mohr, (2004) reported that thé HSV-1 ICPO gene 
product stimulates phosphorylation of eIF4E via Mnkl kinase when activated by p38 
MAPK.
As well as activation of p38 during viral infection, ERK kinase has also been 
demonstrated to be activated in cells infected with Visna virus (W ) (Barber et al, 2002), 
adenovirus (Schumann & Dobbelstein, 2006) and polyomavirus hominis 1 (Seamone et 
al, 2010). This kinase activation is required to promote viral replication by delaying 
apoptosis. Interestingly, in human cytomegalovirus (HCMV) (Rodems & Spector 1998) 
and avian influenza virus (AIV) (Xing et al., 2010) infection, activation of both p38 and 
ERK MAP kinases has been reported to occur during viral infection to promote viral 
replication.
As mentioned before, eIF4E phosphorylation has been reported to be necessary for 
cellular and some viral RNA translation processes. However, this requirement for 
phosphorylation is still unclear as it has been shown to have no effect on eIF4F affinity 
for the cap structure of mRNA. In some viral infections, dephosphorylation of eIF4E was 
shown to enhance viral gene expression and inhibit host cell protein synthesis. Studies
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have shown that adenovirus infection causes dephosphorylation of eIF4E, leading to 
inhibition of host cell protein synthesis (Zhang et al., 1994; Cuesta et al., 2000). Cuesta 
and co-workers demonstrated that dephosphorylation of eIF4E occurred when Mnkl 
bound to eIF4G was replaced by the adenovirus 100-kDa protein. The viral protein has 
been shown to bind eIF4G directly, reducing eIF4F complex affinity for the RNA cap 
structure and thus inhibiting host-cell protein synthesis (Cuesta et al., 2000). Other 
viruses that have also been reported to cause dephosphorylation of eIF4E are 
picomaviruses such as EMCV and poliovirus (Kleijn et al, 1996). The RNAs of these 
viruses are translated in an IRES-dependent translation manner that does not require 
eIF4E for translation initiation because binding of the ribosomal subunit to the viral RNA 
does not depend on binding of eIF4F to the 5' end but to the 1RES motif in the 
untranslated region (UTR) (detailed in Section 1.6.1). In vesicular stomatitis virus 
(VSV) infection, dephosphorylation of eIF4E has been shown to reduce host- cell protein 
synthesis by reducing the interaction between eIF4E and eIF4G while enhancing 
association of eIF4E with 4E-BP1 (Connor & Lyles; 2002). Although this nonsegmented 
negative-sense (nsNS) RNA virus relies on a cap-dependent mechanism for its protein 
synthesis, VSV has been shown to have evolved a unique strategy of méthylation on its 
viral mRNA cap structure, providing it with a way of promoting translation of its own 
RNA by inhibiting host- cell cap-dependent protein synthesis (Li et al, 2006).
So, viruses are able to manipulate host protein synthesis in many ways whether by 
controlling host-cell signal- transduction pathways or by using their viral proteins to 
impair host- cell cap-dependent translation so as to promote their replication. As
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caliciviruses have been shown to hijack the host-cell translation machinery for translation 
of their RNA via a VPg-dependent translation mechanism, we would expect that VPg 
and/or other calicivirus proteins might be involved in regulating the activation of 
translation initiation factors.
1.7.6 Mammalian target of rapamycin (mTOR) signalling pathway
The mammalian target of rapamycin (mTOR) is a regulator for translation initiation 
which can be activated by amino acids, ATP and growth factors. However, nutrient 
(amino acids) and energy (ATP) deprivation significantly downregulate mTOR in the 
presence of growth factors (Dhufiier & Thomas, 1999; Schmelzle & Hall, 2000), 
demonstrated that amino acids and ATP may affect regulation of mTOR signalling 
pathway in the absence of growth factors.
Activation of the mTOR kinase is by phosphorylation and results in the activation of 
translation. There are two forms of mTOR complex (mTOR); mTORCl and mT0RC2. 
mTORCl is made up of mTOR, the regulatory-associated protein of mTOR (Raptor), G- 
protein ^-subunit like protein (GpL) and proline-rich Akt/PKB substrate 40 (PRAS40) 
(Kim et al., 2003; reviewed in Corradetti & Guan, 2006). Raptor, a 150kDa protein 
serves as an indispensable scaffold protein for mTOR that facilitates interaction between 
mTOR and its substrates: 4E-BP1 and p70 S6 kinase (p70S6K) and enable their 
phosphorylation (Hara et al., 2002; Eguchi et al., 2006; Wang et al., 2009). As mTORCl 
complex is associated with Raptor, activity of the binding protein is essential for 4E-BP1
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phosphorylation. Although removal of raptor from mTOR does not inhibit p70 (S6K) 
phosphorylation, it significantly prevents 4E-BP1 phosphorylation. In addition, mTOR 
activation is rapamycin sensitive. Addition of rapamycin causes binding of the inhibitor 
to FKBP-12 FKBP (FK506-binding protein) which destabilizes the interaction between 
raptor and mTOR interaction. Dissociation of raptor-mTOR complex leads to 
dephosphorylation of 4E-BP1 by deactivation of mTORCl kinase. So the presence of 
raptor is crucial for mTOR signalling and for regulating the translation process by 4E- 
BPl phosphorylation (Hara et ah, 2002; Kim et al., 2002; Oshiro et ah, 2004). Another 
mTOR binding protein known as PRAS40 has been shown to act as negative regulator of 
mTORCl. The 40-kDa protein interacts with mTORCl via raptor and prevents 
phosphorylation of mTORCl substrates; 4E-BP1 and p70S6K by inhibiting the access of 
these substrates to mTORCl. Binding of PRAS40 to raptor at TOR signalling (TOS) 
motif demonstrates that this protein shares the same binding domain on raptor as the 
mTORCl substrate such as 4E-BP1 (Wang et ah, 2007; Haar et ah, 2007) (Figure 1.18).
Activation of mTORCl is also regulated by the tumour suppressor proteins, TSCl and 
TSC2. Upon phosphorylation by Akt, deactivation of TSCl/2 upregulates the mTORCl 
complex (Inoki et al, 2002; Manning et ah, 2002) thus phosphorylating the mTORCl 
downstream effectors 4E-BP, eIF4G and p70S6K (Inoki et al, 2002; Manning et ah, 
2002; reviewed in Hay & Sonenberg, 2004; Ikenoue et ah, 2008; Facchinetti et ah, 2008).
mT0RC2 is made up of mTOR, rapamycin-insensitive companion of mTOR (rictor), 
G(3L and mammalian stress-activated protein kinase interacting protein 1 (Sinl) and is 
activated via the PI3K signalling pathway. Gan et al (2011) demonstrated that mT0R2 is
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Figure 1.18 Schematic of mTOR activation
In the presence of rapamycin, PRAS40 binds to raptor to interact with mTORCl. This 
association inhibits mTORCl kinase activity by preventing interaction between 
mTORCl and its substrates including 4E-BP1. PRAS40 and 4E-BP1 share the same 
binding domain (TOS motif) on raptor. In the absence of rapamycin, PRAS40 is released 
from raptor, allowing 4E-BP1 recruitment to mTORCl via raptor (Based on Wang et al.,
2007).
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directly phosphorylated by PI3K. However, phosphorylation via PI3K may also occur via 
multiple mechanisms and the phosphorylation through PI3K downstream kinase is a 
distinct step from PI3K-dependent mTORCl activation (Garcia-Martinez, 2008; 
Cybulski & Hall, 2009; Sparks & Guertin, 2010). Activation of mT0RC2 has been 
reported to be required for phosphorylation of Akt at Ser473 site and protein kinase C
(PKCa) (reviewed in Hay & Sonenberg, 2004). Phosphorylation of ribosomes by PI3K
signalling pathway has been reported to activate the mT0RC2 complex directly in 
melanoma and colon cancer (Zinzalla et al, 2011). Unlike mTORCl, mT0RC2 was 
found not to bind FKBP 12-rapamycin which could be the reason that mT0RC2 
activation is rapamycin-insensitive (Sarbassov et al., 2004; reviewed in Corradetti & 
Guan, 2006; Frias et ah, 2006). Disruption of rictor, the binding protein of mTOR2 was 
shown to inhibit embryonic growth and reduce cell metabolic activity (Shiota et al., 
2006).
mTOR signalling has been reported to regulate a number of cell activities such as cell 
growth and proliferation, and studies on this pathway have resulted in the development of 
new drugs for investigating the signalling pathway in cells. Rapamycin (sirolimus) is an 
antifimgal agent produced by the bacterium Streptomyces hygroscopicus (reviewed in 
Ballou & Lin, 2008). Rapamycin was found to inhibit mTOR activity by causing 
dissociation of the raptor/mTOR complex and preventing phosphorylation of 4E-BP1 
(Hara et al, 2002; Eguchi et al, 2006; Wang et al, 2009). Fumarola et al (2005) found 
that inhibition of the mTOR pathway by rapamycin in Jurkat leukaemic T-cells was 
found to reduce cell size and mass to protect the cells from apoptosis. Although does
68
Chapter 1____________________________________________________ Introduction
inhibit mTOR, rapamycin is considered to be a poor inhibitor as it requires to act in 
combination with other inhibitor such as LY294002 (PI3K inhibitor) for efficient 
inhibition of mTOR. Rapamycin also has a weak effect on mTORC2 activity and long­
term treatment of rapamycin in cells by rapamycin may inhibit assembly of the mT0RC2 
complex, thus downregulating Akt activity (Sabassov et al, 2006). Highly specific 
inhibitors, Torinl (Thoreen & Sabatini, 2009) and KU0063794 (Garcia-Martinez et al.,
2009) have been developed to effectively inhibit mTOR signalling. Unlike rapamycin, 
these inhibitors do not only impair association of raptor mTORCl to form mTORCl but 
inhibits mT0RC2 activity as well. Furthermore, the effect of these compounds on 
phosphorylation of 4E-BP1 is greater than rapamycin (Oshiro et al, 2004; Thoreen et al, 
2009; reviewed in Caron et al, 2010). Another inhibitor, compound 5u has also been 
reported to selectively inhibit mTORCl and mTORC2 but not PI3K activity (Nowak et 
al., 2009). Therefore, as rapamycin was found to be a weak inhibitor of mTOR, we 
decided to use KU0063794 for studying the effect of the mTOR pathway inhibition on 
calicivirus replication as it has been proven to have a greater inhibitory effect on both 
mTORCl and mT0RC2 complexes.
1.7.7 Phosphorylation of 4E-BP1
Regulation of translation initiation is important for the control of cell growth and 
proliferation. Assembly of the translation initiation factor eIF4F from eIF4E, eIF4G and 
eIF4A determines the rate of mRNA translation. Formation of the eIF4F complex can be 
abolished by the small protein repressor, eIF4E-binding protein (4E-BP). 4E-BP exists in
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three isoforms: 4E-BP1, 4E-BP2 and 4E-BP3) (Pause et al,, 1994; Sonenberg & Dever, 
2003). These proteins possess 56% similarity of identity and they function in the 
inhibition of cap-dependent translation but not cap-independent translation (translation 
via an 1RES element) (Pause et al, 1994). Of these three isoforms, 4E-BP1 is the most 
extensively studied by researchers. 4E-BP1 has been reported to be a translational 
repressor that regulates binding of eIF4E to eIF4G for formation of eIF4F complex. The 
phosphorylation state of 4E-binding protein (4E-BP1) plays an important role in the 
control of the translation initiation rate. In the hypophosphorylated state, 4E-BP1 binds to 
and sequesters eIF4E, thus preventing eIF4F assembly and cap-dependent protein 
synthesis (Pyronnet et al, 2001) since 4E-BP1 and eIF4G share the same binding region 
on eIF4E (Feigenblum & Schneider, 1996). In the hyperphosphorylated state (stimulated 
by insulin, growth factors or viral infection), eIF4E dissociates from 4E-BP1 and 
interacts with eIF4G for formation of the eIF4F complex (Gingras et, al, 1996; Gingras 
et. al., 1998; Heesom & Denton, 1999; Wang et al., 2005) (Figure 1.19).
The PI3-kinase/Akt and mammalian target of rapamycin (mTOR) signalling pathways 
were discovered early on to be involved in the phosphorylation of 4E-BP1 (Beretta et. al., 
1996; Gingras et. al 1998; Gingras et. al., 1999; Harris & Lawrence 2003; reviewed in 
Hay & Sonenberg 2004). Whether via activation of Akt or growth factor stimulation, 
phosphorylation of 4E-BP1 apparently occurs at the same amino acid residues. In the 
absence of growth factors, Akt alone is able to abrogate the interaction between eIF4E 
and 4E-BP1, enhancing eIF4E-dependent translation. Although the Akt (PKB) signalling 
pathway could mediate phosphorylation of 4E-BP1, it still required FRAP/mTOR activity
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Figure 1.19 Effect of phophorylation of 4E-BP1 on the formation of eIF4F complex
When the 4E-BP1 is dephosphorylated, this binding protein sequesters the eIF4E. 
Association between the 4E-BP1 and the eIF4E prevents formation of the eIF4F complex 
and inhibits the translation process. When the 4E-BP1 is hyperphosphorylated, it releases 
the elF4E, thus promoting formation of elF4F complex to initiate translation (Pyronnet et 
al, 2001; Wang et al, 2005).
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since activation of the Akt kinase alone was unable to phosphorylate 4E-BP1 directly 
whether in vitro or in vivo (Gingras et al, 1998).
Phosphorylation of 4E-BP1 has been shown to happen at different amino acid residues 
(Figure 1.20). The usual phosphorylation sites on 4E-BP1 are Thr 37, Thr 46, Thr 70 and 
Ser 65. Phosphorylation at Thr 37 and Thr 46 by mTOR has been reported to be the 
primary target for phosphorylation and is required for the next phosphorylation steps 
(Gingras et. al., 1999; Harris & Lawrence, 2003; Hay & Sonenberg, 2004). In addition, 
Gingras et. al. (1999) reported that phosphorylation at Thr 37 and Thr 46 via mTOR is 
not sufficient to diminish the interaction between eIF4E and 4E-BP1.
A study by Heesom and Denton (1999) showed that phosphorylation of 4E-BP1 in rat fat 
cells can be achieved by two separate protein kinases, one of which appears to be mTOR 
itself and the other an mTOR-associated kinase (recently discovered to be raptor). This 
analysis was done by using two different antibodies (Abl and Ab2) for mTOR 
immunoprécipitation. First, phosphorylation of 4E-BP1 at Thr 36 and Thr 45 by mTOR 
itself did not result in dissociation of 4E-BP1 from eIF4E. However, the dissociation of 
the eIF4E-4E-BPl complex can be achieved by phosphorylation of 4E-BP1 at Ser 64 and 
Thr 69 by mTOR-associated kinase. However, in contrast with this finding, Niedzwiecka 
and co-workers claimed that phosphorylation of 4E-BP1 at Ser 65 and Thr 70 does not 
result in dissociation of the 4E-BPl-eIF4E complex (Niedzwiecka et al, 2002). 
(Numbering of the amino acid residues for rat 4E-BP1 is slightly different because of
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Figure 1.20 Phosphorylation sites of 4E-BP1 and binding domain for mTOR.
4E-BP1 is phosphorylated at Thr37, Thr46, Ser65 and Thr70 by mTOR. The TOS motif 
is a raptor (indispensable scaffold protein) target which is crucial for 4E-BP1 
phosphorylation (Based on Harris et al., 2003).
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sequence variation but they refer to the equivalent phosphorylation sites to those of rabbit 
4E-BP1)
Studies have shown that two motifs on 4E-BP1 are required for phosphorylation by 
mTOR and also for raptor recognition. These motifs were identified as TOR signalling 
(TOS) and RAIP (named according to its amino acid sequence Argl3, Ala 14, He 15, 
Pro 16) motifs (Figure 1.20). TOS is a conserved motif located at the C-terminus of 4E- 
BP and has been shown to be important for 4E-BP1 activities. Replacement of 
phenylalanine 114 by alanine in this motif abolished insulin-dependent phosphorylation 
of 4E-BP1 (Schalm & Blenis, 2002). Furthermore, mutation on both the TOS and RAIP 
motifs showed distinct effects on the phosphorylation state of 4E-BP1. Replacement of 
the TOS motif reduced the ability of 4E-BP1 to interact with raptor. In contrast, 
replacement of the RAIP motif did not affect the interaction of 4E-BP1 with raptor 
(Schalm & Blenis, 2002; Choi et al, 2003; Eguchi et al, 2006).
1.7.8 Effect of viral infection on mTOR pathway and 4E-BP1 
phosphorylation
The mammalian target of rapamycin (mTOR) signalling pathway could be a target for 
certain viruses for the promotion of their own RNA translation initiation by inhibiting 
host-cell protein synthesis. In some virus infections, inhibition of the pathway has been 
demonstrated to occur by blocking host-cell protein synthesis and enhancing viral cap- 
independent protein synthesis by limiting the availability of translation initiation factors
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such as eIF4E. In addition, viruses have been reported to use their own proteins to 
regulate the mTOR pathway. The Picomaviridae encephalomyocarditis virus (EMCV) 
and poliovirus (PV) have been shown to induce shutoff of host-cell protein synthesis by 
dephosphorylating 4E-BP1 to limit availability of eIF4E and therefore inhibit the cap- 
dependent protein synthesis of the host cell. Inhibiting cap-dependent translation did not 
affect translation of the viral RNAs because viral protein synthesis occurs in an IRES- 
dependent manner (Gingras et al., 1996). Vesicular stomatitis virus (VSV) has also been 
reported to reduce the phosphorylation level of 4E-BP1 during infection. Association of 
eIF4E and 4E-BP1 abolishes the eIF4F complex and thus inhibits host-cell protein 
synthesis. Although activation of 4E-BP1 was shown to decrease host-cell RNA 
translation, this protein activation did not affect viral protein synthesis, demonstrating 
that formation of the eIF4F complex is not required for the viral RNA translation (Connor 
& Lyles, 2002). In a study by Alain et al (2010), infection of VSV has been shown to 
impair activation of mTORCl, thus not only inhibiting phosphorylation of 4E-BP1 but 
preventing production of interferon (UN). Furthermore, VSV infection was found to 
cause oncolysis of malignant glioma (MGs) cells (Alain et al, 21). Simian virus 40 
(SV40) has also been reported to cause dephosphorylation of 4E-BP1 using its viral 
protein known as the SV40 small t antigen. This protein was found to accumulate late in 
infection and interact with one of the downstream targets of mTOR, protein phosphatase 
2A (PP2A) (Yu et al, 2005). In the mTOR signalling pathway, PP2A performs as a 
negative regulator that controls phosphorylation of 4E-BP1. When mTOR kinase is 
activated, it causes deactivation of PP2A and thus allows phosphorylation of 4E-BP1. 
While in the inactive form, mTOR causes activation of PP2A which prevents
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phosphorylation of the eIF4E-binding protein (reviewed in Bononi et ah, 2011 and Hay 
& Sonenberg, 2004). In the case of SV40 infection, the viral protein binds directly to 
PP2A to activate the protein phosphatase and dephosphorylate 4E-BP1.
Although some viruses cause activation of 4E-BP1 in order to block formation of the 
eIF4F complex, in most studies of virus infection, inactivation of 4E-BP1 through 
hyperphosphorylation has been reported to promote viral replication. As mentioned 
before, phosphorylation of 4E-BP1 at Thr37, Thr46, Ser65 and Thr70 causes dissociation 
of eIF4E-4E-BPl complexes. Free eIF4E released from 4E-BP1 interacts with eIF4G to 
form the eIF4F complex which will then be recruited to the host cell’s mRNA or viral 
mRNA for gene expression (Gingras et al., 1996).
In adenovirus infection, both 4E-BP isoforms (4E-BP1 and 4E-BP1) were observed to be 
phosphorylated which resulted in an increase in viral protein synthesis (Feigenblum & 
Schneider, 1996; Gingras & Sonenberg, 1997). During infection, adenovirus uses its viral 
proteins, E4-0RF1 and E4-ORF4 to enhance mTOR activation which promotes their 
replication. E4-0RF1 is a viral protein that mimics a growth factor identified to activate 
PI3-kinase and PKB, stimulating activation of mTOR for phosphorylation of 4E-BP1. 
Meanwhile, E4-ORF4 was observed to bind to and deactivate PP2A, allowing 
phosphorylation of 4E-BP1. Unlike SV40 that uses the small t antigen to dephosphorylate 
4E-BP1 via its interaction with PP2A, binding of the adenovirus protein E4-ORF4 to 
PP2A seems to stimulate activation of mTOR signalling (O’Shea et al., 2005a; O’Shea et 
a/.,2005b).
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Hepatitis C infection was observed to activate the N-Ras-PI3K-Akt-mT0R pathway to 
sustain cell survival and prevent apoptosis via N-Ras activation and at the same time 
promote viral growth by maintaining optimum conditions for viral replication (Mannova 
& Beretta, 2005). In addition, a recent study has shown that the HCV viral protein, 
nonstructural protein 5A (NS5A) impairs interaction between FK506-binding protein 38 
(FKBP38) and mTOR, leading to activation of the mTOR pathway and phosphorylation 
of 4E-BP1 (Peng et al., 2010; George et al., 2012).
In human cytomegalovirus (HCMV) infection, phosphorylation of 4E-BP1 was reported 
to be increased even when the mTOR signalling pathway was inhibited by rapamycin or 
hypoxia. (Kudchodkar et al., 2004). In addition, to emphasize the Khudchodkar et al. 
(2004) finding, depletion of the mTOR-associated kinases, raptor or rictor also had no 
effect on p70S6K and 4E-BP1 phoshorylation levels during HCMV infection, suggesting 
that either mTORCl or mT0RC2 is able to phosphorylate 4E-BP1. The levels of 
phosphorylation of 4E-BP1 and S6K were also observed to be maintained during the viral 
infection even when mTOR kinase activation was inhibited by another mTORCl and 
mT0RC2 inhibitor, tricyclic benzonaphthyridione inhibitor 37 (Torinl) (Clippinger et 
al., 2011b). In addition, binding of the HCMV viral protein, UL38 to TSC2 has been 
observed to inhibit TSC2 function, therefore phosphorylating and activating mTORCl 
complex (Moorman et al., 2008).
In tumor cells, activation of the mTOR signalling pathway is observed to promote cell 
proliferation and survival. In nasopharyngeal carcinoma (NPC) associated with Epstein- 
Barr virus (EBV) infection, mTOR activation via PI3K/Akt was also observed to be
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enhanced by the viral latent membrane protein, LMPl (Chen et al., 2010) or LMP2A 
proteins, encoded by EBV (Moody et al., 2005) causing phosphorylation of 4E-BP1 and 
p70S6K. As well as having an effect on the PBK/Akt/mTOR transduction pathway for 
regulating phosphorylation of 4E-BP1, LMPl has also been reported to induce activation 
of p38, leading to production of the anti-inflammatory cytokine, interleukin-10 (ILIO) 
(reviewed in Krams and Martinez, 2008). The ILIO gene is expressed by different types 
of cell such as T cells or macrophages, but has also been identified in viral genomes such 
as EBV, equine herpes virus type 2 (EHV2) and HCMV (reviewed in Moore et al., 
2001).
Tumor suppressor proteins, (TSCl and TSC2) are proteins related to cell growth and 
proliferation. They regulate mTOR kinase which is a downstream target of Akt. 
Overexpression of TSCl/2 deactivates mTOR kinase which causes dephosphorylation of 
4E-BP1 and S6K. As mentioned in Section 1.7.6, TSCl/2 deactivation by Akt through 
phosphorylation was identified to enhance mTOR signalling pathway activation (Inoki et 
al, 2002; Manning et al, 2002; Ikenuoe et ah, 2008; Norman & Samow, 2010). In 
herpes simplex virus-1 (HSV-1) infection, virally encoded protein Us3 activates mTOR 
directly by phosphorylation of TSC2 on the same residue as Akt. It was reported that this 
kinase could bypass Akt activation to deactivate TSC2, leading to phosphorylation of 4E- 
BPl (Chuluunbaatar et al, 2010; reviewed in Chuluunbaatar & Mohr, 2011).
To summarise, regulation of signalling pathways during viral infection is not only 
controlled by host cells for cell growth and survival, but changes to the pathways can also
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be modulated by the virus itself using its viral proteins in order to promote viral 
replication in the cells (Figure 1.21).
1.7.9 Cross-talk between MAPK and mTOR
As detailed before, a number of signalling pathways such as the MAPK and mTOR 
pathways are involved in controlling biological activities within cells. Although both of 
the pathways have been reported specifically to inhibit particular kinases, however there 
is some ‘cross-talk’ between MAPK and mTOR signalling suggesting that under certain 
conditions, cells may use an alternative pathway instead of their usual one for regulating 
their growth or survival (Figure 1.22).
For example, p70S6 is normally activated by the mTOR signalling pathway, however 
Wang et al (2001) have reported in adult rat ventricular cardiomyocytes that p70S6K 
could be upregulated by MEK/ERK signalling when inhibition of MEKl/2 using specific 
inhibitors was observed to abolish activation of S6K2. For additional confirmation, this 
group also used endothelin 1, a hyperthropic agent that can activate S6K via MEK 
signalling (Wang et al., 2001). Lehman and Gomez-Cambronero, using peripheral blood 
neotrophils, have also reported that MAPK regulates p70S6K after they found that 
p70S6K and MAPK are co-immunoprecipitated when the cells were stimulated by 
granulated-macrophage colony-stimulating factor (GM-CSF) (Lehman & Gomez- 
Cambronero, 2002). In addition, communication between the two pathways was also 
observed in small cell lung cancer (SCLC) cells stimulated by fibroblast growth factor-2
79
Chapter 1 Introduction
L M P 1/L M P 2A  
(E p stem -B air virus)
E 4 -0 R F 1
(A denovirus)
Us3
(H erpes S im p lex  V irus)
(H epatitis 
C V irus)
r_ EKBF38 ~J
Ü L38
(H um an C y tom egalov irus)
eIF4A
Small t  an tigen  
(S im ian  V irus 40 )
(A denovirus)
(H epatitis « Ë g g g g
1 / l
Figure 1.21 Regulation of activation of host-cell protein by viral proteins during 
infection
Host cell translation initiation takes place in a cap-dependent manner and is regulated by 
elF4E and 4E-BP1. During infection, viruses target signalling pathways involved in 
translation initiation to inhibit host-cell cap-dependent translation so as to promote viral
replication. Activation: --- > ------ >; deactivation:-----1 — I. (Based on Cuesta et al,
2000; Moody et al, 2005; O’Shea et al, 2005a; O’Shea et al, 2005b; Yu et al, 2005; 
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(FGF-2). FGF-2 is a mitogen that can activate ERKl/2. In this study, activation of the 
MEK/ERK signalling pathway by FGF-2 was shown to upregulate S6K2 kinase (Pardo et 
al, 2001). Blocking MEK activation as well as mTOR deactivation by rapamycin, were 
also reported to slow down eell aging confirming that activation of S6K could be 
regulated by both the mTOR and MEK/ERK pathways (Demidenko et al, 2009).
Many studies have shown that phosphorylation of eIF4E by Mnkl/2 occurs via activation 
of MAPK signalling pathway activation. However, a recent study on human cancer cells 
has reported that eIF4E can also be phosphorylated via PI3K as inhibition of mTOR 
signalling by rapamycin or mTOR silencing, enhanced eIF4E phosphorylation (Sun et al, 
2005; Wang et al. 2007a),. However, mTOR inhibition alone did not cause 
phosphorylation of eIF4E in Mnkl/2 knock-out mice, suggesting that phosphorylation of 
the cap-binding protein in human cancer cells occurs in a PI3K-dependent and Mnk- 
dependent manner (Wang et al, 2007a).
Other studies have also indicated communication between the mTOR and MAPK 
signalling pathways. For example, 4E-BP1 can also be phosphorylated by MAP kinases 
such as extracellular signal kinases (ERKs) and Rho GTPase (Herbert 2002; Wang & 
Proud, 2002; Villalonga et al, 2009; reviewed in Mendoza et al, 2011). Also, under 
hypertonic stress, inhibition of cellular protein synthesis occurs due to dephosphorylation 
of eIF4E, 4E-BP1 and ribosomal protein S6 that leads to the formation of eIF4E-4E-BPl 
complex. But when the cells were returned back to isotonic conditions, although 4E-BP1 
phosphorylation could be prevented by rapamycin, RADOOl, wortmaninn and
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LY294002, treatment of the cells with these inhibitors did not prevent cellular protein 
synthesis. Cell recovery from the salt shock was observed to result from upregulation of 
ERKl/2 kinase activity. Interestingly, inhibition of ERKI/2 by U0I26 under the same 
conditions blocked phosphorylation of ERKl/2 and of 4E-BP1 and this eventually 
prevented the cell protein synthesis. This demonstrates that phosphorylation of 4E-BP1 is 
not only mediated by mTOR signalling but can occur through MAPK signalling as well 
(Naegele & Morley, 2004). Moreover, ultraviolet B (UVB) irradiation, has been reported 
to cause phosphorylation of 4E-BP1 at Thr36, Thr45, Ser64 and Thr79 via the p38/MSKI 
pathway as inhibition of p38 by SB203580 inhibited 4E-BP1 phosphorylation but 
downregulation of PI3K by wortmannin did not (Liu et al., 2002).
Therefore, since the effect of calicivirus infection on cell signalling pathways, 
specifically MAPK and mTOR, has not been studied yet, I was interested to know the 
mechanism used by the caliciviruses to control their host cells’ biological activity in 
promoting their replication. In addition to using their viral VPg to hijack the host cell’s 
translation machinery to synthesis their viral protein, I wished to investigate how the 
virus might control the MAPK and mTOR signalling pathways during the translation 
process.
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Caliciviruses have been shown to differ in their requirement for translation initiation 
factors. In order to further dissect these requirements, I have investigated the effect of 
FCV and MNV infection on eIF4E and 4E-BP1. The aims of my project were;
a) To determine the effect of FCV and MNV infection on the 
phosphorylation of eIF4E and its regulator protein, 4E-BP1. I used 
specific phospho-antibodies to analyse changes in the phosphorylation of 
eIF4E and 4E-BP1 during infection.
b) To analyse the activation of signalling pathways involved in the regulation 
of eIF4E and 4E-BP1 and investigate the requirements for activation of 
these signalling pathways for viral translation and replication. To
determine this, I used specific phospho-specific antibodies to study activation 
of kinases in the mTOR and MAPK signalling pathways and specific 
inhibitors of the pathways to analyse the requirements for the activation of 
these kinases by the virus.
c) To analyse the requirement for an interaction between eIF4E—eIF4G in
FCV and MNV  translation. For this study, I used a small-molecule inhibitor 
to disrupt the interaction between eIF4E and eIF4G and analysed the effect of 
the inhibitor on viral replication by estimating the virus titre by TC ID 50 assay.
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2.1 Crandell Rees feline kidney (CRFK) and feline embryonic airway 
(FEA) ceils
CRFK cells (European Culture Collections' Organization) or FEA cells (a gift from Dr 
Alan Radford, University of Liverpool) were grown in Eagle’s Minimum Essential 
Medium (MEM) with Earle’s salts. The medium was supplemented with 10% (v/v) foetal 
bovine serum (FBS), 1% non-essential amino acids and 1% (v/v) penicillin/streptomycin 
(Life Technologies). The cells were incubated at 37®C with 5% carbon dioxide in a 
Galaxy S Incubator (Wolf Laboratories). When the cells were approximately 80% 
confluent, the medium was removed and 3 ml of 1:10 trypsin/versene (10 ml trypsin in 
100 ml versene) (Life Technologies) was added to wash the cells. Then, the 
trypsin/versene was removed and a further 5 ml of 1:10 trypsin/versene were added to 
detach the cells. The detached cells were transferred to a 25-ml universal tube containing 
5 ml of growth medium and centrifuged at 2,500 rpm for 3 min. The medium was 
removed and the pellet was resuspended in 6 ml of growth medium before 1 ml of the 
cell suspension was transferred into a 75-cm^ flask containing 15 ml of medium.
2.2 Mouse leukaemic monocyte-macrophage cells (RAW 264.7)
RAW 264.7 cells (European Culture Collections’ Organization) were grown in vented 
75-cm  ^ cell culture flasks in Dulbecco’s Modified Eagle’s Minimum Essential Medium 
(DMEM) with Earle’s salts. The medium was supplemented with 10% (v/v) foetal bovine 
serum (FBS) and 1% (v/v) penicillin/streptomycin. The cells were incubated at 37°C with
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carbon dioxide (5%) in a Galaxy S Incubator. When the cells were approximately 80% 
confluent, they were scraped off and centrifuged at 2,500 rpm for 3 min. The supernatant 
was removed and the pellet was resuspended in 6 ml of growth medium before 
transferring I ml of the cell suspension into a 75-cm  ^vented cell culture flask containing 
15 ml of growth medium.
2.3 Murine microglial cells (BV2)
Murine microglial cells (BV2) were acquired from Dr Ian Goodfellow (Imperial College, 
UK). The cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% (v/v) FBS, 1% penicillin/streptomycin, 1% L-glutamine and 1% 
sodium bicarbonate (Life Technologies). The cells were incubated at 37°C with carbon 
dioxide (5%) in a Galaxy S Incubator. When the cells were approximately 80% 
confluent, they were scraped off and centrifuged at 2,500 rpm for 3 min. The supernatant 
was removed and the pellet was resuspended in 6 ml of growth medium after which 1 ml 
of the cell suspension was transferred into a 75-cm  ^ vented flask containing 15 ml of 
growth medium.
2.4 Production of feline calicivirus (FCV) stock
FCV (Urbana) was acquired from Dr Ian Goodfellow (Imperial College, UK). A 
confluent 75-cm  ^flask (approximately 80%) of CRFK cells were infected with I ml FCV 
seed stock in 4 ml growth medium and rocked for 1 h at room temperature. An additional
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10 ml of growth medium were added to the flask and the cells were incubated at 37°C in 
5 % carbon dioxide in a Galaxy S Incubator overnight. The cells were centrifuged at 
2,000 rpm for 5 min before the supernatant was aliquoted into 5-mL bijoux and stored at 
-80°C. The titre of the virus was determined using the Tissue Culture 50% Infectious 
Dose (TCIDso) Assay.
2.5 Production of murine norovirus-1 (MNV) stock
MNV was acquired from Prof. Herbert Virgin (Washington University, St. Louis). A 
confluent (approximately 80%) 75-cm  ^flask of RAW 264.7 cells was infected with 1 ml 
of MNV seed stock in 4 ml of growth medium and rocked for an hour at RT. Then, 10 ml 
of growth medium were added to the flask and the cells were incubated at 37°C with 5% 
CO2 for 18-24 h. The cells were frozen at -80°C and subjected to two freeze/thaw cycles. 
The cells were then centrifuged at 2,000 rpm for 5 min. The supernatant was aliquotted 
into 5 ml bijoux and stored at -80°C. A TC ID 50 assay was performed to determine the 
titre of the virus.
2.6 Cell Signalling Reagents
Compounds used to inhibit cell signalling pathways were as follows: PD184352 (Axon 
Medchem), PD98059 and SB203580 (Calbiochem), KU0063794 (Tocris bioscience), 
CGP57380 and SHN-093 (gifts from Prof. Simon Morley, University of Sussex, UK). A
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small-molecule inhibitor, 4E2RCat (a gift from Prof. Jerry Pelletier, McGill University, 
Canada) was used to inhibit the interaction between eIF4E and eIF4G (Table 1.1).
2.7 Antisera
Total 4E-BP1 (Santa Cruz Biotechnology, Inc.), total eIF4E and MnkI (gifts from 
University of Sussex), total ERK, total p38, phospho-eIF4E (Ser 209), phospho-4E-BPl 
(Thr37/46, Thr70, Ser65 sites), phospho-ERKl/2 (Thr202/Try204), phospho-p38 
(ThrI80/Tyrl82), phospho-MnkI (Thrl97/202) (Cell Signalling Technology, Inc), 
GAPDH (Ambion), anti-rabbit and anti-mouse (Dako, Cytomation) antibodies were used 
to analyse protein for Western blotting (Table 2.2).
2.8 Time course of infection
The day before infection, cells were seeded in 35-mm dishes at the following densities: 
CRFK cells 1.2 x 10^  cells per well; and RAW 264.7 cells 9.6 x 10  ^cells per well. The 
cells were infected on the following day at a multiplicity of infection of 3 (MOI of 3) for 
FCV, and MOI of 10 for MNV. Uninfected cells at 8 h (FCV) and 12 h (MNV) were used 
as the controls. The cells were incubated at 37°C in 5% carbon dioxide in a Galaxy S 
incubator and harvested at the following time-points after infection (0, 2, 4, 6 and 8 h for 
FCV, and 0, 6, 8, 10 and 12 h for MNV). Cells were lysed in 200 pi of NLB buffer (50 
mM HEPES at pH 7.4, 150 mM NaCl, 2 mM EDTA, 2 mM Na]V0 4 , 25 mM 
glycerophosphate. Complete Mini protease inhibitor cocktail [Roche], 0.5% NP40) and
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Inhibitors Protein Targets Concentrations (pM)* Suppliers
PDI84352 MEKI/2 5, 25, 50, 75 Axon Medchem
PD98059 ERKI/2 25, 50, 75, 100 Calbiochem
SB203580 p38 1,5, 10, 25 Calbiochem
CGP 57380 MnkI/2 10, 20,40 Prof. Simon Morley, 
University of Sussex, UK
SHN-093 Mock Mnk 1/2 10, 20, 40 Prof. Simon Morley, 
University of Sussex, UK
KU0063794 mT0RCl/C2 5, 10, 25 Tocris bioscience
4E2RCat eIF4E—eIF4G 5, 10, 15, 25, 50 Prof. Jerry Pelletier, 
McGill University, 
Canada
Table 2.1 Inhibitors used for cell signalling studies and eIF4E—eIF4G
interaction study
* All inhibitors were made up in 1% DMSO unless stated otherwise.
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Primary Antibody
Primary
Antibody
Dilution
Secondary
Antibody
Secondary
Antibody
Dilution
Total eIF4E 1:2000 Anti-rabbit 3.5 : 10000
Total 4E-BP1 1:200 Anti-rabbit 1 :2000
Phospho-eIF4E (Ser209) 1:1000 Anti-rabbit 1 :2000
Phospho-4E-BPl (Ser65) 1:1000 Anti-rabbit 1 :2000
Phospho-4E-BPl(Thr37/46) 1:1000 Anti-rabbit 1 :2000
Phospho-4E-BP 1 (Thr70) 1:500 Anti-rabbit 1 :2000
Total p38 1:1000 Anti-rabbit 1 :2000
Phospho-p38 (Thrl80/Tyr 182) 1:2000 Anti-mouse 1 :2000
Total ERKl/2 1:1000 Anti-rabbit 1 :2000
Phospho-ERKl/2 (Thr202/Try204) 1:1000 Anti-rabbit 1 :2000
Total Mnkl 1:1000 Anti-rabbit 1 :2000
Phospho-Mnkl (Thrl97/202) 1:1000 Anti-rabbit 1 :2000
Total mTOR 1:1000 Anti-rabbit 1 :2000
Phospho-mTOR (Ser2448) 1:1000 Anti-rabbit 1 :2000
GAPDH 1:10000 Anti-mouse 1 :2000
Table 2.2 Primary and secondary antibodies used for Western blotting
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centrifiiged at 14,000 rpm for 5 min at 4°C using a microcentrifuge. Cell lysates were 
stored at 20°C.
2.9 Cell cytotoxicity assay
CRFK and RAW 264.7 cells seeded in 35-mm dishes were treated with inhibitors at 5, 
25, 50 and 75 pM for PD 184352; 25, 50, 75 and 100 pM for PD98059; 1, 5, 10 and 25 
pM for SB203580; 10, 20 and 40 pM for CGP57380; 10, 20 and 40 pM for SHN-093; 5, 
10 and 25 pM for KU0063794; or 1% DMSO as a control and incubated at 37°C with 5% 
carbon dioxide in a Galaxy S Incubator for 8 h (FCV) or 12 h (MNV). Aliquots from the 
cultures were collected and drug toxicity was determined using the Cytotoxicity 
Detection Kit^^^^(LDH; Roche Applied Science) by measuring the activity of LDH 
released from damaged cells. The assay was carried out according to the manufacturer’s 
protocol. Samples were measured at a wavelength of 490 nm using an Automated 
Microplate Reader (Bio-tek Instruments Inc.).
2.10 Inhibitor concentration optimization experiment
CRFK or RAW 264.7 cells seeded in 35-mm dishes were pre-treated with cell signalling 
inhibitors at 5, 25, 50 and 75 pM for PD184352; 25, 50, 75 and 100 pM for PD98059; 1, 
5, 10 and 25 pM for SB203580; 10, 20 and 40 pM for CGP57380; 10, 20 and 40 pM for 
SHN-093; 5, 10 and 25 pM for KU0063794; or 1% DMSO as a control, for an hour at 
37°C in 5 % CO2 (Incubator Galaxy S; Wolf Laboratories). Inhibitor-treated cells were
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then infected with FCV or MNV at a MOI of 0.3 and rocked for 30 min at room 
temperature, after which the virus and inhibitors were removed and the cells were washed 
in new growth medium. The new growth medium with the same specific inhibitor at the 
indicated concentrations was added and the cells were incubated at 37°C with 5 % carbon 
dioxide in a Galaxy S Incubator for 8  h or 12 h for FCV and MNV, respectively. The 
virus yields were estimated by the 50% tissue culture infectious dose (TCID50) assay after 
two freeze/thaw cycles.
2.11 Effect of inhibitors on virus replication
Cells were seeded in 35-mm 6 -well plates and left to incubate overnight. On the 
following day, the cells were pre-treated with a specific inhibitor at a particular 
concentration and incubated for an hour at 37°C in 5 % CO2 (Incubator Galaxy S; Wolf 
Laboratories). The cells were then infected with virus at a MOI of 0.3 and rocked for an 
hour at room temperature. The cells were then washed and new growth medium was 
added into each well. Untreated infected cells were used for the control samples. The 
cells were then incubated at 37°C in 5% CO2 in a Galaxy S Incubator and harvested at 0, 
2, 4, 6 and 8 h after infection for FCV, and 0, 6, 8, 10 and 12 h after infection for MNV. 
The culture supernatants were retained for estimation of virus titre by TCID50 assay, 
while the cells were lysed in 200 pi of NLB buffer (appendix) and centrifuged at 14,000 
rpm for 5 min at 4°C using a microcentrifuge. Cell lysates were stored at 20°C to prevent 
proteins from denaturing.
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2.12 The 50% tissue culture infectious dose (TCID50) assay
A 96-well plate was seeded with 35,000 cells per well. Serial ten-fold dilutions of virus 
were prepared in MEM (for FCV) or DMEM (for MNV) and 50 pi of each dilution was 
added to six wells containing cells. The last row contained uninfected cells as a control 
(Figure 2.1). The cells were then incubated at 37°C with 5% carbon dioxide Galaxy S 
Incubator for 18 h (FCV) or 48 h (MNV). The next day, each well was scored as infected 
(+) or uninfected (-) and the titre of the virus in TCID50 units per mililitre was estimated 
by the method of Reed and Muench (1938) using the following formula:
[(% of wells infected at dilution above 50%)-50]
Virus titre =
[(% of wells infected above 50%) - (% infected below 50%)]
=  TCIDsounits/ml 
For a MOI of I, cells were infected at a rate of I TCID50 unit per cell.
2.13 Protein concentration assay
Concentrations of the protein samples (from Sections 2.8 or 2.11) were determined using 
the BCA™ Protein Assay Kit (PIERCE-Thermo Scientific). The assay was carried out 
according to the manufacturer’s protocol. Protein concentration was measured at a 
wavelength of 562 nm using an ELISA plate reader (Perkin Elmer Multilabel counter 
Model 1420-VICTGR^tm) and samples were adjusted to give equal amounts of protein 
before immunoblotting.
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Dilution
Control
O Cells + virus 
O Cells (control)
Figure 2.1 The 50% culture infection dose (TCID50) assay
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2.14 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE)
For each sample, 20 pi of cell lysate (from Section 2.13) were mixed with 10 pi of SDS- 
sample buffer (3X SDS-PAGE sample loading buffer) and 1 pi of DTT (reducing agent) 
(New England Biolabs), Samples were heated at 85°C for 5 min to denature the proteins, 
followed by SDS-PAGE (see appendix for recipe). Mini gels (BIO-RAD) were run at 100 
V, while large gels (30 ml) were run at 250 V. Proteins were then transferred to 
Immobilon-P PVDF membranes (Milipore Corp) by Western blotting as outlined below.
2.15 Western blotting
Following SDS-PAGE, the proteins were transferred to polyvinylidene fluoride (PVDF) 
membranes for 90 min at a constant voltage of 100 V and a maximum current of 400 mA 
in Tris/glycine/methanol buffer (Appendix). The membrane was blocked in 5% milk 
protein (Marvel) in IX TBS (plus 0.1% Tween 20) for one hour and was then exposed to 
specific primary and secondary antibodies at the concentrations shown in Table 2.2. 
However, for 4E-BP1 detection, the membrane was first fixed with 30 pi of 
glutaraldehyde in 15 ml of Ix PBS for 15 min at room temperature before blocking in 5% 
milk protein/TBS Tween as usual. The membrane was developed with Super Signal West 
Pico chemiluminescent substrate (Pierce Biotechnology) and exposed to Fuji 
radiographic film (New England Biolabs) for autoradiography and developed after 
various time intervals. Each experiment was repeated at least three times.
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Infection of cells with UV-treated FCV and MNV
Virus was exposed to ultraviolet-light (UV-light) at a wavelength of 254 nm for 4 min 
(Park et al., 2011; Duizer et al, 2004) before being used to inoculate each well of a 24- 
well plate containing 1.5 X 10^  CRFK, or 2.0 X 10^  RAW 264.7 cells. The cells were 
infected at a MOI of 3 and 10 for FCV and MNV respectively and incubated at 37°C with 
5% carbon dioxide in a Galaxy S Incubator. Cell lysates and culture supernatants were 
collected at 0, 2, 4, 6  and 8  h after infection for FCV, and 0, 2, 6 , 8 , 10 and 12 h after 
infection for MNV and used for specific protein analysis by Western blotting and viral 
replication analysis by TCID50 assay.
2.16 Effect of translation inhibition on cellular protein synthesis
Cells (CRFK or RAW 264.7) were seeded in 24-well plates overnight. On the following 
day, the cells were treated with the eIF4E—eIF4G inhibitor 4E2RCat in 1% DMSO at 5, 
10, 15, 25 and 50 pM, or 1% DMSO (as a control). The cells were then incubated at 37°C 
with 5% carbon dioxide in a Galaxy S Inhibitor for 8  or 12 h for CRFK and RAW 264.7 
respectively. The cells were washed with Met/Cys-free medium (10% dialysed FBS, 1% 
penicillin and streptomycin, 0.5% gentamyein, 1% glutamine) twice before 35-S 
translabel labelling mixture (Met/Cys-free medium and 0.25 ul 35-S translabel [MP 
Biomedicals]) was added to each well. The plates were incubated at 37°C for 20 min 
before the labelling mixture was removed to stop the process. The cells were harvested 
by the addition of 0.2M NaOH. Then, supernatant were transferred into test tubes before 
the addition of 20% trichloroacetic acid (TCA) solution to precipitate proteins. After 15
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min, the samples were filtered and washed twiee with 8% TCA and ethanol through glass 
microfibre filter (GF/C) discs (Camlab, UK). Each disc was then dried and dissolved in 4 
ml of Liquid Scintillation Cocktail (Fisher Scientific, UK) before the scintillation events 
were counted using Liquid Scintillation Analyzer (Perkin Elmer Tri-Carb 2800TR 
Model). The results were analysed using a 1-tailed Student’s  ^test.
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Introduction
Cellular mRNAs are largely translated by a cap-dependent mechanism that requires 
binding of the eIF4E protein to capped mRNA. In contrast to cellular mRNAs, 
calicivirus RNA translation is dependent on the presence of the VPg protein that is 
linked to the 5' end of the viral RNA. Direct interaction between the VPg on FCV 
RNA and eIF4E is required for initiation of viral protein synthesis (Goodfellow et 
ai, 2005). FCV protein synthesis is reduced in eIF4E-depleted lysates which also 
indicates that eIF4E is critical for FCV gene expression (Goodfellow et al, 2005). 
Therefore, investigation of the status of eIF4E and its regulator protein, 4E-BP1 
during FCV infection is important for my understanding of FCV replication.
In this study, my initial aim was to identify the effect of FCV infection on the 
phosphorylation status of eIF4E and 4E-BP1. Then, I extended the investigation to 
an analysis of the signalling pathways that are involved in controlling the 
phosphorylation changes on both proteins during FCV infection.
Results ^
3.1 Phosphorylation status of eIF4E following FCV infection
Activation of eIF4E through phosphorylation occurs under many conditions and has
been shown to increase the affinity of the protein for the cap structure of mRNAs
(Minich et al., 1994). Since eIF4E has been reported to interact with VPg during
FCV infection (Goodfellow et al, 2005), I was interested to study the effect of FCV
infection on the phosphorylation status of eIF4E. For this study, CRFK cells were
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infected with FCV at a MOI of 3 and cell lysates were collected at 2, 4, 6 and 8 h 
post-infection. A control sample was represented by an uninfected cell sample that 
was harvested at 8 h. Samples were analysed by immunoblotting with phospho- 
eIF4E (Ser209) and total eIF4E antibodies.
As shown in Figure 3.1, phosphorylation of eIF4E is gradually increased during 
FCV infection. The phosphorylation starts 4 h after infection and reaches the highest 
level at 8 h post-infection. In contrast, levels of total eIF4E protein during infection 
remain constant. GAPDH expression was monitored as a loading control and showed 
an even loading for each sample.
3.2 Phosphorylation status of 4E-BP1 following FCV infection
Release of eIF4E from 4E-BP1 is regulated by phosphorylation of 4E-BP1. 
Hyperphosphorylation of 4E-BP1 on different amino acids causes dissociation of 
eIF4E and the 4E-BP1 complex (Heesom & Denton, 1999). Free eIF4E protein will 
then interact with other translation initiation factors to form the eIF4F complex. In 
its hypophosphorylated form, 4E-BP1 sequesters eIF4E and thus prevents eIF4E 
participating in the eIF4F complex, resulting in inhibition of protein synthesis 
(Feigenblum & Schneider, 1996; Wang et al., 2005). As we have demonstrated in my 
previous study (Chaudhry et al., 2006), addition of 4E-BP1 to FCV translation 
reactions inhibited FCV RNA translation; therefore, I was interested to analyse 
phosphorylation changes on 4E-BP1 during FCV infection. Samples collected at 
various time-points post-infection of CRFK cells were analyzed using phospho 4E- 
BPl antibodies at different sites of phosphorylation; Serine65, Threonine37/46 and
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Phospho-eIF4E (Ser209)
Total eIF4E
GAPDH
hpiControl 2
Figure 3.1 Phosphorylation status of eIF4E following FCV infection
CRFK cells were infected with FCV for 2, 4, 6 and 8 h at an MOI o f 3. Control 
shows uninfected cells that were harvested at 8 hpi. Total protein from uninfected 
and FCV-infected cells was separated by 10% SDS-PAGE and transferred by 
Western blot to polyvinylidene fluoride (PVDF) membrane. Samples were analyzed 
by immunoblotting with anti-eIF4E antisera (total or phospho-specific). GAPDH 
levels were monitored as a loading control. Detection was carried out with anti­
horseradish peroxidase antibodies using Super Signal W est Pico chemilum inescent 
substrate (Pierce Biotechnology) and Fuji radiographic film (New England Biolabs).
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ThreonineTO. I focused on these particular sites as they have been reported to be the 
main phosphorylation targets required for eIF4E and 4E-BP1 complex dissociation 
(Hay & Sonenberg, 2004; Harris & Lawrence, 2003).
As shown in Figure 3.2, FCV infection causes dephosphorylation of 4E-BP1 later in 
infection. Dephosphorylation occurs as early as 6  h after infection at Ser65 and 
Thr37/46. However, dephosphorylation at Thr70 was not observed until after 6  hpi. 
Total 4E-BP1 levels were maintained during the infection. In contrast to MNV study 
(Figure 4.2) which shows that there are three bands of total 4E-BP1, we are still 
unsure why we only observed two bands of total 4E-BP1 during FCV infection in 
CRFK cells. It could be that different cells (for example CRFKs and RAWs) may 
exhibit different forms of the protein or perhaps the observed result actually had 
hyperphosphorylated forms but much less so that they would only have shown with a 
longer exposure. Further investigation will be done to explain the observed result. 
GAPDH expression was monitored as a loading control and showed an even loading 
for each sample.
3.3 Effect of infection with ultraviolet-inactivated FCV on eIF4E 
and 4E-BF1 phosphorylation status
Activation of eIF4E by phosphorylation at Ser209 occurs through the response of 
host cells to extracellular factors such as cytokines, growth factors and viral 
infection. As my initial study demonstrated changes in phosphorylation of eIF4E and 
4E-BP1 during FCV infection, I hypothesized that these changes resulted from viral
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Figure 3.2 Phosphorylation status of 4E-BP1 following FCV infection
CRFK cells were infected with FCV for 2, 4, 6  and 8  h. Control shows uninfected 
cells that were harvested at 8  hpi. Total protein from uninfected and FCV-infected 
cells was separated by 17.5% SDS-PAGE and transferred by Western blot to PVDF 
membrane. Samples were analyzed by immunoblotting with phospho-specific anti- 
4E-BP1 antisera. GAPDH level was monitored as a loading control. Detection was 
carried out with anti-horseradish peroxidase antibodies using Super Signal West Pico 
chemiluminescent substrate (Pierce Biotechnology) and Fuji radiographic film (New 
England Biolabs).
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RNA translation and replication processes in host cells. To confirm this hypothesis, I 
repeated the experiment with ultraviolet (UV)-inactivated virus that can only bind to 
and invade host cells but is lacking in RNA translation and replication functions. The 
FCV was inactivated and inoculated into CRFK cells at a MOI of 3. Protein samples 
were then separated by 10% SDS-PAGE for eIF4E and 17.5% for 4E-BPI analysis. 
Specific proteins were analysed with phospho-eIF4E (Ser209) and phospho-4E-BPl 
(Ser65) antisera.
As shovm in Figure 3.3A, infection of cells with UV-inactivated FCV did not result 
in changes to the phosphorylation status of either eIF4E or 4E-BP1. This confirms 
that changes to eIF4E and 4E-BP1 phosphorylation are as a direct result of FCV 
infection and replication and not due to virus attachment and entry only.
Having demonstrated that UV treatment of FCV RNA did not cause any changes to 
eIF4E or 4E-BP1 phosphorylation, it was necessary to show that UV treatment did 
indeed inactivate the virus. Cells were infected with inactivated FCV and culture 
supernatants were sampled over a time-course of infection. Virus titres were 
estimated using the TCID50 assay. The results are shown in Figure 3.3B. As 
expected, no viral replication was observed in cells infected with the UV-inactivated 
FCV compared with normal FCV infection. This confirms that UV treatment of 
FCV impairs viral RNA translation and replication.
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Figure 3.3 The effect of inactivated FCV infection on phosphorylation status
of eIF4E and 4E-BP1 and viral replication
A) CRFK cells were infected with UV-inactivated FCV for 2, 4, 6  and 8  h. Control 
shows uninfected cells harvested at 8  hpi. Total protein from control and FCV- 
infected cells was separated by 10% and 17.5% SDS-PAGE, respectively, and 
transferred by Western blot to PVDF membrane. Samples were then analyzed by 
immunoblotting with phospho-elF4E (Ser209) and phospho-specific anti-4E-BPl 
(Se65) antisera. The GAPDH level was monitored as a loading control. Detection 
was carried out with anti-horseradish peroxidase antibodies using Super Signal West 
Pico chemiluminescent substrate (Pierce Biotechnology) and Fuji radiographic film 
(New England Biolabs) B) CRFK cells were infected with FCV and UV-inactivated 
FCV. Culture samples were collected at the times indicated and the viral titre was 
estimated by TCID50 assay. (■) Control (wild type FCV) and (•) UV-inactivated 
FCV.
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3.4 Effect of FCV infection on eIF4E and 4E-BP1 phosphorylation 
in FEA cells
As FCV infection causes phosphorylation of eIF4E and dephosphorylation of its 
regulatory binding protein, 4E-BP1, in CRFK cells, I hypothesized that infection 
with this virus might also cause the same effects in other types of cells. To confirm 
this, I used feline embryonic airway (FEA) cells to study any phosphorylation 
changes to these proteins during FCV infection. FEA cells were infected with FCV at 
a MOI of 3 and harvested using the protocol given in Section 2.8. A control was 
represented by uninfected cells harvested at 8  h. The same dephosphorylation of 4E- 
BPl was seen as in CRFK cells. Surprisingly, the phosphorylation status of eIF4E at 
Ser209 was sustained at a constant level (Figure 3.4). This suggests that changes in 
eIF4E phosphorylation may not affect FCV replication and that the observed increase 
in phosphorylation of eIF4E over the course of infection in CRFK cells may 
represent specific host-cell responses.
3.5 Effect of FCV infection on MAP kinases (ERK, p38 and 
Mnkl)
Phosphorylation of eIF4E has been shown to be important for translation initiation 
on mRNA (Minich et al., 1994). It is regulated by the MAP kinase (MAPK) 
signalling pathway, particularly via activation of extracellular signal-regulated 
kinases (ERK/MEK), p38 and Mnk 1/2 kinases. As my initial results showed an
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Figure 3.4 Effect of FCV infection on eIF4E and 4E-BP1 in FEA cells
FEA cells were infected with FCV for 2, 4, 6  and 8  h. Control cells were harvested 
uninfected at 8  hpi. Total protein from control and FCV-infected cells was separated 
by SDS-PAGE and transferred by Western blot to PVDF membrane. Then, the 
samples were analyzed by immunoblotting with phospho-specific anti-phospho- 
eIF4E (Ser209) and anti-4E-BPl (Se65) antisera. The GAPDH level was monitored 
as a loading control. Detection was carried out with anti-horseradish peroxidase 
antibodies using Super Signal West Pico chemiluminescent substrate (Pierce 
Biotechnology) and Fuji radiographic film (New England Biolabs).
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increase in eIF4E phosphorylation during FCV infection in CRFK cells, I was 
interested to further analyse the signalling pathways involved in this 
phosphorylation.
Activation of ERK, p38 and Mnkl kinases during FCV infection was analysed. 
Samples were collected over a time course of FCV infection of CRFK cells and 
analysed by immunoblotting with phospho-specific antibodies: phospho-ERKl/2 
(Thr202/Try204), phospho-p38 (Thr 180/Try 182), and phospho-Mnkl (Thr197/202).
Phosphorylation of ERK was maintained early in infection before declining late in 
infection. This change was concomitant with an increase in p38 phosphorylation 
levels towards the end of FCV infection. This suggests that FCV infection possibly 
activates p38 and this may be important for viral replication. Surprisingly, the level 
of Mnkl phosphorylation gradually decreased over the course of the infection 
(Figure 3.5) in contrast to other studies (Banerjee et al., 2002; Schumann & 
Dobbelstein, 2006) that found that Mnkl is normally activated in response to viral 
infection. Since I have only analysed the activation of Mnkl, I do not know for 
certain which kinase is involved in the phosphorylation of eFF4E during FCV 
infection. It is possible that Mnk2 kinase activation could be responsible for the 
observed eIF4E phosphorylation.
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Figure 3.5 Effect of FCV infection on MAP kinases (ERK, p38 and Mnkl)
CRFK cells were infected with FCV for 2, 4, 6 and 8  h. Control shows uninfected 
cells harvested at 8  hpi. Samples were separated by 10% SDS-PAGE and transferred 
by Western blot to PVDF membrane. Samples were analysed by immunoblotting 
with A) phospho-ERK (Thr202/Try204) and total ERK; B) phospho-p38 
(Thrl80/Tyr82) and total p38; C) and phospho-Mnkl (Thr 197/202) and total Mnkl 
antisera respectively. Detection was carried out with anti-horseradish peroxidase 
antibodies using Super Signal West Pico chemiluminescent substrate (Pierce 
Biotechnology) and Fuji radiographic film (New England Biolabs).
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3.6 Effect of inhibition of extracellular signal-regulated kinases 
(ERK/MEK) on FCV replication and on the phosphorylation of 
Mnkl and eIF4E
As mentioned before, FCV infection maintains phosphorylation of ERK until 4 h 
after infection. ERK activation is not only important for viral RNA translation but in 
another study it was also reported to be required for herpes simplex virus type 1 
(HSV-1) replication (Qin et al, 2011). We hypothesized that maintenance of ERK 
activation early in infection is possibly required for FCV replication. To clarify this, I 
began by analysing what happens when MEK is inhibited using the small-molecule 
inhibitor PD l84352 that is highly specific for MEK 1/2. PD184352 has been shown 
(Allen et al, 2003) to block activation of MEK 1/2 and also its downstream kinase, 
ERK, and therefore blocks signal transduction along this pathway (Allen et a l, 
2003). CRFK cells were treated with the inhibitor at concentrations of 5, 25, 50 and 
75 pM and infected with FCV at a MOI of 0.3 for 8  h. I originally used a MOI of 3 
on all cell signalling inhibition tests, but then I decided to use a MOI of 0.3 as it 
allowed better discrimination of the effects of cell signalling inhibition on viral 
replication. The viral titres were determined by TCID50 assay 8  h after infection. 
Figure 3.6A shows that FCV replication is significantly inhibited at high 
concentrations of the inhibitor. To further validate that the compound does not affect 
host cell viability, I carried out a cell cytotoxicity test on CRFK cells at the same 
concentrations of the inhibitor. Figure 3.6B indicates that this compound has no 
toxic effect on CRFK cells even at high concentrations.
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Figure 3.6 Effect of inhibition of MEK on FCV replication
A) CRFK cells were pre-treated with MEK inhibitor (PDl84352) at the indicated 
concentrations or with 1% DMSO alone as control for one hour. The cells were 
subsequently infected with FCV at a MOI of 0.3 for 8  h. Virus titre was estimated 
using the TCID50 assay. Shown are the means +/- SEM from three separate 
experiments, *p<0.01 (1-tailed Student t test) B) CRFK cells were treated with MEK 
inhibitor (PDl84352) at the indicated concentrations or with 1% DMSO alone for 8  
h. Control sample shows cells treated with Triton X-100 to release the highest level 
of lactase dehydrogenase (LDH). LDH released from dead or damage cells was 
measured using Cytotoxicity Detection Kit*’^ ^^  (LDH: Roche Applied Science).
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Since FCV replication was shown to be inhibited at 50pM PD l84352, I used this 
concentration for a time-course experiment. Cells were treated with 50 pM 
PD l84352 and infected with FCV at a MOI of 3. At 2, 4, 6  and 8  h after infection, 1 
sampled the culture supernatant for determination of viral replication, and harvested 
the cell in lysis buffer for subsequent analysis of the effect on Mnkl and elF4E 
phosphorylation. The results showed that inhibition of viral replication was already 
observed at 4 h post-infection. A significant reduction in viral titre was observed at 6  
and 8  h post-infection, compared with the control lacking the inhibitor (Figure 
3.7A); this confirms that down-regulation of MEK inhibits FCV replication.
Since inhibition of MEK inhibited viral replication, I decided to investigate whether 
this inhibition might also affect the phosphorylation of either Mnkl or elF4E during 
FCV infection. Without inhibition, both Mnkl and elF4E were observed to be 
already phosphorylated. However, as shown in Figure 3.7B, inhibition of MEK 
kinase did not block elF4E phosphorylation and phosphorylation of Mnkl was 
increased at 4-6 h after infection. These results indicate that MEK kinase activation 
and transduction of signals via the MEK pathway are important for FCV replication. 
However, since 1 have seen that inhibition of MEK did not affect phosphorylation of 
elF4E, here, the requirement for MEK activation by FCV for translation of its 
mRNAs is still unclear.
As well as analyzing the effects of MEK inhibition on host cell protein synthesis and
FCV replication, 1 next looked at the effect of ERK kinase inhibition on FCV
replication. This was done in order to confirm the hypothesis that this extracellular
signal-regulated transduction pathway is important for FCV replication, as ERK
113
Chapter 3 The effect of FCV infection on eIF4E and 4E-BP1
1 .0 0 E + 1 0  1
1 .O 0 E + 0 S  -
I -  1 .0 0 E -K Ï4  -
6 82 4
-MEK
Inhibitor
-Control
(DtilSO)
Tim eafterFCV infectiion (hpi)
B
Control 2
Phospho-Mnkl (Thrl97/202)
Phospho-eIF4E (Ser209) 
hpi
Figure 3.7 Effect of MEK inhibition on FCV replication and on Mnkl and 
eIF4E phosphorylation
A) CRFK cells were treated with MEK 1/2 inhibitor (PDl 84352) at 50pM or with 1% 
DMSO alone as a control and infected with FCV at a MOI of 0.3. Culture 
supernatant samples were collected at 2, 4, 6  and 8  h after infection and virus titres 
were estimated by TCID50 assay. Shown are the means +/- SD from three separate 
experiments. Significant reduction at 6  and 8  hpi are based on t-test of normalized 
data. *p<0.01 (1-tailed Student t test) B) CRFK cells were treated with MEK 1/2 
inhibitor (PDl84352) at 50pM or with 1% DMSO and infected with FCV for 2, 4, 6  
and 8  h at a MOI of 3. Control shows uninfected cells that were harvested at 8  hpi. 
Total protein from control and FCV-infected cells was separated by 10% SDS-PAGE 
and transferred by Western blot to polyvinylidene fluoride (PVDF) membrane. 
Samples were immunoblotted with phospho-Mnkl (Thr 197/202) and phospho-elF4E 
(Ser209) antibodies. Detection was carried out with anti-horseradish peroxidase 
antibodies using Super Signal West Pico chemiluminescent substrate (Pierce 
Biotechnology) and Fuji radiographic film (New England Biolabs).
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kinase is a downstream kinase of MEK. PD98059 was used to down-regulate ERK 
kinase (Reviewed in English & Cobb, 2002). Toxicity testing of PD98059 on CRFK 
cells verified that this compound does not cause toxicity to host cells (Figure 3.8A). 
In accordance with the hypothesis, the FCV viral titre was reduced when ERK kinase 
activation was blocked by PD98059 (Figure 3.8B).
So, this finding further strengthened the hypothesis that the extracellular signal- 
regulated kinase (ERK/MEK) pathway is important for FCV replication.
3.7 Effect of p38 inhibition on FCV replication and on Mnkl and 
eIF4E phosphorylation
As shown in Figure 3.5, an increase in phosphorylation of p38 was observed as soon 
as ERK kinase was dephosphorylated at 4 h post-infection. The activation of p38 has 
been reported to be important for regulation of interferon (IFN) signalling in many 
virus-infected cells as a defensive response (Li et ah, 2004). So, inhibition of p38 
might also block FCV infection. The pyridinyl imidazole compound, SB203580 
(Young et al, 1997) was used to inhibit the activation of p38. Cytotoxicity testing of 
SB203580 on CRFK cells showed that the p38 inhibitor had toxic effect on the host 
eells at high concentrations (Figure 3.9A). Again, I observed the effect of the 
inhibitor on FCV replication. The experiment was carried out using SB203580 at 
different concentrations (1,5, 10 and 25 pM) by the method detailed in Section 2.10 
and virus titres were analysed after 8 hpi. In contrast to my results with ERK, p38
115
Chapter 3 The effect of FCV infection on eIF4E and 4E-BP ]
100 1
— 0
Control DMSO 25 50 75 100
PD98059 (uM)
B
1 2 0  -1
100  -
% 2 
S c
9  8
I!
*
DMSO
llii
25 50 75 100
PD98059 (jiM)
Figure 3.8 Effect of inhibition of ERK on FCV replication
A) CRFK cells were treated with ERK inhibitor (PD98059) at the indicated 
concentrations or with 1% DMSO alone for 8  h. Control sample shows cells treated 
with Triton X-100 to release the highest level of lactase dehydrogenase (LDH). LDH 
released from dead or damage cells was measured using Cytotoxicity Detection 
KitPLUs Roche Applied Science) B) CRFK cells were treated with ERK
inhibitor (PD98059) at the indicated concentrations or with 1% DMSO alone for one 
hour. The cells were subsequently infected with FCV at a MOI of 0.3 for 8  h. Virus 
titre was estimated using the TCID50 assay. Shown are the means +/- SEM from 
three separate experiments, *p<0.01 (1-tailed Student  ^test).
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Figure 3.9 Effect of inhibition of p38 on FCV replication
A) CRFK cells were treated with p38 inhibitor (SB203580) at the indicated
eoncentrations or with 1% DMSO alone for 8 h. Control sample shows cells treated 
with Triton X-100 to release the highest level of lactase dehydrogenase (LDH). LDH 
released from dead or damage cells was measured using Cytotoxicity Detection
KitPLUs (-LQjq. Roche Applied Science) B) CRFK cells were treated with p38
inhibitor (SB203580) at the indicated concentrations or with 1% DMSO alone for 
one hour. The cells were subsequently infected with FCV at a MOI of 0.3 for 8 h. 
Virus titre was estimated using the TCID50 assay. Shown are the means +/- SEM 
from three separate experiments, n.s: not significant (1-tailed Student t test).
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inhibition at these concentrations did not significantly reduce the virus titre (Figure 
3.9B).
To confirm that p38 activation is not required for FCV replication, I conducted time 
courses with inhibition of p38. CRFK cells were treated with lOpM of SB203580 
and infected with FCV at a MOI of 0.3. At 2, 4, 6 and 8 h post-infection, culture 
supernatants were collected for determining virus replication and cell lysates were 
collected to investigate the effect of the inhibition on Mnkl and eIF4E 
phosphorylation status during the infection. As before, the growth curves 
demonstrated that inactivation of p38 had no effect on FCV replication (Figure 
3.10A).
If p38 activation is not necessary for FCV replication, maybe it plays a role in elF4E 
phosphorylation? To investigate this, 1 analysed the cell lysates from the time course 
experiment and found that as in normal FCV infection, Mnkl kinase was 
dephosphorylated 4 h after infection. However, the level of elF4E phosphorylation 
remained constant during the infection (Figure 3.10B). Since 1 observed an increase 
in elF4E phophorylation over the course of normal infection, this might suggest that 
phosphorylation of elF4E following p38 activation occurs via Mnk2 and not Mnkl 
kinase.
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Figure 3.10 Effect of p38 inhibition on FCV replication and on Mnkl and 
eIF4E phosphorylation
A) CRFK cells were treated with p38 inhibitor (SB203580) at lOpM or with 1% 
DMSO alone as a control and infected with FCV at a MOI of 0.3. Culture 
supernatant samples were collected at 2, 4, 6 and 8 h after infection and virus titres 
were estimated by TCID50 assay B) CRFK cells were treated with p38 inhibitor 
(SB203580) at lOpM and 1% DMSO and infected with FCV for 2, 4, 6 and 8 h at a 
MOI of 3. Control shows uninfected cells that were harvested at 8 hpi. Total protein 
from control and FCV-infected eells was separated by 10% SDS-PAGE and 
transferred by Western blot to polyvinylidene fluoride (PVDF) membrane. Samples 
were immunoblotted with phospho-Mnkl (Thrl97/202) and phospho-elF4E (Ser209) 
antibodies. Detection was carried out with anti-horseradish peroxidase antibodies 
using Super Signal West Pico chemiluminescent substrate (Pierce Biotechnology) 
and Fuji radiographic film (New England Biolabs).
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3.8 Effect of Mnkl/2 inhibition on FCV replication
Phosphorylation of eIF4E by Mnkl occurs when eIF4E forms part of the eIF4F 
complex. Mnkl is activated by the upstream kinases, ERK or p38, in response to 
factors including growth factors, cytokines and viral infection.
Since Mnkl was dephosphorylated 2 h after FCV infection, I was interested to study 
the effect of an inhibitor of Mnkl activation, CGP57380, on FCV replication. As 
shown in Figure 3.11A, Mnkl inhibition does not affect FCV replication even at 
high concentrations of CGP57380.
Recently, CGP57380 was shown not to be specific to Mnkl/2 kinases and was 
shown to inhibit other kinases as well (Bain et a l, 2007). So, instead of using only 
CGP57380 to investigate the requirement of Mnkl/2 kinase for FCV replication, I 
carried out a control experiment with the mock Mnkl/2 inhibitor, SHN-093. This 
compound has the same molecular structure as CGP57380 apart from one methyl 
group substitution. It does not inhibit Mnkl/2 kinase but has the same inhibitory 
effect on other kinases as CGP57380 (Hou et al, 2012). This compound was used to 
analyse whether specific deactivation of Mnkl/2 was responsible for the observed 
results in the test with CGP57380. A significant reduction in virus titre was observed 
in cells treated with this SFIN-093 as opposed to no inhibition with CGP 57380. 
Without specific inhibition of Mnkl/2 that would accentuate the normal effect of 
infection, FCV replication is inhibited (Figure 3.11B). This result suggests that 
replication of FCV is also associated with inhibition of Mnkl/2 and possibly also the 
activation of other unknown kinases.
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Figure 3.11 Effect of Mnkl/2 inhibition on FCV replication
CRFK cells were pre-treated with A) Mnkl/2 inhibitor (CGP57380); B) Mock 
Mnkl/2 inhibitor (SHN-093) at indicated concentrations or with 1% DMSO alone as 
control for an hour. Then, the cells were infected with FCV at a MOI of 3 for 8 h. 
Virus titre was estimated using the TCID50 assay. Shown are the means +/- SEM 
from three separate experiments. *p < 0.01 (1-tailed Student t test)
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3.9 Effect of inhibition of m TO R  on FC V  replication
Activation of the mammalian target of rapamycin (mTOR) signalling pathway has 
been found to occur in cells infected with a number of viruses (Kudchodkar et al., 
2004; O’Shea et al., 2005a; Chen et al., 2010; Peng et al., 2010). This pathway 
controls 4E-BP1 phosphorylation which is necessary ,to regulate the availability of 
eIF4E that is required for the translation initiation process.
Having demonstrated that 4E-BP1 was dephosphorylated later in FCV infection, I 
was interested to observe mTOR activation over the course of infection. As I 
predicted that activation of mTOR contributes to phosphorylation of 4E-BP1,1 found 
that the phosphorylation status of mTOR followed the same pattern of decreasing 
phosphorylation as that of 4E-BP1 (Figure 3.12). mTOR kinase was initially activate 
during infection before declining at later time-points; I therefore speculated that these 
changes could be important for FCV replication. To confirm this, CRFK cells were 
treated with the mTOR inhibitor KU0063794 at 5, 10 and 25 pM and infected with 
FCV at a MOI of 0.3 for 8  h. Culture supernatants were collected at 8  hpi and virus 
titres were determined by TCID50 assay. As shown in Figure 3.13B, the inhibition of 
mTOR kinase activation significantly reduced FCV replication. This finding was 
verified by viral growth curves determined from the time-course experiment (Figure 
3.14). Taken together, the data show that phosphorylation of 4E-BP1 is regulated by 
mTOR signalling and that activation of this pathway is crucial for FCV infection.
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Figure 3.12 Effect of FCV infection on mTOR kinase
CRFK cells were infeeted with FCV at a MOI of 3 for 2, 4, 6 and 8 h. Control shows 
uninfected cells harvested at 8 h after infection. Total protein from control and FCV- 
infected cells was separated by 10% and 17.5% SDS-PAGE for mTOR and 4E-BP1 
respeetively, and transferred by Western blot to PVDF membrane. Samples were 
analysed by immunoblotting phospho-4E-BPl (Ser65), phospho-mTOR (Ser2448) 
and total mTOR antibodies. GAPDH levels were monitored as a loading control. 
Detection was carried out with anti-horseradish peroxidase antibodies using Super 
Signal West Pico chemiluminescent substrate (Pierce Biotechnology) and 
autoradiography (Fuji radiographic film; New England Biolabs).
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Figure 3.13 Effect of mTOR inhibition on FCV replication
A) CRFK cells were treated with mTOR inhibitor (KU0063794) at the indicated 
concentrations or with 1 % DMSO alone for 8 h. Control sample shows cells treated 
with Triton X-100 to release the highest level of lactase dehydrogenase (LDH) 
released. LDH released from dead or damaged cells was measured using 
Cytotoxicity Detection Kit^^^  ^ (LDH: Roche Applied Science) B) CRFK cells were 
treated with mTOR inhibitor (KU0063794) at the indicated concentrations or with 
1% DMSO alone for one hour. The cells were subsequently infected with FCV at a 
MOI of 0.3 for 8 h. Virus titre was estimated using the TCID50 assay. Shown are the 
means +/- SEM from three separate experiments, *p<0.001 (1-tailed Student t test).
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Figure 3.14 Growth curves of FCV replication with mTOR inhibition
CRFK eells were treated with mTOR inhibitor (KU0063794) at 10p.M or with 1% 
DMSO alone as a eontrol and infected with FCV at a MOI of 0.3. Culture 
supernatant samples were collected at 2, 4, 6 and 8 h after infection and virus titres 
were estimated by TCID50 assay. Shown are the means +/- SD from three separate 
experiments. Significant reduction at 6 and 8 hpi are based on t-test of normalized 
data. *p<0.01 (1-tailed Student r test).
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3.10 Discussion
The process of mRNA translation initiation has been determined to be the main focus 
for regulating protein synthesis (reviewed in Holcik & Pestova, 2010). Multiple 
proteins are involved in this process, including the translation initiation factors that 
comprise the elF4F complex and ribosomal proteins that bind to mRNA (Pestova et. 
al, 2007; reviewed in Hinnebusch, 2006). Cap-dependent translation initiation 
occurs through binding of the eIF4F complex to the methyl guanosine cap at the 5' 
end of mRNA via the cap-binding protein, elF4E (Reviewed in Borden et. ah, 2011). 
An increase of eIF4F complex affinity for the cap structure was observed when 
eIF4E was in the phosphorylated form (Minich et al, 1994). However, Scheper et al. 
(2002) found that phosphorylation of elF4E reduced the protein’s affinity for the cap 
structure of mRNA and thus inhibited protein synthesis. In addition, the binding of 
eIF4G to eIF4E has been shown to increase the affinity of the eIF4F initiation 
complex for capped mRNA to promote protein synthesis (Haghighat & Sonenberg, 
1997).
In addition to the idea that eIF4E phosphorylation is important for the binding of the 
eIF4F complex to capped mRNA, phosphorylation of the 4E-BPs has also been 
shown to play a role in regulating the mRNA translation initiation process. 
Hyperphosphorylation of certain amino acids causes the eIF4E-binding protein to 
release eIF4E which becomes free to interact with eIF4G to form the translation 
initiation complex (Wang et al., 2005). In other words, the phosphorylation status of 
4E-BP1 is a key regulator for cap-dependent translation initiation.
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Hijacking of host-cell protein synthesis machinery by viruses during infection for 
viral gene expression has been reported by many studies. Viruses have evolved novel 
mechanisms such as 1RES- and VPg-dependent translation in order to translate and 
replicate their RNAs in host eells (Goodfellow et al., 2005; Grzela et a l, 2006). VPg 
is a viral protein linked to the 5' end of Picornavirus and Calicivirus mRNA 
(Ambros & Baltimor, 1978; Burrough & Brown, 1978). The VPg on FCV mRNA 
interacts with the eIF4F complex via eIF4E to initiate the translation process 
(Goodfellow et al, 2005). Hijacking of the host-cell translation machinery to 
translate viral mRNA probably prevents cell protein synthesis and leads to cell death.
To further analyse the requirement by FCV of specific translation initiation factors 
for protein synthesis, 1 investigated the effect of FCV infection on eIF4E and its 
regulator protein, 4E-BP1. I began by analysing the effeet on elF4E. FCV infection 
was found to induce phosphorylation of eIF4E late in infection (Figure 3.1). 
Phosphorylation of eIF4E has also been reported in a number of other virus 
infections including human cytomegalovirus (HCMV) (reviewed in Mohr, 2006). 
Some studies suggest that phosphorylation of eIF4E enhances the affinity of the 
elF4F complex for the cap structure of the mRNA (Lamphear & Panniers, 1990; 
Minich et al, 1994; Rau et al., 1996), whereas another study has reported a decrease 
in affinity (Scheper et a l, 2002a). To date, the effect of phosphorylation of eIF4E on 
its binding to VPg remains to be determined.
I then investigated the effect of FCV infection on the eIF4E-binding protein, 4E- 
BPl. As 4E-BP1 can be phosphorylated at several different amino aeid sites, in this 
study I analysed three common phosphorylation sites of 4E-BP1: Ser65; Thr37/46;
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and Thr70. Ser65 and Thr70 have been identified as the main targets for 4E-BP1 
hyperphosporylation leading to eIF4E—4E-BP1 eomplex dissociation (Heesom & 
Denton, 1999). In FCV infection, we found that the phosphorylation level of 4E-BP1 
was maintained for the first 4 h of infection but decreased by 6 h after infection. As 
shown in Figure 3.2, the dephosphorylation starts at Ser65 followed by Thr37/46 
and then Thr70. Western blotting for total 4E-BP1 was used to verify these results 
and showed that the level was sustained throughout the infection Figure 3.2. Taken 
together, the data eonflrm that the observed decrease in 4E-BP1 phosphorylation is 
not due to protein degradation as the result from Western blotting shows that the total 
level of 4E-BP1 did not diminish throughout the infeetion.
Since the level of 4E-BP1 phosphorylation is maintained early in infection, this 
suggests that during this time, eIF4E is free to assemble with the other components 
of the eIF4F complex; the seaffold protein, eIF4G, and the RNA helicase, eIF4A. 
This complex can be employed by either host cell or viral RNA for protein synthesis. 
Dephosphorylation of 4E-BP1 late in infection suggests that during this phase of 
infection the hypophosphorylated form of 4E-BP1 will compete with eIF4G for the 
same binding site on eIF4E and eventually prevent participation in the eIF4F 
complex leading to the shut-down of translation, both for the host eell and the virus. 
These data support our previous study showing that addition of purified recombinant 
4E-BPI to FCV mRNA caused inhibition of viral protein synthesis on the VPg- 
linked RNA (Goodfellow et al, 2005). Translation and replication have been 
reported to occur on the same strand of positive-strand RNA viruses (Novak & 
Kirkegaard, 1994; Garmanik & Andino, 1998). I hypothesise that shutting down of 
the translation process will free up the viral RNA to allow binding of the viral RNA
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polymerase to the 3' end of the same virus RNA strand. It is possible that the 
observed decrease in phosphorylation of 4E-BP1 might induce this switch from 
translation to replication.
Intracellular protein kinases are phosphorylated under many conditions including 
viral infection. Activation might occur through cell surface receptors or as a direct 
effect of viral replication inside the cell (Errieo et al, 2001; Barber et al, 2002). To 
determine whether the changes in eIF4E and 4E-BP1 phosphorylation resulted from 
viral replication and not viral binding, I used ultraviolet (UV)-treated FCV to infect 
CRFK cells. UV-treated virus is thought to bind to eellular receptors and penetrate 
host cells, but the RNA eannot be translated or replicated inside the eells. My results 
show that UV-treated FCV does not affect the phosphorylation of either eIF4E or 4E- 
BPl (Figure 3.3A). Furthermore, viral replication data from time-course 
experiments also supports the hypothesis that the changes in phosphorylation of 
eIF4E and 4E-BP1 are as a result of viral replieation and not viral binding (Figure 
3.3B).
To discover whether or not the observed effects on phosphorylation could be cell- 
specifie, I also studied the effect of FCV infection on the phosphorylation of eIF4E 
and 4E-BPlin a different cell line. Feline embryonic airway (FEA) cells were chosen 
as a comparison to CRFK since it also allows replication of FCV. Infection of these 
cells resulted in dephosphorylation of 4E-BP1 as observed in CRFK cells, but 
surprisingly, the level of eIF4E phosphorylation was stable during the infection 
(Figure 3.4). The fact that FCV infection in different eell lines does not have the 
same effect on the phosphorylation of eIF4E would suggest that the phosphorylation
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of eIF4E has no effect on viral replication. The host cell defensive response eould be 
responsible for the observed differences in eIF4E phosphorylation between the two 
cell lines because different cells have different types of receptors on their surfaces to 
recognise microorganisms for triggering the innate immune response (reviewed in 
Medzhitov, 2007).
Having established that FCV infection causes phosphorylation of eIF4E and 
dephosphorylation of 4E-BP1 late in infeetion, I was interested to identify the 
signalling pathways involved. I began by investigating the signalling pathway that 
regulates phosphorylation of eIF4E. The main regulator for eIF4E phosphorylation is 
the mitogen activated protein kinase (MAPK) transduction pathway. Growth factors, 
stress, cytokines, phorbol esters and viral infection induce activation of MAP kinases 
such as extracellular signal-regulated kinase (ERK) and p38 kinase (Wang et al., 
1998; Herbert et al., 2000). Activation of either or both of these kinases may activate 
Mnkl/2 kinase, eventually phosphorylating eIF4E (reviewed in Pyronnet, 2000). In 
most viral infeetions, activation of this signalling pathway has been seen to occur via 
phosphorylation of extracellular signal-regulated kinase (ERK) and p38 kinase 
(Norman et al., 2004; reviewed in Mohr, 2006). This pathway has been extensively 
studied by researchers in an effort to understand the mechanism of eIF4E 
phosphorylation and the role played by this phosphorylation in the translation 
initiation process.
An initial investigation into the activation of MAP kinases during FCV infection 
found that ERK was phosphorylated early in infection but phosphorylated ERK 
decreased 4 h after infection (Figure 3.5A). Although activation of ERK does not
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seem to be required for FCV infection as it was dephosphorylated later in infection, I 
hypothesized that a sustained level of 4E-BP1 phosphorylation early in infection 
could be important in promoting viral replication. The reason for this is that 
ERK/MEK activation is not only important for phosphorylation of eIF4E but has also 
been reported to be important for synthesis of growth factors and cell entry when this 
activated ERK translocates from cytoplasm to nucleus (Brunet et al., 1999). ERK 
activation has also been reported to be required in cells infected with Kaposi’s 
sarcoma-associated herpes simplex virus type 1 (Qin et al, 2011). Inhibition of this 
pathway, using the inhibitor compounds PD l84352 and PD98059, reduced virus 
replication and supports the idea that activation of these kinases early in infection is 
important for FCV replication (Figures 3.6A and 3.8B).
The dephosphorylation of ERK was concomitant with an increase in p38, suggesting 
that FCV needs activation of p38 for replication (Figure 3.5B). However, I 
demonstrated that activation of p38 seems not to be required for FCV replication 
since inhibition of this kinase did not affect the virus titre (Figures 3.9B and 3.10A). 
Apart from its function in phosphorylating eIF4E through Mnkl/2, p38 activation 
has also been reported to be involved in the immune response of host cells to viral 
infection, being important for interferon (IFN) signalling (reviewed in Platanias, 
2003). Taken together, the data might suggest that the phosphorylation changes 
controlled by these kinases during infection could be necessary for the host-cell 
immune response rather than for viral replication.
However, activation of ERK and p38 kinase is important for eIF4E phosphorylation 
through activation of Mnkl/2. With binding sites located at the C-terminus of eIF4G,
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these kinases directly phosphorylate eIF4E when they are incorporated into the eIF4F 
complex (reviewed in Pyronnet, 2000). In normal infection, FCV causes 
dephosphorylation of Mnkl which is in contrast to the results of other virus infection 
studies (Banerjee et al., 2002; Schumann & Dobbelstein, 2006) (Figure 3.5C). In 
addition, inhibition of this kinase does not affect FCV replication (Figure 3.11 A). 
These results would imply that downregulation of Mnkl/2 kinase is probably 
necessary for FCV replication. CGP57380 is not thought to be completely specific. 
Apart from down-regulating Mnkl kinase, this compound has also been reported 
(Hou et ai, 2012) to inhibit Mnk2 and to cause deactivation of some other kinases. 
To control for these possible side-effects of Mnkl inhibition on FCV replication by 
CGP57380,1 used the compound SH-093. This compound has the same structure as 
CGP57380 but has no effect on Mnkl phosphorylation (Hou et al., 2012). 
Surprisingly, a decreased virus titre was observed with this inhibitor (Figure 3.1 IB). 
So, 1 may conclude that deactivation of Mnkl enhances FCV replication and the 
control experiment with SH-093 indicates that other factors might also play a role in 
viral replication.
Phosphorylation of 4E-BP1 is regulated by the mammalian target of rapamycin 
(mTOR) signalling pathway. FCV infection results in dephosphorylation of 4E-BP1 
late in infection (Section 3.2). So, mTOR activation during FCV infection was 
analysed and, as expected, mTOR phosphorylation shows the same pattern as for 4E- 
BPl phosphorylation with both proteins being dephosphorylated by 8 h after 
infection (Figure 3.12). Maintaining phosphorylation of 4E-BP1 early in infection 
probably induces the release of eIF4E from 4E-BP1 and allows eIF4E assembly with 
other initiation factors to form the eIF4F complex. The dephosphorylation of 4E-BP1
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later in infection might cause binding of the 4E-BP1 to the eIF4E, leading to 
disruption of the eIF4F complex, thus switching viral RNA translation to replication. 
Inhibition of mXOR during viral infection has also confirmed the hypothesis that this 
signalling pathway is important for viral replication (Figures 3.13B and 3.14).
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Introduction
The requirement of the translation initiation factor eIF4E has been shown to be vital 
for cap-dependent translation as this binding protein is required for recruiting the 
eIF4F complex to the cap-structure at the 5' end of the mRNA (reviewed in Borden 
et al, 2011). In addition, the presence of elF4E has also been reported to be a 
requirement for the VPg-dependent translation process of caliciviruses (Burrought & 
Brown, 1978). However, the requirement for elF4E and how it is regulated by its 
binding protein, 4E-BP1, during murine norovirus 1 (MNV) mRNA translation is 
still unclear. Although Chaudhry et al (2006) have reported that MNV VPg can 
interact directly with elF4E, unlike FCV that requires elF4E for its protein synthesis, 
MNV protein synthesis was observed to be unaffected by elF4E depletion in the 
presence of 4E-BP1, which suggests that VPg—elF4E interaction might not be 
required for MNV RNA translation. Therefore, further investigation is necessary to 
elucidate to what extent and to what purpose elF4E and 4E-BP1 are required for 
MNV RNA translation initiation. In this study, 1 began by analyzing the effect of 
MNV infection on the phosphorylation levels of elF4E and 4E-BP1 during the viral 
infection. Increased phosphorylation of elF4E has been reported to enhance binding 
of elF4E to the cap structure of the mRNA while for the 4E-BP1 (Minich et al., 
1994), the phosphorylation causes deactivation of the protein, which causes 
dissociation of the elF4E—4E-BP1 complex to release elF4E for formation of elF4F 
(Feigenblum & Schneider; 1996). Therefore, analysis of the phosphorylation of 
elF4E and 4E-BP1 is necessary to understand the requirement of the phosphorylation 
for MNV VPg-dependent translation. Further investigation was made into the
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signalling pathways that are involved in regulating these protein phosphorylation 
changes during MNV infection.
Results
4.1 Phosphorylation status of eIF4E following MNV infection
Activation of eIF4E has been reported to be regulated by phosphorylation of Ser209 
and this has been reported by some workers to affect the affinity of the eIF4F 
complex for the cap structure of the mRNA (Minich et al., 1994; Scheper et al.,
2002). However, Haghighat and Sonenberg (1997) reported that affinity of the elF4F 
complex for the cap structure is affected by the interaction between elF4G and elF4E 
but not by the phosphorylation of elF4E. In a previous study, we reported that 
although MNV VPg can interact directly with elF4E, depletion of elF4E by addition 
of 4E-BP1 did not affect MNV RNA (Chaudhry et al., 2006). Therefore, 1 was 
interested to investigate the effect of MNV infection on the phosphorylation of 
elF4E. In this study, 1 infected RAW 264.7 cells with MNV at a MOl of 10 and 
sampled cell lysates at 2, 6, 8 10 and 12 h post-infection. For control, 1 used 
uninfected cells harvested at 12 h. Samples were then fractionated by SDS-PAGE 
and immunoblotted with phospho-elF4E (Ser209) and total elF4E antisera.
Phosphorylation of elF4E was observed to increase 8 h after infection and sustained 
until 12 h after infection (Figure 4.1). In contrast, levels of total elF4E during 
infection remain constanst. GAPDH expression was monitored as a loading control 
and showed an even loading for each sample.
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Figure 4.1 Phosphorylation status of eIF4E following MNV infection
RAW 264.7 cells were infected with MNV at a MOI of 10 for 2, 6,8, 10 and 12 h. 
Control shows uninfected cells harvested at 12 hpi. Total protein from control and 
MNV-infected cells was separated by 10% SDS-PAGE and transferred by Western 
blot to PVDF membrane. The samples were immunoblotted with anti-elF4E antisera 
(total or phospho-specific). GAPDEI levels were monitored as a loading control. 
Detection was carried out with anti-horseradish peroxidase antibodies using Super 
Signal West Pico chemiluminescent substrate (Pierce Biotechnology) and Fuji 
radiographic film (New England Biolabs).
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4.2 Phosphorylation status of 4E-BP1 following MNV infection
Phosphorylation of eIF4E has been shown to occur when the protein forms part of 
the eIF4F complex, and complex formation is controlled by its regulator protein, 4E- 
BPl. In the hypophosphorylated form, 4E-BP1 actively binds and sequesters eIF4E, 
preventing formation of the eIF4F complex. In the presence of insulin, growth 
factors or viral infection, 4E-BP1 becomes hyperphosphorylated and dissociates 
from eIF4E (Gingras et al, 1996; Gingras et al, 1998; Heesom & Denton, 1999; 
Wang et aL, 2005). The free eIF4E and the other translation initiation factors, eIF4A 
and eIF4G are then able to form the eIF4F complex to initiate protein synthesis. In in 
vitro experiments, MNV translation was seen to be unaffected by eIF4E depletion 
although the MNV VPg can interact directly with eIF4E (Chaudhry et aL, 2006), 
suggesting that eIF4E is not required for MNV translation. In this study, I was 
interested to determine the effect of MNV infection on the phosphorylation of eIF4E. 
I infected RAW 264.7 cells with MNV at a MOI of 10 and collected cell lysates at 2, 
6 ,8,10 and 12 h post-infection. Uninfected cells harvested 12 h after infection were 
used as a control. I analysed phosphorylation of Ser65, Thr37/46 and Thr70 of 4E- 
BPl as these amino acids have been shown to be the main phosphorylation targets 
for 4E-BP1 (Gingras et aL, 1999; Haris & Lawrence, 2003; Hay & Sonenberg, 
2O&0.
As shown in Figure 4.2, MNV infection causes dephosphorylation of 4E-BP1 during
infection. The Ser65 residue was observed to be the first site targeted for
dephosphorylation as the phosphorylation level was already decreased 6 h after
infection. Unlike Ser65, dephosphorylation at Thr37/46 and Thr70 was seen to occur
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Figure 4.2 Phosphorylation status of 4E-BP1 following MNV infection
RAW 264.7 cells were infected with MNV at a MOI of 10 for 2, 6,8, 10 and 12 h. 
Control shows uninfected cells harvested at 12 hpi. Total protein from control and 
MNV-infected cells was separated by 17.5 % SDS-PAGE and transferred by 
Western blot to PVDF membrane. Then, the samples were immunoblotted with 4E- 
BPl antibodies (total or phospho-specific; Ser65, Thr37/46 and Thr70). GAPDH 
levels were monitored as a loading control. Detection was carried out with anti­
horseradish peroxidase antibodies using Super Signal West Pico chemiluminescent 
substrate (Pierce Biotechnology) and Fuji radiographic film (New England Biolabs).
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from 8 and 10 h after infection, respectively. The total levels of 4E-BP1 were 
maintained throughout the infection. GAPDH expression was monitored as a loading 
control and showed an even loading for each sample.
4.3 Effect of ultraviolet-inactivated MNV on eIF4E and 4E-BP1 
phosphorylation status
Viral infection and extracellular factors such as insulin, growth factors and phorbol 
esters have been reported to affect the phosphorylation status of eIF4E and 4B-BP1 
(reviewed in Joshi et aL, 1995; Hay & Sonenberg, 2004). Having demonstrated that 
a normal MNV-1 infection causes phosphorylation of eIF4E and dephosphorylation 
of 4E-BP1 late in infection, we hypothesized that these changes resulted from the 
effects of the viral RNA translation and replication processes on the cells. I used 
ultraviolet (UV)-treated MNV to infect RAW 264.7 cells. UV-inactivated virus is 
able to bind to, and enter, host cells but its RNA cannot be translated or replicated 
(Sanfilippo et al, 2004; Park et al, 2011). The viral inoculum was exposed to UV 
light at 254 nm for 4 min and inoculated into each well of a 24-well plate containing 
RAW 264.7 cells at a MOI of 10. Cell lysates and culture suspensions were collected 
at 2, 6, 8, 10 and 12 h post-infection for protein analysis and viral replication assay. 
Cell lysate samples were fractionated by 10% and 17.5% SDS-PAGE for eIF4E and 
4E-BP1, respectively. Samples were then immunoblotted using phospho-specific 
antibodies for phospho-eIF4E (Ser209) and phospho-4E-BPl (Ser65). GAPDH level 
was monitored as a loading control. To determine the effect of the UV treatment on 
viral replication, the virus titres of the culture suspension samples were estimated 
using TCIDso assay.
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As shown in Figure 4.3 A, infection of cells with UV-treated MNV did not cause any 
change to eIF4E phosphorylation throughout the infection. However, 
phosphorylation of 4E-BP1 was found to decrease in the same way as that observed 
during the untreated wild-type MNV infection Although UV treatment made no 
difference to 4E-BP1 phosphorylation, the viral replication was seen to be 
completely inhibited by the treatment. No viral replication was detected throughout 
the time-course experiment (Figure 4.3B). So, it would appear that 4E-BP1 
phosphorylation does not deerease in response to viral replication but might be 
caused by the presence of cytokines in the virus suspension used in this experiment 
or activation of specific signalling pathway triggered by binding of viruses to 
receptors at cell surface.
4.4 Effect of MNV infection on eIF4E and 4E-BP1 
phosphorylation in BV2 cells
As MNV infection causes phosphorylation of eIF4E and dephosphorylation of its 
binding protein, 4E-BP1, in RAW 264.7 cells, my hypothesis was that MNV 
infection might have similar effects on eIF4E and 4E-BP1 in other types of cell. I 
used murine microglial cells (BV2) in order to investigate whether the same 
phosphorylation effects might be observed with eIF4E and 4E-BP1 if the cells were 
infected with MNV. BV2 cells were infected with MNV at a MOI of 10 for 2, 6, 8, 
10 and 12 h. Control was represented by uninfected cells harvested 12 h after 
infection. In BV2 cells, I found that MNV had the same effect on 4E-BP1 as that
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Figure 4.3 The effect of UV-inactivated MNV on phosphorylation status of 
eIF4E and 4E-BP1 and viral replication
A) RAW 264.7 cells were infeeted with UV-inaetivated MNV at a MOI of 10 for 2, 
6, 8, 10 and 12 h. Control shows uninfected cells harvested 12 h after infection. Total 
protein from control and infected cells was separated by 10% and 17.5% SDS-PAGE 
for elF4E and 4E-BP1 respeetively, and transferred by Western blot to PVDF 
membrane. Samples were immunoblotted with phospho-elF4E (Ser209) and 
phospho-4E-BPl (Ser65). GAPDH level was monitored as a loading control. 
Detection was carried out with anti-horseradish peroxidase antibodies using Super 
Signal West Pico chemiluminescent substrate (Pieree Biotechnology) and Fuji 
radiographic film (New England Biolabs) B) RAW 264.7 cells were infected with 
MNV and UV-treated MNV. Culture samples were colleeted at the times indicated 
and viral titre was estimated by TCID50 assay. Virus titres: ■, control (wild type 
MNV); • , UV-inactivated MNV.
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observed in RAW 264.7 cells. Surprisingly, a constant phosphorylation level for 
eIF4E at Ser209 was observed throughout the infection, suggesting that the 
phosphorylation changes to eIF4E observed during normal infection in RAW 264.7 
cells are not part of the MNV infection strategy but that the different effects 
observed in these two cell lines may represent different host-cell responses (Figure 
4.4).
4.5 Effect of MNV infection on MAPK kinases (ERK, p38 and 
Mnkl)
Phosphorylation of eIF4E has been shown to be regulated by the MAP kinase 
(MAPK) signalling pathway (reviewed in Pyronnet et aL, 2000; Walsh & Mohr, 
2004; Shvevgert et al, 2010). The phosphorylation changes are controlled by the 
activation of MAP kinases, specifically the extracellular signal-regulated kinase 
(ERK), p38 and Mnkl/2. Having demonstrated that MNV infection in RAW 264.7 
cells caused phosphorylation of eIF4E late in infection, I was interested to 
investigate the signalling pathways involved in controlling these phosphorylation 
changes.
I began by analysing the effect of MNV infection on ERK, p38 and Mnkl 
phosphorylation. Cell lysate samples were collected over a time-course of MNV 
infeetion of RAW 264.7 cells and the samples were analysed by immunoblotting 
with phospho-specific antibodies: phospho-ERKl/2 (Thr202/204); phospho-p38 
(Thrl 80/Try 182); and phospho-Mnkl (Thrl 97/202).
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Figure 4.4 Phosphorylation status o f eIF4E and 4E-BP1 following M NV
infection in BV2 cells
BV2 cells were infected with MNV at a MOI of 10 for 2, 6, 8, 10 and 12 h. Control 
shows uninfected cells harvested at 12 h after infeetion. Total protein from control 
and infected cells was separated by SDS-PAGE and transferred by Western blot to 
PVDF membrane. The samples were then analyzed by immunoblotting with 
phospho-elF4E (Ser209) and phospho-4E-BPl (Ser65) antisera. GAPDH level was 
monitored as loading eontrol. Detection was carried out with anti-horseradish 
peroxidase antibodies using Super Signal West Pico chemiluminescent substrate 
(Pieree Biotechnology) and Fuji radiographic film (New England Biolabs).
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As shown in Figure 4.5, phosphorylation of ERK was maintained throughout MNV 
infection. Increased phosphorylation of p38 was observed at 10 h after infection, 
suggesting that MNV induces activation of p38 for phosphorylation of eIF4E.
Surprisingly, since having shown that MNV inceases phosphorylation of elF4E, I 
found that phosphorylation of Mnkl gradually decreased over the course of the 
infection. This observed effect is contras to the results of other viral infection studies 
where Mnkl kinase has been reported to be phosphorylated in infected cells 
(Banerjee et al, 2002; Schumann & Dobbelstein, 2006). As with FCV, future work 
will investigate the role of Mnk2 as Mnkl does not appear likely to be responsible 
for eIF4E phosphorylation during MNV infection either.
4.6 Effect o f inhibition of E R K /M E K  on MNV replication and  on 
M n k l and eIF4E phosphorylation
Activation of ERK is regulated by a phosphorylation process in response to growth 
factors or phorbol esters. It is important for regulating cell growth and survival, cell 
proliferation and RNA transcription (Wang et a l, 1998; reviewed in Johnson and 
Lapadat, 2002; Zhao et al, 2003). As shown before, MNV infection maintains 
phosphorylation of ERK and the level was observed to be sustained until 12 h after 
infection. My hypothesis was that maintenance of ERK activation during MNV 
infection might be required for viral replication. To investigate this, I used a 
MEKl/2 inhibitor, PD184352, which not only blocks MEKl/2 activation but also 
that of the downstream effectors, ERK 1/2. Deactivation of these therefore blocks 
signal transduction in this pathway (Allen et aL, 2003). I analysed the toxicity of
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Figure 4.5 Effect o f M NV infection on M AP kinases (ERK, p38 and M n k l)
RAW 264.7 cells were infeeted with MNV and harvested in lysis buffer at 2, 6, 8, 10 
and 12 h after infection. Control shows uninfected cells harvested at 12 h after 
infection. Samples were separated by 10% SDS-PAGE and transferred by Western 
blot to PVDF membrane. Samples were analysed by immunoblotting with A) 
phospho-ERK (Thr202/Try204) and total ERK; B) phospho-p38 (Thrl 80/Tyr82) and 
total p38; and C) phospho-Mnk-1 (Thr 197/202) and total Mnkl, antisera 
respectively. Detection was carried out with anti-horseradish peroxidase antibodies 
using Super Signal West Pico chemiluminescent substrate (Pierce Biotechnology) 
and Fuji radiographic film (New England Biolabs).
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PD 184352 on RAW 264.7 cells to ensure that the compound has no adverse effect. 
The cells were treated with PD 184352 at concentrations of 5, 25, 50 and 75 pM and 
incubated for 12 h. The treated RAW 264.7 cells were analysed using the 
Cytotoxicity Detection Kit^^^  ^ (LDH: Roche Applied Science) by measuring lactate 
dehydrogenase (LDH) activity released from damaged cells. This toxicity test was 
chosen because LDH is an enzyme present in major organ systems that is released 
into peripheral blood by the death of cells. Therefore, LDH activity can provide an 
indicator of toxicity of compounds in cells (reviewed in Drent et aL, 2006). Figure 
4.6A shows that PD 184352 has toxic effect on RAW 264.7 cells at high 
concentrations. Having confirmed that PD 184352 does not kill RAW 264.7 cells, I 
further investigated the effect of MEKl/2 inhibition on MNV replication. RAW 
264.7 cells were treated with PD 184352 at concentrations of 5, 25, 50 and 75 pM 
and infected with MNV at a MOI of 0.3 for 12 h. 1 had previously used a MOI of 3 
on all cell signalling inhibition tests, but then I decided to use a MOI of 0.3 as it 
allowed better discrimination of the effects of cell signalling inhibition on viral 
replication.
Viral titres from culture supernatant samples eollected after 12 h were estimated by 
TCIDso assay. As shown in Figure 4.6B, MNV replication is significantly inhibited 
even at lower concentrations, suggesting that MEKl/2 activation during MNV 
infection is essential for viral replication.
To look at the effects of MEKl/2 inhibition in more detail, we also carried out a
time-course experiment to determine the viral growth in cells in the presence of 50
pM of MEKl/2 inhibitor and the effect of inhibition on phosphorylation of Mnkl
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Figure 4.6 Effect o f inhibition o f M EK on M NV replication
A) RAW 264.7 cells were treated with MEK inhibitor (PD 184352) at the indicated 
eoncentrations or with 1% DMSO as a inhibitor control for 12 h. Control sample 
shows eells treated with Triton X-100 to release the highest level of lactate 
dehydrogenase (LDH) released. LDH released from dead or damaged cells was 
measured using Cytotoxicity Detection Kit’^^^  (LDH: Roche Applied Seience) B) 
RAW 264.7 cells were pre-treated with MEK inhibitor (PD184352) or DMSO as 
control at the indicated coneentrations for one hour. The cells were subsequently 
infected with MNV at a MOI of 0.3 for 12 h. Virus titre was estimated using the 
TCIDso assay. Shown are the means +/- SEM from three separate experiments, 
*p<0.01, **p<O.OOI (I-tailed Student / test).
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and eIF4E. The virus growth curves (Figures 4.7A) show that MNV replication 
which is observed after 8  h in untreated cell is inhibited in PD 184352-treated cells. 
This result confirms that MNV replication requires activation of MEKl/2. As well as 
demonstrating that inhibition of MEKl/2 affected MNV replication, interestingly I 
found that phosphorylation of Mnkl and elF4E was exactly as observed in normal 
MNV infection without the MEKl/2 inhibition (Figure 4.7B). Since all cells were 
pre-treated with PD 184352, no phosphorylated form of elF4E was observed in 
control sample as compared to the experiment in the absence of PD 184352. It is 
showing that the phosphorylation of elF4E could be important for RAW 264.7 cells 
growth. These results suggest that for MNV, activation of the MEKl/2 is important 
for viral replication but for host-cells, the role played by the kinase activation in cell 
defence remains to be determined.
Having shown that MNV infection requires the activation of MEKl/2, I 
hypothesized that signalling transduction via the extracellular signal-regulated 
transduction pathway is important for MNV replication. Therefore, the requirement 
of this signalling pathway activation for MNV replication were further analysed 
using another inhibitor, PD98059 (reviewed in English & Cobb, 2002) that 
specifically blocks the activation of the MEKl/2 downstream effector, ERK. 
Toxicity testing of PD98059 on RAW 264.7 cells verified that at 25, 50, 75 and 100 
pM concentrations the compound has no toxic effect on host cells (Figure 4.8A). As 
shown in Figure 4.8B, inhibition of ERK signalling by PD98059 at concentrations 
of 25, 50, 75 and 100 pM causes significant reduction in MNV replication at all 
concentrations, confirming that extracellular signal-regulated kinases (ERK/MEK) 
play a role in promoting viral growth.
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Figure 4.7 Effect of MEK inhibition on Mnkl and eIF4E phosphorylation and 
virus titre in MNV infected cells
A) RAW 264.7 cells were treated with MEKl/2 inhibitor (PD 184352) at 50|aM or 
with 1% DMSO alone as a control and infected with MNV at a MOI of 0.3. Culture 
supernatant samples were colleeted at 2 , 6 , 8 , 1 0  and 1 2  h after infeetion and virus 
titres were estimated by TCID50 assay. Shown are the means +/- SD from three 
separate experiments. Significant reduction at 12 hpi is based on t-test of normalized 
data. *p<0.001 (1-tailed Student t test) B) RAW 264.7 cells were treated with 
MEKl/2 inhibitor (PD 184352) at 50pM and 1% DMSO and infected with MNV for 
2, 6 , 8 , 10 and 12 h at a MOI of 10. Control shows uninfected cells that were 
harvested at 8  hpi. Total protein from control and MNV-infected cells was separated 
by 10% SDS-PAGE and transferred by Western blot to PVDF membrane. Samples 
were immunoblotted with phospho-Mnkl (Thrl97/202) and phospho-eIF4E 
(Ser209) antibodies. Detection was carried out with anti-horseradish peroxidase 
antibodies using Super Signal West Pico chemiluminescent substrate (Pierce 
Biotechnology) and Fuji radiographic film (New England Biolabs).
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Figure 4.8 Effect of ERK inhibition on MNV replication
A) RAW 264.7 eells were treated with ERK inhibitor (PD98059) at the indicated 
eoncentrations or with 1% DMSO alone for 12 h. The control sample shows cells 
treated with Triton X-100 to release the highest level of lactate dehydrogenase 
(LDH) released. LDH released from dead or damaged cells was measured using the 
Cytotoxicity Detection Kit^^^  ^ (LDH: Roche Applied Seience) B) RAW 264.7 eells 
were pre-treated with PD98059 or DMSO alone as control at the indicated 
concentrations for one hour. The cells were subsequently infeeted with MNV at a 
MOI of 0.3 for 12 h. Virus titre was estimated using the TCID50 assay. Shown are 
the means +/- SEM from three separate experiments, *p<0.01 (1-tailed Student t 
test).
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4.7 The effect of p38 inhibition on MNV replication and on Mnkl 
and eIF4E phosphorylation
Viral infection usually causes activation of p38 in host cells, thus promoting viral 
replication (Norman et al, 2004; Walsh & Mohr, 2004; Khatri & Sharma, 2006; 
Kono et ah, 2008) and cell apoptosis (Mortola & Larsen, 2010; Nakatsue et aL, 
1998; Su et al, 2002). MNV causes activation of p38 at Thrl80/Tyrl82 late in 
infection. As this increase in p38 phosphorylation was observed to occur after 
dephosphorylation of ERK, it was hypothesized that MNV switches over from 
activation of ERK to activation of p38 as part of the strategy for promoting the viral 
replication but the observed effect could also result from the host-eell immune 
system response. To investigate this, a pyrinidyl imidazole compound, SB203580, 
was used to block activation of p38 (Young et al, 1997). First, the toxicity of the 
compound was tested at 1, 5, 10 and 25 pM coneentrations on RAW 264.7 cells to 
ensure that the compound does not kill the cells. As shown in Figure 4.9, SB203580 
has no toxic effect on RAW 264.7 cell at these concentrations. Next, the effect of the 
compound on MNV replication was investigated using the method detailed in 
Section 2.10. MNV replication was found to be significantly inhibited by SB203580 
at coneentrations of 5 pM and above. Furthermore, the viral growth curves (Figure 
4.10A) confirm that MNV requires activation of p38 for its replication as in the 
presence of SB203580, viral replication started to be inhibited as early as 6 h after 
infection as compared with the control lacking the compound.
Since inhibition of p38 decreased viral replication, I decided to investigate whether 
this inhibition might also affect phosphorylation of Mnkl and eIF4E. In the presence
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Figure 4.9 Effect of p38 inhibition on MNV replication
A) RAW 264.7 cells were treated with p38 inhibitor (SB203580) or with 1% DMSO 
alone for 12 h. Control sample shows eells treated with Triton X-100 to release the 
highest level o f lactase dehydrogenase (LDH) released. LDH released from dead or 
damaged cells was measured using Cytotoxicity Detection Kit^^^^ (LDH: Roche 
Applied Scienee) B) RAW 264.7 cells were pre-treated with SB203580 and DMSO 
as control at the indicated coneentrations for one hour. The eells were subsequently 
infected with MNV at a MOI o f 0.3 for 12 h. Virus titre was estimated using the 
TCID 50 assay. Shown are the means +/- SEM from three separate experiments, 
*p<0.01, **p<0.001 (1-tailed Student 7 test).
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Figure 4.10 Effect of p38 inhibition on MNV replication and phosphorylation of 
Mnkl and eIF4E
A) RAW 264.7 cells were treated with p38 inhibitor (SB203580) at lOpM or with 
1% DMSO alone as a control and infected with MNV at a MOI of 0.3. Culture 
supernatant samples were collected at 2 , 6 , 8 , 1 0  and 1 2  h after infection and virus 
titres were estimated by TCID50 assay. Shown are the means +/- SD from three 
independent experiments. Significant reductions at 8 , 10 and 12 hpi are based on t- 
test of normalized data. *p<0.01, **p<0.001 (1-tailed Student t test) B) RAW 264.7 
cells were treated with p38 inhibitor (SB203580) at lOpM and infected with MNV 
for 2, 6 , 8 , 10 and 12 h at a MOI of 10. Control shows uninfected cells that were 
harvested at 8  hpi. Total protein from control and MNV-infected cells was separated 
by 10% SDS-PAGE and transferred by Western blot to PVDF membrane. Samples 
were immunoblotted with phospho-Mnkl (Thrl97/202) and phospho-elF4E 
(Ser209) antibodies. Detection was carried out with anti-horseradish peroxidase 
antibodies using Super Signal West Pico chemiluminescent substrate (Pierce 
Biotechnology) and Fuji radiographic film (New England Biolabs).
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of the SB203580 (Figure 4.10B), Mnkl is dephosphorylated at 8 h after infection. 
This finding is similar to that observed in other MNV infection experiments either 
without any inhibitor treatment or with PD 184352. However, the phosphorylation 
level of elF4E was found to remain fairly constant throughout the MNV infection, 
whereas in the absence of the inhibitor, MNV infection increases phosphorylation of 
eIF4E, suggesting that signal transduction via the p38 pathway is required both for 
phosphorylation of elF4E and for MNV replication.
4.8 Effect of Mnkl/2 inhibition on MNV replication
Mnkl and Mnk2 interact with eIF4G at the C-terminus of the scaffold protein and 
have been reported to be responsible for the phosphorylation of eIF4E in the eIF4F 
complex (Waskiewicz et al, 1999; Scheper et al., 1999; Pyronnet et al., 2001). 
Activation of Mnk by phosphorylation at Thrl 97/202 as a result of either ERK or 
p38 activation leads to phosphorylation of eIF4E. So, having demonstrated that 
inhibition of the ERK/MEK and p38 pathways significantly reduced MNV 
replication, my hypothesis was that inhibition of Mnkl might also affect viral 
growth. To investigate this, I used CGP 57380 to inhibit activation of Mnkl/2 (Bain 
et al, 2007). RAW 264.7 cells were treated with CGP 57380 and infected with 
MNV for 12 h. Culture supernatants were collected 12 h after infection and the viral 
titres were estimated by TCID50 assay. Surprisingly, CGP 57380 was found to 
increase MNV virus titre, suggesting that inhibition of Mnkl/2 enhances MNV 
replication (Figure 4.11 A).
155
Chapter 4 The effect of MNV infection on eIF4E and 4E-BP1
B
1000
800 -
® 600 - 
Ia 400
200  -
DMSO 10
CGP57380 (laM)
120 1
l li
100  -
80
60 -
40 ■
20
n.s n.s
n .s
f'
%
■ 1
-I.
: 1 !»■ ' '' yp. k
' ^
DMSO 10 20 
SHN-093 (uM)
40
Figure 4.11 Effect of Mnkl/2 inhibition on MNV replication
RAW 264.7 cells were pre-treated with A) Mnkl/2 inhibitor (CGP57380); B) Mock 
Mnkl/2 inhibitor (SHN-093) at the indicated concentrations or with 1% DMSO 
alone as control for an hour. Then, the cells were infected with MNV at a MOI of 3 
for 12 h. Virus titre was estimated using the TCID50 assay. Shown are the means +/-
SEM from three separate experiments. 
Student t test).
'p < 0 .0 1 , n.s: not significant ( 1 -tailed
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Since MNV replication was increased by CGP 57380 treatment, I used a mock 
Mnkl/2 inhibitor, SHN-093, to carry out a negative control experiment. SHN-093 
has the same chemical structure as CGP 57380 except for a methyl group (CH3) 
instead of a hydrogen atom at one position. It has been demonstrated to have the 
same inhibitory effect on kinases as CGP 57380 except for the Mnkl/2 kinases (Hou 
et aL, 2012). SHN-093 was used to analyse whether the observed results from the 
inhibition test with CGP 57380 were due to inhibition of Mnkl/2 or in fact, the 
inhibition of other kinases. The results showed that SHN-093 had no effect on MNV 
growth as compared with a control experiment using untreated cells (Figure 4.11B), 
supporting my results with the CGP 57380 inhibitor that inhibition of Mnkl/2 does 
indeed promote MNV replication.
4.9 Inhibition of the mTOR pathway in MNV infected cells
The mammalian target of rapamycin (mTOR) signalling pathway is known to 
regulate phosphorylation of 4E-BP1 which in turn acts to regulate formation of the 
elF4F complex by controlling the availability of eIF4E. Since MNV infection was 
shown to result in dephosphorylation of 4E-BP1, my hypothesis was that these 
changes might be controlled via mTOR activation. I carried out a time-course 
experiment and analysed activation of mTOR during MNV infection. As expected, 
mTOR showed the same pattern of dephosphorylation as that for 4E-BP1. The level 
of total mTOR was maintained during infection indicating that dephosphorylation of 
mTOR occurs due to the viral infection and not mTOR degradation, and this result 
parallels the observed decrease in 4E-BP1 phosphorylation (Figure 4.12).
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Figure 4.12 Effect of MNV infection on mTOR activation
RAW 264.7 cells were infected with MNV at a MCI of 10 for 2, 6,8, 10 and 12 h. 
Control shows uninfected cells harvested at 12 h after infection. Total protein from 
control and MNV-infected cells was separated by 10% and 17.5% SDS-PAGE for 
mTOR and 4E-BP1 respectively, and transferred by Western blot to PVDF 
membrane. Samples were analysed by immunoblotting with phospho-4E-BPl 
(Ser65), phospho-mTOR (Ser2448) and total mTOR antibodies. GAPDH levels 
were monitored as a loading control. Detection was carried out with anti-horseradish 
peroxidase antibodies using Super Signal West Pico chemiluminescent substrate 
(Pierce Biotechnology) and Fuji radiographic film (New England Biolabs).
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Since the mTOR pathway is activated during MNV infection, I hypothesized that 
signalling transduction via the mTOR pathway is crucial for MNV replication and 
that blocking the pathway might affect viral growth. To investigate this, mTOR 
activation was inhibited using the inhibitor KU0063794. KU0063794 was chosen 
instead of rapamycin since this compound has been identified to block mTORCl and 
mT0RC2 more effectively than rapamycin (Garcia-Martinez et al., 2009). 
Rapamycin has also been reported to inhibit mTORCl but it only has a weak effect 
on mTOR activity unless used over a longer exposure (Sabassov et al, 2006). We 
treated RAW 264.7 cells with KU0063794 at 5, 10 and 25 \iM concentrations and 
infected with MNV at a MOI of 0.3 for 12 h. Virus titres for culture supernatant 
samples collected at 12 h after infection were estimated by TCID50 assay. The results 
are presented graphically in Figures 4.13B and 4.14, and show that the mTOR 
inhibition significantly reduced MNV replication and that this effect can be observed 
as early as 6 h after infection. Taken together, the data show that the phosphorylation 
of 4E-BP1 during MNV infection is regulated by mTOR activation and is important 
in promoting viral replication.
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Figure 4.13 Effect of mTOR inhibition on MNV replication
A) RAW 264.7 cells were treated with mTOR inhibitor (KU0063794) at the 
indicated concentrations or with 1% DMSO alone for 12 h. Control sample shows 
cells treated with Triton X-100 to release the highest level of lactate dehydrogenase 
(LDH) released. LDH released from dead or damaged cells was measured using 
Cytotoxicity Detection Kit*’^ ^^  (LDH: Roche Applied Science) B) RAW 264.7 cells 
were pre-treated with KU0063794 or 1 % DMSO as control at the indicated 
concentrations for one hour. The cells were subsequently infected with MNV at a 
MOI of 0.3 for 12 h. Virus titre was estimated using the TCID50 assay. Shown are 
the means +/- SEM from three separate experiments, *p<0.01, **p<0.001 (1-tailed 
Student t test).
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Figure 4.14 Growth curves of MNV replication with mTOR inhibition
RAW 264.7 cells were treated with mTOR inhibitor (KU0063794) at lOpM or with 
1% DMSO alone as a control and infected with MNV at a MOI of 3. Culture 
supernatant samples were collected at 2 , 6 , 8 , 1 0  and 1 2  h after infection and virus 
titres were estimated by TCID50 assay. Shown are the means +/- SD from three 
separate experiments. Significant reductions at 8 , 10 and 12 hpi are based on t-test of 
normalized data. *p<0.001, **p<0.0001 (1-tailed Student f test).
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4.10 Discussion
Norovirus is a member of the calicivirus family and causes gastroenteritis in humans 
(reviewed in Thornton et al, 2004) and investigation into the calicivirus replication 
mechanism will provide knowledge and information that may lead to the control of 
viral infection and antiviral drug development. Murine norovirus 1 (MNV) has been 
used as a model for norovirus infection since its discovery in 2003 (Karst et aL,
2003) because human norovirus cannot be propagated efficiently in tissue culture 
(reviewed in Wobus et aL, 2006). Its 7.7 kb positive-sense single-stranded RNA 
possesses a viral protein (VPg) covalently linked to the 5' end (reviewed in 
Goodfellow, 2011) and this VPg has been reported to interact with the cellular 
translation initiation factor complex eIF4F. MNV VPg has been shown in GST-pull- 
down assays to interact with eIF3, eIF4GI and eIF4E (Daughenbaugh et aL, 2006). 
However, whereas FCV requires eIF4E for viral translation, depletion of eIF4E does 
not affect MNV RNA translation (Chaudhry et aL, 2006) and the role of eIF4E is 
therefore still unclear. Furthermore, neither the addition of 4E-BP1 nor cleavage of 
eIF4G by foot-and-mouth disease virus Lb protease affects MNV protein synthesis 
(Chaudhry et aL, 2006). Since eIF4E and 4E-BP1 have been shown to play roles in 
the cellular translation initiation process, I investigated the effect of MNV infection 
on eIF4E and 4E-BP1 to gain a better understanding of the eIF4E requirement in 
MNV VPg-dependent protein synthesis.
The effect of MNV infection on phosphorylation of eIF4E was first analysed and
MNV infection was found to increase phosphorylation of eIF4E (Figure 4.1). The
increase in phosphorylation was not observed until 8 h after infection. The same
effect has also been reported for other viruses such as hepatitis C virus type 1 (HCV-
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1) and visna virus (W ) where phosphorylation of eIF4E seems to be important for 
promoting formation of the eIF4F initiation complex for protein synthesis (Walsh & 
Mohr, 2004). Etowever, in some cases, viruses including adenovirus, 
encephalomyocarditis virus (EMCV), poliovirus and versicular stomatitis virus 
(VSV) have been reported to show dephosphorylation of eIF4E during infection 
which leads to inhibition of host cell protein synthesis (Kleijn et al, 1996; Zhang et 
aL, 1994; Cuesta et aL, 2000; Connor & Lyles 2002). To date, the effect of eIF4E 
phosphorylation on its binding to the calicivirus VPg remains to be determined.
The effect of MNV infection on the eIF4E regulator protein, 4E-BP1 was also 
analysed As explained in section Section 1.7.7, phosphorylation of 4E-BP1 at Ser65 
and Thr70 causes dissociation of the eIF4E and 4E-BP1 complex, which results in 
release of the eIF4E to form the eIF4F complex. Although phosphorylation also 
occurs at Thr37/46, this phosphorylation has been reported to have no effect on the 
eIF4E—4E-BP1 interaction but is important for subsequence phosphorylation, at 
Ser65 and Thr70 (Heensom & Denton, 1999). In this study, 4E-BP1 was found to be 
phosphorylated, and hence deactivated, early in MNV infection before becoming 
dephosphorylated later in infection (Figure 4.2). The deactivation of 4E-BP1 is 
thought to promote the availability of free eIF4E to participate in formation of the 
eIF4F complex which can then function in host-cell or viral RNA protein synthesis 
as reported in a number of studies (Gingras et aL, 1996; Gingras et aL, 1998; 
Heesom & Denton, 1999; Wang et aL, 2005). Here, dephosphorylation was observed 
to begin at Ser65 6  h after infection, and by 12 h after infection, 4E-BP1 was 
completely dephosphorylated. Dephosphorylation on Ser65 was followed by 
dephosphorylation on Thr37/46 and then on Thr70. Evidence for the hypothesis that
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MNV infection might be causing dephosphorylation of 4E-BP1 was provided by the 
results of our analysis of total 4E-BP1 during the infection. We found that the level 
of total 4E-BP1 was maintained throughout the infection, confirming that the 
decrease in phosphorylation was specific and was not a result of 4E-BP1 
degradation. On dephosphorylation, 4E-BP1 is activated and sequesters eIF4E 
(Feigenblum & Schneider, 1996) and this results in disruption of the eIF4F complex 
and inhibition of cap-dependent translation (Pyronnet et al, 2001). However, a 
previous work has shown that addition of 4E-BP1 did not affect MNV translation 
(Chaudhry et al, 2006), suggesting that dephosphorylation of 4E-BP1 may have 
little effect on MNV translation. In this study, analysis of mTOR activation has 
demonstrated that dephosphorylation of 4E-BP1 occurred at the same time as 
deactivation of mTOR. As shown in Figure 1.22, mTOR also plays a role in the 
activation of other proteins such as p70S6K, eIF4B and eIF4A. Since our earlier 
work has demonstrated that eIF4A is required for the translation of MNV RNA, I 
suggest that deactivation of mTOR may also affect eIF4A activity via p70S6K thus 
inhibiting MNV translation.
Phosphorylation of eIF4E and 4E-BP1 has been reported to be regulated by MAPK 
and mTOR signalling pathways respectively, in response to many factors including 
viral infection. The phosphorylation may occur through activation of receptors on the 
cell surface or as a response to viral replication within cells (Errico et aL, 2001; 
Barber et al, 2002). As MNV infection is accompanied by changes to the 
phosphorylation status of eIF4E and 4E-BP1, UV-treated MNV was used to validate 
my hypothesis that these changes occur in response to viral replication and not as a 
result of this binding to the cell. UV-treated MNV has shown no effect on the
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phosphorylation of eIF4E but dephosphorylation of 4E-BP1 was still observed. As 
UV treatment is thought to inhibit viral RNA translation and replication without 
affecting the virus binding to cell surface receptors (Sanfilippo et al, 2004; Park et 
al, 2011), I propose that the changes to 4E-BP1 phosphorylation in cells infected 
with UV-treated MNV might occur by binding of the virus to the host-cell receptor. 
To confirm that UV treatment of MNV prevents viral replication in cells, a time- 
course experiment was carried out to determine the virus growth curve. UV-treated 
MNV was found to unable to replicate in cells when compared with control 
untreated MNV. As mentioned in Section 2.5, I did not use purified virus for UV 
exposure because the virus inoculum I used in this study was taken directly from 
culture supernatant in normal infection. It is possible that cytokines present in this 
inoculum could cause activation of some receptors on the cell surface, leading to 
activation of signal transduction pathways within cells.
To investigate whether or not changes to eIF4E and 4E-BP1 phosphorylation during 
MNV infection in RAW264.7 cells are cell-specific, the effect of MNV infection on 
these proteins was analysed in a different macrophage cell line, murine microglial 
cells (BV2). As shown in Figure 4.4, MNV infection of these cells had no effect on 
phosphorylation of eIF4E but surprisingly 4E-BP1 becomes dephosphorylated 10 h 
after infection as was observed in RAW 264.7 cells. This suggests that the different 
effects observed may be cell-specific host defensive responses. Since MNV infection 
had different effects on the phosphorylation of eIF4E in different cell lines, I suggest 
that changes in eIF4E phosphorylation do not play any major role in MNV 
replication.
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Having demonstrated that MNV infection appears to stimulate an increase in the 
phosphorylation of eIF4E and a reduction in phosphorylation of the eIF4E-binding 
protein, 4E-BP1, late in infection, it seemed a good idea to investigate the signalling 
pathways involved in modulating these phosphorylation changes. First, the activation 
of the MAPK signalling pathway during MNV infection was analysed. As detailed in 
Section 1.7.4, phosphorylation of eIF4E is controlled by MAP kinases which 
become activated in response to many stimuli such as growth factors, phorbol esters, 
cytokines and viral infection (Wang et aL, 1998; Barber et aL, 2002; Regan et aL, 
2009). ERK, p38 and Mnkl/2 are reported to be the main kinases responsible for 
phosphorylation of eIF4E (reviewed in Pyronnet et a l, 2000). Interestingly, Wang et 
aL (2007a) have reported that inhibition of mTOR by rapamycin in human cancer 
cells could also mediate eIF4E phosphorylation through the activation of the Mnk 
kinases. They found that phosphorylation of elF4E could be enhanced when mTOR 
or its associated protein, raptor, or Mnkl/2 were knocked-down by siRNA, which 
demonstrated that activation of Mnkl and Mnk2 in cancer cells is PI3K/mT0R- and 
Mnkl/2-dependent.
In this study, it was found that over the course of MNV infection, phosphorylation of 
ERK was maintained suggesting that activation of ERK may be important for MNV 
replication. To test this idea, experiments we carried out using specific inhibitors of 
ERK and its upstream kinase, MEK: PD98059 and PD184352, respectively. 
Inhibition of either ERK or MEK was found to inhibit MNV replication (Figures 
4.6B and 4.8B), suggesting that replication of this virus requires activation of the 
ERK/MEK signalling pathway. In resting cells, the phosphorylation of ERK is 
thought to maintain cell growth because activation of the kinase has been reported to
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be involved in translation and regulation of activation of transcription factors such as 
Elk-1 (Gille et aL, 1995; reviewed in Johnson and Lapadat, 2002; Zhao et aL, 2003). 
Although activation of ERK has been shown to promote viral replication in the case 
of HCV-1, the role of this kinase during the viral life cycle is still unknown (Gretton 
et al, 2010). Based on my results, it is suggested that MNV maintains activation of 
ERK to promote replication of the virus.
Having demonstrated that phosphorylation of ERK was maintained at a more or less 
constant level during MNV infection, activation of another MAPK kinase, p38, was 
investigated. MNV infection was found to give rise to p38 activation late in 
infection. As shown in Figure 4.5B, a low phosphorylation level of p38 at 
Thrl81/Tryl82 residues at the outset rises above that seen in the resting cells by 10 h 
after infection. This increased phosphorylation observed later during infection might 
result from the cell defensive response because during normal viral infection, p38 is 
expected to be activated to stimulate the production of pro-inflammatory cytokines 
and control the interferon (IFN) cascade signalling pathway (Meusel & Imani, 2003; 
Hui et al, 2009; Regan et al, 2009). The inflammatory cytokines, IFNs, are 
produced and released by infected cells as a warning sign to neighbouring cells. 
Interactions between the cytokines and receptors on the neighbouring cells trigger 
antiviral and immune responses of host cells (Biron et aL, 1999). In addition to the 
role of p38 in cytokine production, activation of this kinase is considered necessary 
for mRNA translation through its activation of Mnkl/2 that are responsible for the 
phophorylation of the cap-binding protein, eIF4E (reviewed in Roux & Blenis,
2004). Since eIF4E becomes phosphorylated during MNV infection, the effect of 
inhibition of p38 activation on the viral replication was observed. Blocking
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activation of p38 using SB203580 demonstrated that replication of MNV is p38 
activation-dependent as the drug treatment of RAW 264.7 cells significantly reduced 
the viral replication even at low concentrations (p < 0.01) (Figure 4.9B). This 
supports the conclusion that phosphorylation of p38 during MNV replication may be 
important for both the host-cell immune responses and also for viral RNA 
replication.
Further investigation of the MAPKs involved in the phosphorylation of eIF4E was 
carried out by analysing the activation of the eIF4G-associated kinases, Mnkl/2. 
Scheper et al. (2001) have reported that Mnk2 kinase provides a better substrate than 
Mnkl for the phosphorylation of eIF4E. However, Mnkl has generally been 
considered as the main kinase responsible for the phosphorylation of eIF4E since it 
is normally present at a low level of basal activity, allowing it to be easily activated 
by stimuli, as opposed to Mnk2 that is normally present at a high level of basal 
activity (reviewed in Scheper & Proud, 2002). In contrast to other virus studies 
(Schumann & Dobbelstein, 2006; Banerjee et. al., 2002), I found that Mnkl became 
deactivated over the course of MNV infection (Figure 4.5C) and inhibition of the 
kinase using CGP57380 was observed to increase MNV replication (Figure 4.11A). 
In order to confirm that MNV replication was enhanced due to the inhibition of 
Mnkl/2, I carried out a control experiment using a mock Mnkl/2 inhibitor, SHN- 
093. Having an almost identical chemical structure to CGP 57380, this compound 
has been reported to have the same non-specific effects as CGP 57380 on other 
kinases but it does not inhibit Mnkl/2. As expected, treatment of RAW264.7 cells 
with SHN-093 had no effect on MNV replication as compared with an untreated 
sample (Figure 4.1 IB). Taken together, the data suggest that phosphorylation of
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eIF4E might be occurring through activation of Mnk2 because inhibition of Mnkl/2 
during MNV infection seems to be required for viral replication. In addition, 
increasing on Mnkl/2 deactivation enhanced replication of the virus which also 
suggests that this phenomenon must be important for the virus replication.
The mammalian target of rapamycin (mTOR) has been identified as a regulator in 
modulating activation of 4E-BP1 and also providing a major target for viruses to 
hijack the host-cell translation machinery during infection (detailed in Section 
1.7.8). Having demonstrated that MNV infection induces a decrease in 
phosphorylation of 4E-BP1 later in infection, it was of interest to analyse the mTOR 
signalling pathway during infection. As expected, a decrease in phosphorylation of 
mTOR during MNV infection was observed to mirror the pattern of 4E-BP1 
phosphorylation (Figure 4.12), indicating that this signalling pathway might be 
responsible for controlling virally induced 4E-BP1 activation. To further extend this 
analysis, a dose—response test and time-course experiment of mTOR deactivation 
were carried out by using KU0063794. In accordance with the hypothesis, MNV 
replication was significantly inhibited under conditions of mTOR inhibition (Figures 
4.13B and 4.14), confirming that the dephosphorylation of 4E-BP1 observed during 
MNV infection is under the control of the mTOR signalling pathway and that this 
change is important for viral replication, suggesting that a decrease in 
phosphorylation of 4E-BP1 might switch the viral RNA from translation to 
replication.
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Introduction
The association of eIF4E with eIF4G is important in translation initiation for the 
process whereby the eIF4F complex and ribosomal subunits are recruited to the 
mRNA. As explained in Section 1.5.3b, elF4E binds the mRNA cap-structure at the 
5' end of mRNA. Through its association with eIF4G, other factors involved in the 
translation initiation process are assembled at the cap structure (reviewed in Pestova 
et. al, 2007). The interaction between eIF4E and eIF4G is regulated by eIF4E- 
binding proteins, 4E-BPls. These proteins share the same binding domain region, 
Tyr-X4 -L- 0  (O denotes a hydrophobic amino acid) on eIF4E with eIF4G, leading 
them to compete with eIF4G for binding to eIF4E (Hershey & Merrick, 2000). 
Binding of eIF4G to eIF4E has been shown to increase eIF4F complex affinity for 
the cap structure of mRNA (Haghighat & Sonenberg, 1997). In other words, 
interaction between initiation factors in the eIF4F complex enhances the rate of 
complex recruitment to the mRNA.
In many virus infections, translation initiation factors such as eIF3, eIF5, eIF4A and 
eIF4G are targeted by viruses to shut off host-cell protein synthesis in order to 
promote viral protein synthesis. The enterovirus protease has been reported to cleave 
the cellular translation initiation factor, eIF5 (de Breyne et a l, 2008). The 
picomavirus FMDV protease has been shown to cleave eIF3 (Rodriguez Pulido et. 
al, 2007) and eIF4A (Belsham et al, 2000). eIF4G is the protein most targeted by 
viruses, usually involving cleavage by viral proteases. It has been reported to be 
cleaved by FMDV L protease during the FMDV infection (Belsham et aL, 2000). 
Other picomaviruses such as poliovirus (Haghighat et aL, 1996), coxsackievirus and
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rhinovirus (Lamphear et aL, 1993) use their protease, to cleave eIF4G into two 
fragments to shut off host-cell cap-dependent translation. In Haghighat’s study, they 
found that the interaction between eIF4E and eIF4G changes the conformation of 
eIF4G, thus making the eIF4G more susceptible to cleavage by rhinovirus 2A^ ™ 
(Haghighat et aL, 1996) to inhibit host-cell cap-dependent translation to promote 
their own IRES-dependent protein synthesis.
Ventoso et aL (2001) found three cleavage sites at positions 678, 681, and 1086 on 
eIF4GI that could be targeted by the retrovirus protease, HIV-1 protease (PR) to 
separate the three domains of eIF4G, thus efficiently inhibiting cap-dependent 
translation to promote HIV-1 IRES-dependent translation. Another study further 
showed that the HIV-1 PR cleaved eIF4GI more efficiently than eIF4GII. Although 
intact eIF4GII was present in the experiment, cleavage of the intact eIF4Gl alone by 
the HIV-1 PR was shown to inhibit cap-dependent protein synthesis significantly, 
suggesting that eIF4GI is important to sustain cap-dependent translation (Perales et 
aL, 2003). Cleavage of eIF4GI during HIV-2 infection has also been reported, and is 
similar to that of HIV-1, thereby inhibiting host-cell cap-dependent translation and in 
turn promoting HIV-1 IRES-dependent translation (Alvarez et aL, 2003).
Feline calicivirus has also been reported to cause cleavage of eIF4G later in infection 
(Willcocks et aL, 2004), resulting in inhibition of host-cell cap-dependent translation. 
Interestingly, intact eIF4G has been shown to be important for early infection in FCV 
VPg-dependent translation (explained further in Section 1.6.2). In contrast to FCV, 
MNV has been demonstrated not to require intact eIF4G. However, both FCV and 
MNV VPg-dependent translation have been reported to require the RNA helicase
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eIF4A, showing that caliciviruses have different overall requirements for translation 
initiation factors (^Chaudhry et al, 2006). Having demonstrated that eIF4E interacts 
directly with VPg in FCV and MNV RNA translation (Chaudhry et aL, 2006), it was 
of interest to investigate the requirement for an interaction between eIF4E and eIF4G 
to further dissect the requirement by these caliciviruses for translation initiation 
factors of the eIF4F complex. I used 4E2RCat (Cencic et aL, 2011) (gift from Prof. 
Jerry Pelletier, McGill University, Canada) to inhibit the interaction between eIF4E 
and eIF4G and observed the effect of this inhibition on replication in vivo.
Results
5.1 The effect of the eIF4E—eIF4G inhibitor (4E2RCat) on CRFK 
and RAW 264.7 cells
I began by testing for any cytotoxicity of 4E2RCat on CRFK and RAW264.7 cells. 
The cells were treated with 5, 10, 15, 25 and 50 pM 4E2RCat for 8  and 12 h, 
respectively. Tissue culture supernatant samples were collected and analysed for 
toxicity of the compound using the Cyotoxicity Detection Kit^^^^ (LDH: Roche 
Applied Science) by measuring LDH activity released from damaged cells. As 
shown in Figures 5.1A and B, 4E2RCat only exhibits toxic effect on CRFK or 
RAW 264.7 cells at high concentration (50pM), confirming that this compound does 
not kill these cells during the time period used for study of the viral infections.
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Figure 5.1 Test for cytotoxicity of 4E2RCat on CRFK and RAW 264.7 cells
A) CRFK and B) RAW264.7 cells were treated with 4E2RCat at the indicated 
concentrations. Culture supernatant samples were collected and toxicity of the 
compound on the cells was determined using Cytotoxicity Detection KitPLUS 
(LDH; Roche Applied Science) by measuring activity of lactate dehydrogenase 
(LDH) activity released from damaged cells. Data are normalised to the control 
values which are set to 1 0 0 % cell death.
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5.2 The effect of the eIF4E— eIF4G interaction inhibitor (4E2RCat) 
on protein synthesis in CRFK and RAW264.7 cells
As well as testing for any toxic effect of 4E2RCat on CRFK and RAW 264.7 cells, I 
have carried out another control experiment to confirm that the compound affects 
translation in both cell lines. A TCA precipitation experiment was carried out using 
labelling as detailed in Section 2.17. Using this method, proteins synthesized in 
the reaction were precipitated and labelled with methionine/cysteine and the 
incorporation of the radiolabel was measured to estimate the amount of protein 
synthesis. Protein synthesis in both CRFK and RAW 264.7 was found to be inhibited 
at concentrations above 10 and 15pM, respectively (Figures 5.2A and 5.3A).
5.3 The effect of the eIF4E—eIF4G interaction inhibitor (4E2RCat) 
on FCV and MNV replication
The effect of the 4E2RCat inhibitor on FCV and MNV replication was investigated 
as follows: both cell lines were treated with 5, 10, 15, 25 and 50 pM 4E2RCat and 
infected with FCV (MOI of 0.3) and MNV (MOI of 0.3) for 8  and 12 h, respectively. 
Virus titres in the supernatant samples collected from the infected cell cultures were 
estimated using TCID50 assay and shown graphically in Figures 5.2B and 5.3B. 
FCV replication was already significantly reduced by 4E2RCat at a concentration of 
5 pM (p<0.001. Student t test) (Figure 5.2B). At this concentration, MNV 
replication was not affected (Figure 5.3B). A decrease in MNV replication was only 
observed at higher concentrations (15 pM and above). However, at higher 
concentrations of the inhibitor the observed sensitivity of both FCV and MNV is
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Figure 5.2 Inhibition of FCV replication by eIF4E—eIF4G inhibitor
A) CRFK cells were treated with eIF4E—eIF4G interaction inhibitor (4E2RCat) or 
1% DMSO as control at the indicated eoncentrations for 8  h. The cells were then 
labelled with 35-S translabel and eell protein synthesis was measured by Liquid 
Scintillation Analyzer (Perkin Elmer Tri-Carb 2800TR Model). B) CRFK cells were 
pre-treated with 4E2RCat or DMSO as eontrol at the indicated concentrations for an 
hour. Then, the eells were infected with MNV at a MOI of 0.3 for 12 h. Virus titre 
was determined by TCID50 assay. Shown are the means +/- SEM from three separate 
experiments. *p<0.01, **p<0.001, ***p<0.0001(l-tailed Student  ^test).
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Figure 5.3 Inhibition of MNV replication by eIF4E—eIF4G inhibitor
A) RAW 264.7 cells were treated with eIF4E— eIF4G interaction inhibitor 
(4E2RCat) or 1% DMSO as control at the indicated concentrations for 12 h. The 
cells were then labelled with 35-S translabel and cell protein synthesis was measured 
by Liquid Scintillation Analyzer (Perkin Elmer Tri-Carb 2800TR Model). B) RAW
264.7 cells were pre-treated with 4E2RCat or DMSO as control at the indieated 
concentrations for an hour. Then, the eells were infeeted with MNV at a MOI o f  0.3 
for 12 h. Virus titre was determined by TCID 50 assay. Shown are the means +/- SEM 
from three separate experiments. *p<0.01, **p<0.001, ***p<0.0001 (1-tailed Student 
t test).
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likely to be as a result of the effect of 4E2RCat on the cells. These results suggest 
that the interaction between eIF4E and eIF4G is crucial for FCV but not MNV RNA 
translation.
5.4 Discussion
The rate of mRNA translation has been reported to be regulated by many factors 
including the binding of translation initiation factors, in the form of the eIF4F 
complex, to the cap structure of the mRNA, and the recruitment of ribosomal 
subunits to the mRNA (Pestova et aL, 2007). The interaction between eIF4E and 
eIF4G is not only required for the phosphorylation of eIF4E by Mnkl/2 located at 
the C-terminus of eIF4G (Pyronnet et aL, 1999), but the interaction between these 
two translation initiation factors has also been determined to increase eIF4E affinity 
for the cap structure of mRNA (Haghighat & Sonenberg, 1997).
Cencic et al (2007a and b) first identified an eIF4E—eIF4G inhibitor, namely 
4ElRCat that is able to block the interaction between these two eIF4F subunits, 
inhibiting cap-dependent translation of host cells. They used this compound on 
cancer cells and showed that it induced cell apoptosis, suggesting that targeting the 
eIF4F complex could have cancer therapy potential. Recently, the same group has 
used a second eIF4E—eIF4G inhibitor, 4E2RCat, to study the effect of inhibiting the 
eIF4E—eIF4G interaction on replication of human coronavirus 229E (HCoV-229E) 
and found that inhibition of the interaction significantly inhibited coronavirus 
replication (Cencic et aL, 2011).
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We have shown previously that FCV and MNV VPg interact with eIF4E directly, but 
eIF4E only seems to be important for FCV translation initiation, as depletion of 
eIF4E by addition of 4E-BP1 had no effect on MNV RNA translation (Chaudhry et 
al, 2006). Furthermore, cleavage of eIF4G into two fragments by FMDV Lb 
protease also affected only FCV translation but not MNV. However, both FCV and 
MNV have been shown to require the RNA helicase, eIF4A, to unwind the secondary 
structure of the viral RNA (Chaudhry et aL, 2006). Since FCV and MNV 
demonstrate different requirements for translation initiation factors (elFs), I was 
interested to further analyse the requirements for these eIF4F subunits by preventing 
the interaction between eIF4E and eIF4G using 4E2RCat.
I analysed the effect of 4E2RCat on FCV and MNV replication over a range of
concentrations and compared the results with the analysis of the 4E2RCat effect on
cap-dependent protein synthesis in both CRFK and RAW 264.7 cells. FCV
replication was found to be significantly inhibited by the compound at a 5 pM
concentration of the inhibitor. Cap-dependent translation was unaffected at this
concentration (Figures 5.2A and B). This suggests that FCV replication requires the
interaction between eIF4E and eIF4G to recruit other initiation factors in the eIF4F
complex to the viral VPg and supports our previous studies showing that eIF4E and
eIF4G are both required for FCV RNA translation (Chaudhry et aL, 2006). RAW
264.7 cell cap-dependent protein synthesis was not affected by the compound at low
concentrations but only above a concentration of 15 pM. Similarly, MNV replication
was only inhibited at concentrations above 15 pM, in contrast to the effect on FCV at
lower concentrations. These results support our previous study that the requirement
of eIF4E for VPg-dependent translation is critical for FCV translation but not for
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MNV translation (Goodfellow et aL, 2005). Again, these data support our previous 
results indicating that the eIF4E—eIF4G interaction is a requirement for FCV 
replication as compared with MNV, showing that caliciviruses have different 
requirements for the translation initiation factors necessary to synthesize their 
proteins.
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Conclusion
Noroviruses (NV) belong to the family Caliciviridae and are responsible for the 
majority of viral gastroenteritis worldwide. They have been reported to occur 
particularly in confined places such as hospitals and nursing homes (Schmid et aL,
2005), cruise ships (Cramer et aL, 2006), schools (Kim et aL, 2005) and restaurants 
(Baker et aL, 2010). Every year, there are about 21 million cases of norovirus 
infection in the United States of America (Hall, 2012) and two million in England 
(Phillips et aL, 2010). In England, this problem costs the National Health Service 
(NHS) alone about £100 million every year (Health Protection Agency, 2012). People 
infected with norovirus show symptoms such as vomiting, diarrhoea, nausea and fever 
(reviewed in Glass et aL, 2009). The costs associated with outbreaks of infection in 
adults and children have prompted researchers to investigate and develop new drugs 
and treatments for NV. Our study of the molecular biology of calicivirus infection has 
been foeused on the translation proeess, and has previously led to the discovery that 
caliciviruses have evolved a novel mechanism of protein synthesis. The positive-sense 
single-stranded calicivirus RNA genome has a viral protein, VPg, covalently linked to 
the 5' end and this protein is able to act as a proteinaceous cap substitute, thus 
enabling cap-independent translation (Burrough & Brown, 1978). Hence caliciviruses 
use a VPg-dependent mechanism to hijack the host-cell translation machinery for the 
synthesis of their viral proteins. I have used feline calicivirus (FCV) and murine 
norovirus (MNV) as models for calicivirus infection as, unlike NV, they are able to 
replicate efficiently in tissue culture.
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Although FCV and MNV both use VPg for assembly of the necessary initiation 
factors to recruit the ribosome to their RNA, the cellular initiation factors required by 
these viruses for their protein synthesis are not the same. In our previous study, in 
vitro, we have shown that eIF4E, eIF4A and eIF4G are required for FCV replication. 
MNV also requires eIF4A but has been shown not to require eIF4E or intact eIF4G 
for its translation. Depletion of eIF4E or cleavage of eIF4G by FMDV Lb protease 
into two functional fragments have been shown to have no effect on MNV RNA 
translation (Chaudhry et al., 2006). However, cleavage of eIF4G into three functional 
fragments using HIV2 protease, did inhibit MNV RNA translation suggesting that a 
particular fragment of eIF4G is required for translation (Royall, unpublished data) 
(Figure 6.1). In addition, PABP is cleaved during the later stages of FCV infection, 
which suggest that the presence of PABP is necessary for FCV replication early in 
infection (Kuyumcu-Martinez et al., 2004). Since we have demonstrated that FCV 
and MNV RNAs differ in their requirements for eIF4E, my work aimed to analyse 
further the effect of FCV and MNV infection on eIF4E and its regulator, 4E-BP1. In 
addition, I observed the effect of inhibition of the eIF4E-eIF4G interaction on FCV 
and MNV replication, to further define the requirements for the canonical translation 
initiation factors in the translation process of both viruses.
For the first time, my results showed an increased phosphorylation of eIF4E and a 
decreased phosphorylation of 4E-BP1 later in FCV and MNV infection. Different 
studies have reported different effects of the phosphorylation of eIF4E on its affinity 
for the cap structure and subsequently different effects on translation (Minich et al., 
1994; Wang et. al, 1998; Scheper et al., 2002; Furie et al, 2010). Therefore, the 
likely effect of this phosphorylation of eIF4E on viral protein synthesis is still
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uncertain and remains to be determined. To investigate this, we could carry out an in 
vitro experiment using phosphorylated and unphosphorylated forms of eIF4E 
(Scheper et a l, 2002) to analyse the effect of phosphorylation on the affinity of eIF4E 
for the viral VPg. Phosphorylation of 4E-BP1 has been shown to play a role in 
regulating the formation of the eIF4F complex. Dephosphorylation of 4E-BP1 causes 
activation of the eIF4E-binding protein which inhibits mRNA translation by 
sequestering eIF4E (Pyronnet et al, 2001). Here, it is suggested that 
dephosphorylation of 4E-BP1 might act to stop mRNA translation allowing a switch 
to transcription for the viral RNA. This idea is supported by our previous work 
showing that addition of 4E-BP1 inhibited translation of FCV RNA (Goodfellow et 
a/., 2005).
As well as studying the effect of FCV and MNV infection on eIF4E and 4E-BP1, I 
have also now analysed the signalling pathways involved in regulating 
phosphorylation of both proteins. Since eIF4E is phosphorylated via the mitogen 
activated protein kinase (MAPK) signalling pathway, I began by determining the 
activation of the MAP kinases -  extracellular signal-regulated kinase (ERK/MEK), 
p38 and Mnkl/2, which are upstream kinases of eIF4E. It was shown that MNV 
infection does not alter the phosphorylation level of ERK during infection, but the 
kinase was seen to become dephosphorylated late in FCV infection. Analysis using 
ERK and MEK inhibitors demonstrated that activation of these kinases is important 
for both FCV and MNV replication, but the specific roles of kinase activation during 
infection remains to be determined. For p38, both FCV and MNV infection were 
found to increase the phosphorylation of this kinase. However, only the replication of 
MNV was affected by a p38 inhibitor; FCV replication was not affected. From this, I
184
Chapter 6____________________________________________________ Conclusion
conclude that activation of p38 is required for MNV replication but not FCV 
replication. An increase in phosphorylated p38 later in infection might be important 
for the immune response of both CRFK and RAW 264.7 cells as reported for other 
cells infected with viruses (Khatri & Sharma, 2006; Cheung et. al., 2005). p38 
activation might be important for MNV because inhibition of p38 prevented an 
increase in eIF4E phosphorylation during MNV infection. Phosphorylation of eIF4E 
could potentially stimulate viral RNA translation.
Although we found that phosphorylation of eIF4E is increased later in FCV and MNV 
infection, the kinase responsible for this phosphorylation, Mnkl, was found to be 
deactivated during infection suggesting that Mnk2 might be responsible for 
phosphorylation of eIF4E. Interestingly, inhibition of Mnkl and Mnk2 was observed 
to increase MNV replication but had no effect on FCV replication. To further analyse 
the requirement for Mnkl and Mnk2 activation in the phosphorylation of eIF4E 
during replication of these caliciviruses, we could knock down the expression of these 
kinases using specific siRNAs to target either the Mnkl or the Mnk2 genes. This 
experiment might enable us to determine which kinase is responsible for eIF4E 
phosphorylation during calicivirus infection and to what degree Mnkl and Mnk2 
influence FCV and MNV replication.
My results also show that replication of FCV and MNV requires phosphorylation of 
4E-BPI. In this study, the phosphorylation changes to 4E-BP1 have been shown to 
occur through mTOR activation, and inhibition of this kinase affected the replication 
of both FCV and MNV. Although phosphorylation of 4E-BP1 was observed to
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decrease later in infection, maintenance of the phosphorylation level early in infection 
might help to provide free eIF4E (eIF4F) for translation.
Wang et al (2001) have reported crosstalk between the ERK/MEK and mTOR 
pathways, demonstrating that activation of ERK/MEK may regulate activation of 
p70S6K, a downstream kinase of mTOR. p70S6K is responsible for increasing 
protein biosynthesis by enhancing the helicase activity of eIF4A and stimulating 
ATPase via activation of eIF4B for recruitment of ribosomes to RNA (Rogers et al., 
2001; Rogers et al., 2002). Therefore, deactivation of ERK later in FCV infection 
may also act via this crosslink between the MAPK and mTOR signalling pathways, 
leading to the inhibition of host-cell and viral protein synthesis. To investigate this, 
we could look at the activation of p70S6K during viral infection and analyse the effect 
of inhibiting the ERK/MEK and mTOR pathways on p70S6K activation.
To summarise and integrate these data, I have put together models of the way in 
which calicivirus infection controls phosphorylation of eIF4E and 4E-BP1 by 
influencing the cellular MAPK and mTOR signalling pathways (Figure 6.1). Early in 
infection, FCV and MNV maintain the availability of the eIF4F complex and hijack 
the cellular machinery to translate their own mRNAs. Dephosphorylation of 4E-BP1 
occurs as mTOR is downregulated later in infection inhibiting formation of the eIF4F 
complex thus prompting a switch from translation to viral mRNA replication. My 
results indicate that phosphorylation of eIF4E occurs via activation of p38 and not 
ERK. The p38-activation requirements for both FCV and MNV replication are 
different because inhibition of p38 only inhibits MNV but not FCV replication.
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showing that different caliciviruses use different strategies to control MAPK 
signalling for their viral RNA replication.
Controlling these signalling pathways is important for the viral replication strategy 
since the host cells modulate the same pathways as the virus to elicit their immune 
responses to inhibit viral replication. Viruses have evolved a variety of ways to 
regulate the activation of specific pathways for promoting their replication (Cuesta et 
al, 2000; Moody et a l, 2005; O’Shea et a l, 2005a; O’Shea et al., 2005b; Yu et al., 
2005; Moorman et al., 2008; Chen et al., 2010; Peng et al, 2010; Chuluunbaatar & 
Mohr, 2011; George et a l, 2012). My investigation into the effects of FCV and MNV 
infection on mTOR and the MAP kinases has provided an insight into the 
mechanisms used by caliciviruses to modulate the cell signalling pathways during 
infection.
Finally, in chapter 5, 1 describe how my results show that the interaction of elF4E 
with elF4G is crucial for FCV RNA translation whereas for MNV translation, this 
interaction is not a requirement. These data support our previous study indicating that 
FCV and MNV have different requirements for translation initiation factors for their 
viral protein synthesis (Chaudhry et a l, 2006).
Overall, the future experiments set out here will help us to improve our understanding 
of the requirements for the canonical eukaryotic initiation factors in FCV and MNV 
RNA translation, and the cell signalling pathway requirements for both caliciviral 
RNA translation and calicivirus replication. This information will be important for 
designing antiviral strategies to combat these calicivirus infections.
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Appendix
TISSUE CULTURE
T rypsin/Versene solution
10ml of Trypsin 
100ml of Versene 
Stored at 4°C
CRFK and FEA cells growth medium
90ml Ix Eagles MEM with Earles salts 
10ml foetal bovine serum (FBS)
1ml Penicillin and Streptomycin (P/S)
1ml non-essential amino acids (NEAA)
Stored at 4°C
RAW 264.7 cells growth medium
90ml Dulbecco’s MEM with 4500 g/L Glucose 
10ml foetal bovine serum (FBS)
1ml Penicillin/streptomycin (P/S)
Stored at 4°C
BV2 cells growth medium
90 ml Dulbecco’s MEM with 4500 g/L Glucose 
10 ml foetal bovine serum (FBS)
I
1 ml Penicillin/streptomycin (P/S)
1 ml L-glutamine 
1 ml Sodium bicarbonate 
Store at 4°C
NLB Lysis Buffer
SOmMHEPES (pH 7.4)
ISOmMNaCl 
2mM EDTA 
2mM Na3V0 4  
25mM Glycerophosphate
Complete Mini Protease Inhibitor Cocktail (Roche) 
0.5 %NP40
0.1% Triton X-100
100 pi Triton X-100 (BDH Ltd)
100 ml mQH2 0
WESTERN BLOT
SDS-PAGE Running Buffer
3g Tris
14.4g Glycine (Sigma)
5ml 20% SDS (Sigma)
Make up to 1 L with mQH]0
II
Transferring Buffer
3g Iris 
14.4g Glycine
Make up to 800ml of mQHiO
200ml Methanol
Keep cool at 4°C before use.
Ammonium Persulfate (AP)
0.3 g of ammonium persulfate 
3 ml of mQHiO
PBS solution
PBS tablets (GibcoBRL)
Each tablet was dissolved in 100ml of mQH20 (pH 7.45) 
Stored at room temperature 
Stored at 4°C
Blocking Solution
5 g Marvel (milk powder)
100ml TBS Tween (0.1%)
10% Sodium Dodecyl Sulfate SDS 
lOg SDS
100ml mQH2 0
III
20% Sodium Dodecyl Sulfate SDS
20g SDS 
100ml mQH2 0
A X 2 buffer (resolving gel buffer): 500 ml
45.3g Tris 
500ml mQH20 
Adjust pH to pH8.8
B X 2 buffer (stacker gel buffer): 500 ml
15.12g Tris 
500ml mQH20 
Adjust pH to 6.8
lOX TBS-0.1% Tween
24.2 g Tris 
80 gNaCl
Dissolve in 800 ml mQH20 
Adjust pH to 7.6 
Add 10 ml Tween 20 
Make up to 1 L with mQH20 
Store at 4°C
IV
Resolving gels Stacking Gels
Content 10% 17.5% 4%
Sterile mQH20 4.5 ml 2.6 ml 3.7 ml
A X 2 10 ml 10 ml
B X 2 5 ml
Acrylamide: Bis 
40%
5 ml 8.75 ml 1 ml
10% SDS 200 pi 200 pi 100 pi
Ammonium
persulfate
200 pi 200 pi 100 pi
TEMED 50 pi 50 pi 30 pi
Acrylamide: Bis (Biorad)
Ammonium persulfate (Sigma)
TEMED (Sigma)
35-S LABELLING, TCA PRECIPITATION TEST
35-S labelling mixture
90 ml Met/Cys-free medium 
10 ml dialysed FBS 
1 ml Penicillin/streptomycin 
0.5 ml Gentamycin 
1 ml Glutamine 
35-S Labelling mixture
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